
<html lang="en"     class="pb-page"  data-request-id="357cd0c0-17b9-4504-8897-b7b732b424e3"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2011.54.issue-20;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/jm200855b"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of Isoxazole Analogues of Sazetidine-A as Selective α4β2-Nicotinic Acetylcholine Receptor Partial Agonists for the Treatment of Depression" /></meta><meta name="dc.Creator" content="Jianhua  Liu" /></meta><meta name="dc.Creator" content="Li-Fang  Yu" /></meta><meta name="dc.Creator" content="J. Brek  Eaton" /></meta><meta name="dc.Creator" content="Barbara  Caldarone" /></meta><meta name="dc.Creator" content="Katie  Cavino" /></meta><meta name="dc.Creator" content="Christina  Ruiz" /></meta><meta name="dc.Creator" content="Matthew  Terry" /></meta><meta name="dc.Creator" content="Allison  Fedolak" /></meta><meta name="dc.Creator" content="Daguang  Wang" /></meta><meta name="dc.Creator" content="Afshin  Ghavami" /></meta><meta name="dc.Creator" content="David A.  Lowe" /></meta><meta name="dc.Creator" content="Dani  Brunner" /></meta><meta name="dc.Creator" content="Ronald J.  Lukas" /></meta><meta name="dc.Creator" content="Alan P.  Kozikowski" /></meta><meta name="dc.Description" content="Depression, a common neurological condition, is one of the leading causes of disability and suicide worldwide. Standard treatment, targeting monoamine transporters selective for the neurotransmitte..." /></meta><meta name="Description" content="Depression, a common neurological condition, is one of the leading causes of disability and suicide worldwide. Standard treatment, targeting monoamine transporters selective for the neurotransmitte..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="September 30, 2011" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm200855b" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2011 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm200855b" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm200855b" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm200855b" /></link>
        
    
    

<title>Discovery of Isoxazole Analogues of Sazetidine-A as Selective α4β2-Nicotinic Acetylcholine Receptor Partial Agonists for the Treatment of Depression | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm200855b" /></meta><meta property="og:title" content="Discovery of Isoxazole Analogues of Sazetidine-A as Selective α4β2-Nicotinic Acetylcholine Receptor Partial Agonists for the Treatment of Depression" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm200855b/production/images/large/jm-2011-00855b_0004.jpeg" /></meta><meta property="og:description" content="Depression, a common neurological condition, is one of the leading causes of disability and suicide worldwide. Standard treatment, targeting monoamine transporters selective for the neurotransmitters serotonin and noradrenaline, is not able to help many patients that are poor responders. This study advances the development of sazetidine-A analogues that interact with α4β2 nicotinic acetylcholine receptors (nAChRs) as partial agonists and that possess favorable antidepressant profiles. The resulting compounds that are highly selective for the α4β2 subtype of nAChR over α3β4-nAChRs are partial agonists at the α4β2 subtype and have excellent antidepressant behavioral profiles as measured by the mouse forced swim test. Preliminary absorption, distribution, metabolism, excretion, and toxicity (ADMET) studies for one promising ligand revealed an excellent plasma protein binding (PPB) profile, low CYP450-related metabolism, and low cardiovascular toxicity, suggesting it is a promising lead as well as a drug candidate to be advanced through the drug discovery pipeline." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm200855b"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm200855b">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm200855b&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm200855b&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm200855b&amp;href=/doi/10.1021/jm200855b" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2011</span><span class="cit-fg-volume">, 54</span><span class="cit-fg-issue">, 20</span><span class="cit-fg-pageRange">, 7280-7288</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/54/20" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm2008419" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm200862h" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of Isoxazole Analogues of Sazetidine-A as Selective α4β2-Nicotinic Acetylcholine Receptor Partial Agonists for the Treatment of Depression</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jianhua++Liu">Jianhua Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Li-Fang++Yu">Li-Fang Yu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=J.+Brek++Eaton">J. Brek Eaton</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Barbara++Caldarone">Barbara Caldarone</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Katie++Cavino">Katie Cavino</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christina++Ruiz">Christina Ruiz</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Matthew++Terry">Matthew Terry</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Allison++Fedolak">Allison Fedolak</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daguang++Wang">Daguang Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Afshin++Ghavami">Afshin Ghavami</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David+A.++Lowe">David A. Lowe</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dani++Brunner">Dani Brunner</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ronald+J.++Lukas">Ronald J. Lukas</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alan+P.++Kozikowski">Alan P. Kozikowski</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Drug Discovery Program, Department of Medicinal Chemistry and Pharmacognosy, University of Illinois at Chicago, 833 South Wood Street, Chicago, Illinois 60612, United States</span></div><div class="aff-info" id="aff2"><span class="aff-text">Division of Neurobiology, Barrow Neurological Institute, 350 West Thomas Road, Phoenix, Arizona 85013, United States</span></div><div class="aff-info" id="aff3"><span class="aff-text">PsychoGenics, Inc., 765 Old Saw Mill River Road, Tarrytown, New York 10591, United States</span></div><div class="aff-info" id="aff4"><span class="aff-text">Department of Psychiatry, Columbia University, NYSPI, 1051 Riverside Drive, New York, New York 10032</span></div><div class="corresp-info">Phone +1-312-996-7577; fax +1-312-996-7107; e-mail <a href="/cdn-cgi/l/email-protection#294246534042465e48695c404a074c4d5c"><span class="__cf_email__" data-cfemail="8ae1e5f0e3e1e5fdebcaffe3e9a4efeeff">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm200855b&amp;href=/doi/10.1021%2Fjm200855b" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2011</span></span><span class="cit-volume">, 54</span><span class="cit-issue">, 20</span><span class="cit-pageRange">, 7280–7288</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 9, 2011</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>30 June 2011</li><li><span class="item_label"><b>Published</b> online</span>30 September 2011</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 27 October 2011</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm200855b" title="DOI URL">https://doi.org/10.1021/jm200855b</a></div><div class="article_header-article-copyright"><strong>Copyright © 2011 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7280%26pageCount%3D9%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJianhua%2BLiu%252C%2BLi-Fang%2BYu%252C%2BJ.%2BBrek%2BEaton%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D54%26issueNum%3D20%26contentID%3Djm200855b%26title%3DDiscovery%2Bof%2BIsoxazole%2BAnalogues%2Bof%2BSazetidine-A%2Bas%2BSelective%2B%25CE%25B14%25CE%25B22-Nicotinic%2BAcetylcholine%2BReceptor%2BPartial%2BAgonists%2Bfor%2Bthe%2BTreatment%2Bof%2BDepression%26numPages%3D9%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7288%26publicationDate%3DOctober%2B2011">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm200855b"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2305</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">55</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm200855b" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of Isoxazole Analogues of Sazetidine-A as Selective α4β2-Nicotinic Acetylcholine Receptor Partial Agonists for the Treatment of Depression&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Jianhua&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Li-Fang&quot;,&quot;last_name&quot;:&quot;Yu&quot;},{&quot;first_name&quot;:&quot;J.&quot;,&quot;last_name&quot;:&quot;Brek Eaton&quot;},{&quot;first_name&quot;:&quot;Barbara&quot;,&quot;last_name&quot;:&quot;Caldarone&quot;},{&quot;first_name&quot;:&quot;Katie&quot;,&quot;last_name&quot;:&quot;Cavino&quot;},{&quot;first_name&quot;:&quot;Christina&quot;,&quot;last_name&quot;:&quot;Ruiz&quot;},{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;Terry&quot;},{&quot;first_name&quot;:&quot;Allison&quot;,&quot;last_name&quot;:&quot;Fedolak&quot;},{&quot;first_name&quot;:&quot;Daguang&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Afshin&quot;,&quot;last_name&quot;:&quot;Ghavami&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;A. Lowe&quot;},{&quot;first_name&quot;:&quot;Dani&quot;,&quot;last_name&quot;:&quot;Brunner&quot;},{&quot;first_name&quot;:&quot;Ronald&quot;,&quot;last_name&quot;:&quot;J. Lukas&quot;},{&quot;first_name&quot;:&quot;Alan&quot;,&quot;last_name&quot;:&quot;P. Kozikowski&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2011&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;30&quot;,&quot;issue&quot;:&quot;20&quot;,&quot;volume&quot;:&quot;54&quot;,&quot;pages&quot;:&quot;7280-7288&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm200855b&quot;},&quot;abstract&quot;:&quot;Depression, a common neurological condition, is one of the leading causes of disability and suicide worldwide. Standard treatment, targeting monoamine transporters selective for the neurotransmitters serotonin and noradrenaline, is not able to help many patients that are poor responders. This study advances the development of sazetidine-A analogues that interact with α4β2 nicotinic acetylcholine receptors (nAChRs) as partial agonists and that possess favorable antidepressant profiles. The resulting compounds that are highly selective for the α4β2 subtype of nAChR over α3β4-nAChRs are partial agonists at the α4β2 subtype and have excellent antidepressant behavioral profiles as measured by the mouse forced swim test. Preliminary absorption, distribution, metabolism, excretion, and toxicity (ADMET) studies for one promising ligand revealed an excellent plasma protein binding (PPB) profile, low CYP450-related metabolism, and low cardiovascular toxicity, suggesting it is a promising lead as well as a drug candidat&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm200855b&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm200855b" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm200855b&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm200855b" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm200855b&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm200855b" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm200855b&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm200855b&amp;href=/doi/10.1021/jm200855b" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm200855b" /></input><a href="/doi/pdf/10.1021/jm200855b" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm200855b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm200855b%26sid%3Dliteratum%253Aachs%26pmid%3D21905669%26genre%3Darticle%26aulast%3DLiu%26date%3D2011%26atitle%3DDiscovery%2Bof%2BIsoxazole%2BAnalogues%2Bof%2BSazetidine-A%2Bas%2BSelective%2B%25CE%25B14%25CE%25B22-Nicotinic%2BAcetylcholine%2BReceptor%2BPartial%2BAgonists%2Bfor%2Bthe%2BTreatment%2Bof%2BDepression%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D54%26issue%3D20%26spage%3D7280%26epage%3D7288%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/54/20" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jmcmar.2011.54.issue-20/production/jmcmar.2011.54.issue-20.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm200855b/production/images/medium/jm-2011-00855b_0004.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm200855b/production/images/large/jm-2011-00855b_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200855b&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Depression, a common neurological condition, is one of the leading causes of disability and suicide worldwide. Standard treatment, targeting monoamine transporters selective for the neurotransmitters serotonin and noradrenaline, is not able to help many patients that are poor responders. This study advances the development of sazetidine-A analogues that interact with α4β2 nicotinic acetylcholine receptors (nAChRs) as partial agonists and that possess favorable antidepressant profiles. The resulting compounds that are highly selective for the α4β2 subtype of nAChR over α3β4-nAChRs are partial agonists at the α4β2 subtype and have excellent antidepressant behavioral profiles as measured by the mouse forced swim test. Preliminary absorption, distribution, metabolism, excretion, and toxicity (ADMET) studies for one promising ligand revealed an excellent plasma protein binding (PPB) profile, low CYP450-related metabolism, and low cardiovascular toxicity, suggesting it is a promising lead as well as a drug candidate to be advanced through the drug discovery pipeline.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32007" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32007" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Depression, a common neurological condition, affects approximately 151 million people globally.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Depressed patients suffer from various symptoms daily, such as difficulty in concentrating, insomnia, and anhedonia.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Although there is still a dispute as to whether depression represents a syndrome associated with other illnesses or a disease of its own, this question is immaterial to the fact that depression is one of the leading causes of disability and suicide worldwide.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3, 4)</a>Today, most medications used to treat depression target serotonergic and/or noradrenergic transmitter systems or inhibit monoamine oxidase to reduce the degradation of serotonin and noradrenaline.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Some patients who take antidepressant drugs experience serious side effects, with fewer than half of patients responding well to currently available treatments.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a>Clearly, there is still an urgent need to find safer and more effective drugs for treating depression.</div><div class="NLM_p">Along with the discovery of other neurotransmitters and enzymes that relate to depression, various endeavors to find antidepressant medications based on different strategies have been pursued.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a> Histone deacetylase (HDAC) inhibitors,<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> κ opioid receptor antagonists,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a>and <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartic acid (NMDA) receptor antagonists<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> all show an antidepressant profile in preclinical rodent models. Although there is no consensus yet, K<sup>+</sup> channel modulators are also believed to have potential in the treatment of depression.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Furthermore, it is likely that nicotinic acetylcholine receptors (nAChRs) provide promising targets for the treatment of depression based on the following findings. First, some classic antidepressants, including tricyclics and selective serotonin reuptake inhibitors (SSRIs), inhibit nAChRs. Second, nicotine exhibits an antidepressant behavioral profile in animals. Third, and most interestingly, presynaptic nAChRs may modulate the release of monoamines.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div><div class="NLM_p">The α4β2-nAChRs are the most prevalent high-affinity nicotine-binding nAChR subtypes found in the central nervous system (CNS). Some of the known α4β2-nAChR-selective ligands exhibit antidepressant activities in depression models.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11, 12)</a> The antidepressant effects of mecamylamine,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> and even those of the tricyclic antidepressant amitriptyline,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> are abolished in the nAChR β2 subunit knockout mice that lack α4β2-nAChR.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Moreover, the α3β4*-nAChR-mediated autonomic nicotinic signaling could contribute to the unwanted, adverse side effects observed in vivo.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a> Therefore, highly selective α4β2-nAChR ligands over the α3β4 are regarded as promising antidepressant medications. Sazetidine-A (<b>1</b>) is a potent and selective agonist at the high-sensitivity (HS) isoform of α4β2 nAChRs<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> and exhibits antidepressant-like effects in rodents (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Although its structural simplicity, efficacy in vivo, and high potency make compound <b>1</b> a promising lead, the presence of a metabolically unstable acetylene group diminishes the attractiveness of this compound for further development. However, compound <b>1</b> is still useful as a starting point for the design of new ligands.<a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20, 21)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm200855b/production/images/medium/jm-2011-00855b_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm200855b/production/images/large/jm-2011-00855b_0006.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure of sazetidine-A and proposed structure with a heteroaromatic ring replacing the acetylene group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm200855b/production/images/large/jm-2011-00855b_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200855b&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Many structural modifications of compound <b>1</b> are conceivable to create more attractive compounds. However, replacement of the acetylene with other functional groups to increase metabolic stability is a logical first choice.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a>Aromatic heterocycles (as in <b>2</b>), for example, an isoxazole ring that is present in many bioactive compounds, are potential candidates for this purpose because of their planarity, which adds a minimum of bulk compared to the acetylene group. Several bioactive compounds bearing isoxazole rings have been reported by our group, such as HDAC inhibitors,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> anti-tuberculosis agents,<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23, 24)</a> and peroxisome proliferator-activated receptor agonists.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><div class="NLM_p last">In this study, several analogues of compound <b>1</b> containing an isoxazole ring replacing the acetylene are reported. These compounds are all α4β2 nAChR-selective partial agonists. Some of them exhibit promising behavioral profiles in the mouse forced swim test and appear to be leads for the development of novel antidepressants. In preliminary absorption, distribution, metabolism, excretion, and toxicity (ADMET) studies, one of the active compounds was found to display a druglike profile, thereby commending it for further development. Additionally, all compounds showed very weak binding to α3β4-nAChRs, which mediate autonomic nicotinic signaling, suggesting that few if any peripheral side effects should be observed.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80478" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80478" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Compound <b>3</b>, in which the number of carbon atoms between the pyridine ring and the terminal hydroxyl group matches that in compound <b>1</b>, was synthesized first as the most likely candidate to maintain the biological activity of compound <b>1</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm200855b/production/images/medium/jm-2011-00855b_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm200855b/production/images/large/jm-2011-00855b_0007.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Analogues of sazetidine-A with an isoxazole ring in place of the acetylene group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm200855b/production/images/large/jm-2011-00855b_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200855b&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>3</b> was first assayed for [<sup>3</sup>H]epibatidine binding competition. Its <i>K</i><sub>i</sub> values at seven different rat nAChRs subtypes are listed in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. The LogBB value was calculated and is shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> to estimate the capability of compound <b>3</b> to cross the blood brain barrier (BBB).<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27, 28)</a> With the exception of α2β2-nAChRs, the compound proved selective for α4β2-nAChRs over other subtypes, with a <i>K</i><sub>i</sub> value of 0.67 nM for α4β2-nAChRs. Moreover, this compound also exhibited high binding affinity at native α4β2*-nAChRs with a <i>K</i><sub>i</sub> value of 1.9 nM. The selectivity for α4β2- over α3β4-nAChR was nearly 15 000-fold, suggesting that ganglionic nAChR-mediated side effects<a onclick="showRef(event, 'ref26 ref29'); return false;" href="javascript:void(0);" class="ref ref26 ref29">(26, 29)</a> would be highly unlikely. Because nicotine has a similar affinity for α4β2*- as it does for α2β2-nAChRs, and since the expression of α2β2-nAChRs in the central nervous system is limited, high binding affinity to that subtype is unlikely to be problematic. Having passed the nAChR subtype selectivity screen, compound <b>3</b> was subjected to a broad radioligand binding screen to evaluate off-target activity at a variety of CNS neurotransmitter receptors. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, compound <b>3</b> showed no significant binding (>50%) to other neurotransmitter receptors, including serotonergic, dopaminergic, and adrenergic receptors, with the exception of the κ opioid receptor in the initial screening. However, a secondary screen revealed that its <i>K</i><sub>i</sub> value for the κ opioid receptor was in fact greater than 10 000 nM. Taken together, the data presented in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> predict that there would be few side effects of compound <b>3</b> caused by its interaction with other neurotransmitter receptors.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Binding Affinities of Compounds <b>3</b>–<b>5</b> at Seven Rat nAChR Subtypes</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="rowsep1 colsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="7" align="center" char="."><i>K</i><sub>i</sub><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a> (nM) </th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">α2β2</th><th class="colsep0 rowsep0" align="center" char=".">α2β4</th><th class="colsep0 rowsep0" align="center" char=".">α3β2</th><th class="colsep0 rowsep0" align="center" char=".">α3β4</th><th class="colsep0 rowsep0" align="center" char=".">α4β2</th><th class="colsep0 rowsep0" align="center" char=".">α4β4</th><th class="colsep0 rowsep0" align="center" char=".">α4β2*<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">LogBB <a class="ref internalNav" href="#t1fn4" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="char" char=".">0.90 ± 0.05</td><td class="colsep0 rowsep0" align="char" char="0">1410<a class="ref internalNav" href="#t1fn5" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="char" char="6">16 ± 4</td><td class="colsep0 rowsep0" align="char" char=".">>10 000</td><td class="colsep0 rowsep0" align="char" char=".">0.67 ± 0.20</td><td class="colsep0 rowsep0" align="char" char=".">182</td><td class="colsep0 rowsep0" align="char" char=".">1.9 ± 0.3</td><td class="colsep0 rowsep0" align="char" char=".">–0.93</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="char" char=".">0.32 ± 0.04</td><td class="colsep0 rowsep0" align="char" char=".">310</td><td class="colsep0 rowsep0" align="char" char=".">2.9 ± 0.5</td><td class="colsep0 rowsep0" align="char" char=".">6660</td><td class="colsep0 rowsep0" align="char" char=".">0.31 ± 0.10</td><td class="colsep0 rowsep0" align="char" char="1">81 ± 7</td><td class="colsep0 rowsep0" align="char" char=".">0.61 ± 0.10</td><td class="colsep0 rowsep0" align="char" char=".">–0.99</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="char" char=".">0.76 ± 0.20</td><td class="colsep0 rowsep0" align="char" char=".">518</td><td class="colsep0 rowsep0" align="char" char=".">8.4 ± 1.5</td><td class="colsep0 rowsep0" align="char" char=".">>10 000</td><td class="colsep0 rowsep0" align="char" char=".">0.37 ± 0.10</td><td class="colsep0 rowsep0" align="char" char=".">219</td><td class="colsep0 rowsep0" align="char" char=".">1.8 ± 0.2</td><td class="colsep0 rowsep0" align="char" char=".">–0.99</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">nicotine<a class="ref internalNav" href="#t1fn3" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="char" char=".">5.5</td><td class="colsep0 rowsep0" align="char" char=".">70</td><td class="colsep0 rowsep0" align="char" char=".">29</td><td class="colsep0 rowsep0" align="char" char=".">260</td><td class="colsep0 rowsep0" align="char" char=".">4.9</td><td class="colsep0 rowsep0" align="char" char=".">23</td><td class="colsep0 rowsep0" align="char" char=".">9.8</td><td class="colsep0 rowsep0" align="char" char=".">0.03</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">See <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">The asterisk means that other unidentified subunits also may be present, because membrane fractions prepared from rat forebrain contain nAChR subtypes whose subunit composition has not been precisely determined, although they have features of nAChRs containing α4 and β2 subunits.</p></div><div class="footnote" id="t1fn4"><sup>c</sup><p class="last">LogBB was calculated from the following equation: LogBB = −0.0148PSA + 0.152CLogP + 0.139.</p></div><div class="footnote" id="t1fn5"><sup>d</sup><p class="last">SEM values are not provided for <i>K</i><sub>i</sub> values >100 nM.</p></div><div class="footnote" id="t1fn3"><sup>e</sup><p class="last">The binding data for nicotine are from the PDSP Assay Protocol Book (<a href="http://pdsp.med.unc.edu/" class="extLink">http://pdsp.med.unc.edu/</a>).</p></div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Binding Competition Efficacies of Compound <b>3</b> at Various Neurotransmitter Receptors at 10 μM<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="9" align="center">serotonergic receptors</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">5-HT<sub>1A</sub></th><th class="colsep0 rowsep0" align="center">5-HT<sub>1B</sub></th><th class="colsep0 rowsep0" align="center">5-HT<sub>1D</sub></th><th class="colsep0 rowsep0" align="center">5-HT<sub>1E</sub></th><th class="colsep0 rowsep0" align="center">5-HT<sub>2A</sub></th><th class="colsep0 rowsep0" align="center">5-HT<sub>2B</sub></th><th class="colsep0 rowsep0" align="center">5-HT<sub>2C</sub></th><th class="colsep0 rowsep0" align="center">5-HT<sub>3</sub></th><th class="colsep0 rowsep0" align="center">5-HT<sub>5A</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">% inhibition</td><td class="colsep0 rowsep0" align="left">0.3</td><td class="colsep0 rowsep0" align="left">–9.9 <a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">7.1</td><td class="colsep0 rowsep0" align="left">4.1</td><td class="colsep0 rowsep0" align="left">22.2</td><td class="colsep0 rowsep0" align="left">17.7</td><td class="colsep0 rowsep0" align="left">14.6</td><td class="colsep0 rowsep0" align="left">18.8</td><td class="colsep0 rowsep0" align="left">–17.8</td></tr></tbody></table><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">serotonergic receptors</th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="5" align="center">dopaminergic receptors</th><th class="rowsep1 colsep0" rowspan="2" align="center">BZPR<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">5-HT<sub>6</sub></th><th class="colsep0 rowsep0" align="center">5-HT<sub>7</sub></th><th class="colsep0 rowsep0" align="center">GABA<sub>A</sub></th><th class="colsep0 rowsep0" align="center">D1</th><th class="colsep0 rowsep0" align="center">D2</th><th class="colsep0 rowsep0" align="center">D3</th><th class="colsep0 rowsep0" align="center">D4</th><th class="colsep0 rowsep0" align="center">D5</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">% inhibition</td><td class="colsep0 rowsep0" align="left">22.3</td><td class="colsep0 rowsep0" align="left">16.2</td><td class="colsep0 rowsep0" align="left">26.9</td><td class="colsep0 rowsep0" align="left">–3.3</td><td class="colsep0 rowsep0" align="left">19.8</td><td class="colsep0 rowsep0" align="left">15.3</td><td class="colsep0 rowsep0" align="left">19.8</td><td class="colsep0 rowsep0" align="left">–1.8</td><td class="colsep0 rowsep0" align="left">21.7</td></tr></tbody></table><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="9" align="center">adrenergic receptors</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">α1A</th><th class="colsep0 rowsep0" align="center">α1B</th><th class="colsep0 rowsep0" align="center">α1D</th><th class="colsep0 rowsep0" align="center">α2A</th><th class="colsep0 rowsep0" align="center">α2B</th><th class="colsep0 rowsep0" align="center">α2C</th><th class="colsep0 rowsep0" align="center">β1</th><th class="colsep0 rowsep0" align="center">β2</th><th class="colsep0 rowsep0" align="center">β3</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">% inhibition</td><td class="colsep0 rowsep0" align="left">–9.5</td><td class="colsep0 rowsep0" align="left">–0.4</td><td class="colsep0 rowsep0" align="left">2.9</td><td class="colsep0 rowsep0" align="left">–0.5</td><td class="colsep0 rowsep0" align="left">10.8</td><td class="colsep0 rowsep0" align="left">22.0</td><td class="colsep0 rowsep0" align="left">–3.2</td><td class="colsep0 rowsep0" align="left">–1.0</td><td class="colsep0 rowsep0" align="left">–17.7</td></tr></tbody></table><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center">histaminergic receptors</th><th class="rowsep1 colsep0" colspan="5" align="center">muscarinic receptors</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">H1</th><th class="colsep0 rowsep0" align="center">H2</th><th class="colsep0 rowsep0" align="center">H3</th><th class="colsep0 rowsep0" align="center">H4</th><th class="colsep0 rowsep0" align="center">M1</th><th class="colsep0 rowsep0" align="center">M2</th><th class="colsep0 rowsep0" align="center">M3</th><th class="colsep0 rowsep0" align="center">M4</th><th class="colsep0 rowsep0" align="center">M5</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">% inhibition</td><td class="colsep0 rowsep0" align="left">–19.9</td><td class="colsep0 rowsep0" align="left">42.6</td><td class="colsep0 rowsep0" align="left">6.2</td><td class="colsep0 rowsep0" align="left">–4.4</td><td class="colsep0 rowsep0" align="left">2.0</td><td class="colsep0 rowsep0" align="left">11.4</td><td class="colsep0 rowsep0" align="left">–6.8</td><td class="colsep0 rowsep0" align="left">2.0</td><td class="colsep0 rowsep0" align="left">–18.9</td></tr></tbody></table><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">opioid receptors<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></th><th class="rowsep1 colsep0" colspan="3" align="center">transporters<a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></th><th class="rowsep1 colsep0" colspan="2" align="center">σ receptors</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">DOR</th><th class="colsep0 rowsep0" align="center">KOR</th><th class="colsep0 rowsep0" align="center">MOR</th><th class="colsep0 rowsep0" align="center">DAT</th><th class="colsep0 rowsep0" align="center">NET</th><th class="colsep0 rowsep0" align="center">SERT</th><th class="colsep0 rowsep0" align="center">σ1</th><th class="colsep0 rowsep0" align="center">σ2</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">% inhibition</td><td class="colsep0 rowsep0" align="left">6.4</td><td class="colsep0 rowsep0" align="left">20<a class="ref internalNav" href="#t2fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">14.2</td><td class="colsep0 rowsep0" align="left">–10.1</td><td class="colsep0 rowsep0" align="left">14.2</td><td class="colsep0 rowsep0" align="left">–0.6</td><td class="colsep0 rowsep0" align="left">25.9</td><td class="colsep0 rowsep0" align="left">–4.3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">The default concentration for primary binding experiments is 10 μM (<i>n</i> = 4). The inhibition data were generously provided by the National Institute of Mental Health's Psychoactive Drug Screening Program (NIMH PDSP), Contract HHSN-271-2008-00025-C.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Negative inhibition represents a stimulation of binding.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">BZPR, benzodiazepine receptor (rat brain site).</p></div><div class="footnote" id="t2fn4"><sup>d</sup><p class="last">DOR, δ opioid receptor; KOR, κ opioid receptor; MOR, μ opioid receptor.</p></div><div class="footnote" id="t2fn5"><sup>e</sup><p class="last">DAT, dopamine transporter; NET, norepinephrine transporter; SERT, serotonin transporter.</p></div><div class="footnote" id="t2fn6"><sup>f</sup><p class="last">Replication of the binding assay for this receptor did not confirm the initial result, and the more accurate figure from the secondary assay run is provided instead.</p></div></div></div><div class="NLM_p">The functional activity of compound <b>3</b> was determined by the <sup>86</sup>Rb<sup>+</sup> ion flux assay<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> in SH-EP1-hα4β2 cells (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>).<a onclick="showRef(event, 'ref31 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref31 ref32 ref33">(31-33)</a> Its nanomolar EC<sub>50</sub> and low efficacy characterized compound <b>3</b> as a partial agonist of α4β2-nAChRs.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Sensitivities and Efficacies of Ligand Agonism and Inactivation of Human α4β2-nAChR<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">agonism<a class="ref internalNav" href="#tbl3-fn1" aria-label="b">b</a></th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">inactivation<a class="ref internalNav" href="#tbl3-fn2" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">EC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char=".">efficacy (%)</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char=".">efficacy (%)</th><th class="colsep0 rowsep0" align="center" char=".">α4β2 <i>K</i><sub>i</sub><a class="ref internalNav" href="#tbl3-fn3" aria-label="d">d</a> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="char" char=".">36</td><td class="colsep0 rowsep0" align="char" char=".">13</td><td class="colsep0 rowsep0" align="char" char=".">61</td><td class="colsep0 rowsep0" align="char" char=".">68</td><td class="colsep0 rowsep0" align="char" char=".">0.67 ± 0.20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="char" char=".">25</td><td class="colsep0 rowsep0" align="char" char=".">13</td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">66</td><td class="colsep0 rowsep0" align="char" char=".">0.31 ± 0.10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="char" char=".">110</td><td class="colsep0 rowsep0" align="char" char=".">20</td><td class="colsep0 rowsep0" align="char" char=".">44</td><td class="colsep0 rowsep0" align="char" char=".">85</td><td class="colsep0 rowsep0" align="char" char=".">0.37 ± 0.10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(−)-nicotine</td><td class="colsep0 rowsep0" align="char" char=".">290</td><td class="colsep0 rowsep0" align="char" char=".">88</td><td class="colsep0 rowsep0" align="char" char=".">430</td><td class="colsep0 rowsep0" align="char" char=".">93</td><td class="colsep0 rowsep0" align="char" char=".">4.9</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">SEM values were determined for each parameter and, although not presented here, typically are less than 15% for efficacy measures and no more than a factor of 2 for molar EC<sub>50</sub> or IC<sub>50</sub> values. Results for compounds <b>3</b>, <b>4</b>, and <b>5</b> are from four independent determinations. Results for nicotine are from ref <a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">13</a>.</p></div><div class="footnote" id="tbl3-fn1"><sup>b</sup><p class="last">The indicated compounds were used in <sup>86</sup>Rb<sup>+</sup> efflux assays to define their intrinsic activities as agonists defined by their EC<sub>50</sub> values (nanomolar) and efficacies (normalized to that of a full agonist at a maximally efficacious concentration; see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>) when acting at human α4β2-nAChRs heterologously and stably expressed in transfected SH-EP1 human epithelial cells.</p></div><div class="footnote" id="tbl3-fn2"><sup>c</sup><p class="last">The compounds also were used in efflux assays to define their abilities to inactivate responses to a full agonist at its EC<sub>90</sub> concentration as defined by inactivation IC<sub>50</sub> values (nanomolar) and inhibitory efficacy (normalized to complete functional inhibition; see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>) when acting at human α4β2-nAChRs. The term “inactivation” is used because compounds may be acting to desensitize receptors and/or as competitive or noncompetitive antagonists, and further work is needed to make such a distinction.</p></div><div class="footnote" id="tbl3-fn3"><sup>d</sup><p class="last">Shown for reference are <i>K</i><sub>i</sub> values (nanomolar) for blockade of specific binding of [<sup>3</sup>H]epibatidine to membrane fractions prepared from (α4β2) HEK cells transfected to express rat α4 and β2 subunits. </p></div></div></div><div class="NLM_p">Encouraged by these findings, we pursued additional modifications of compound <b>3</b>. In the case of analogues of compound <b>1</b>, it is known that shortening the oligomethylene chain generally results in retention of affinity and agonist efficacy, while extending the chain reduces these characteristics. Therefore, compounds <b>4</b> and <b>5</b> featuring shorter chains were synthesized. As is evident from Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, both of these compounds exhibit high binding affinity at α4β2-nAChRs and native α4β2*-nAChRs, with <i>K</i><sub>i</sub> values in the nanomolar range, and possess high selectivity for α4β2-nAChRs over other nAChR subtypes, with the nonproblematic exception of α2β2-nAChRs. The selectivity for α4β2-over α3β4-nAChRs of compound <b>4</b> is an impressive 20 000-fold. The functional characterization reported in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> shows that both compounds <b>4</b> and <b>5</b> are partial agonists at α4β2-nAChRs.</div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> In Vivo Behavioral Pharmacology</h3><div class="NLM_p">To determine whether the high activity of our compounds at α4β2-nAChR would translate into antidepressant-like efficacy in a behavioral model, compounds <b>3</b>–<b>5</b> were investigated in the mouse forced swim test. In this assay, antidepressants decrease the amount of time mice spend immobile when forced to swim in a confined space.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> When our compounds were injected intraperitoneally (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>), compound <b>5</b> showed the best antidepressant-like response, with a significant reduction in immobility seen at 1 and 3 mg/kg, while compound <b>3</b> produced a significant reduction in immobility at 3 mg/kg but only an insignificant trend at 1 mg/kg. Compound <b>4</b> was surprisingly weakly active only at 30 mg/kg. Compound <b>5</b> showed the highest level of ex vivo receptor occupancy at β2* receptors at 3 mg/kg (around 80%) compared to compounds <b>3</b> and <b>4</b>, which showed approximately 60–70% occupancy at that dosage (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). The greater efficacy of compound <b>5</b> as compared to the other two compounds in the forced swim test may be related to the higher level of receptor occupancy of β2* receptors. Despite the high level of receptor occupancy observed, the poor antidepressant behavior of compound <b>4</b> in the forced swim test may indicate subtle differences between ligands that could be missed in a <sup>86</sup>Rb<sup>+</sup> efflux assay, such as the in vivo elevation of cholinergic tone. As compounds <b>3</b> and <b>5</b> were both active at 3 mg/kg when administered intraperitoneally in the forced swim test, they were next tested for their antidepressant activity following oral administration. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a> both compounds <b>3</b> and <b>5</b> decreased the time immobile at 10 mg/kg in the forced swim test, but <b>3</b> failed to show significant activity when tested at the 1 and 3 mg/kg level.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm200855b/production/images/medium/jm-2011-00855b_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm200855b/production/images/large/jm-2011-00855b_0008.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Compounds <b>3</b> and <b>5</b> reduced immobility in the forced swim test in mice at the medium and highest dose tested. Compound <b>4</b> showed an insignificant trend at the highest dose only. The SSRI sertraline produced the expected decrease in immobility. ANOVAs: <i>F</i> (11 108) = 6.9, <i>p</i> < 0.001. *Fisher’s PLSD post hoc test: <i>p</i> < 0.05 versus vehicle. All drugs were injected intraperitoneally; <i>n</i> = 10/group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm200855b/production/images/large/jm-2011-00855b_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200855b&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm200855b/production/images/medium/jm-2011-00855b_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm200855b/production/images/large/jm-2011-00855b_0001.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Receptor occupancy studies of compounds <b>3</b>–<b>5</b> in mice showed a significant occupancy level. Compound <b>5</b> showed a higher receptor occupancy than compounds <b>3</b> and <b>4</b>. *Mann–Whitney U: <i>p</i> < 0.05. All drugs were injected intraperitoneally; <i>n</i> = 3/group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm200855b/production/images/large/jm-2011-00855b_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200855b&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm200855b/production/images/medium/jm-2011-00855b_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm200855b/production/images/large/jm-2011-00855b_0002.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Compound <b>3</b> reduced immobility in the forced swim test in mice when given orally at 10 mg/kg. Immobility was slightly higher at the lowest dose. Compound <b>5</b> was efficacious at all doses tested. The SSRI sertraline produced the expected decrease in immobility. ANOVAs: <i>F</i> > 34.5; <i>p</i> < 0.001. *Fisher’s PLSD post hoc tests: <i>p</i> < 0.05 versus vehicle. <i>N</i> = 9–10/group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm200855b/production/images/large/jm-2011-00855b_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200855b&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Preliminary ADMET Study<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></h3><div class="NLM_p last">Encouraged by these favorable biological data, we submitted compound <b>3</b> for a preliminary ADMET test. In vitro metabolism studies with human and mouse liver microsomes at a concentration of 1 μM showed no detectable metabolism. Assays of the compound’s inhibitory potential toward nine different CYP450 enzymes also revealed no significant inhibition. Plasma protein binding (PPB) assays were conducted with both human and mouse plasma (CD-1) at 10 μM. In human plasma, only 0.4% binding was observed, while in mouse plasma the bound fraction was as high as 26%. The weak PPB translates to a high concentration of free drug in the blood, suggesting that compound <b>3</b> should easily diffuse through cell membranes and cross the BBB to reach its biological target. Cardiotoxicity associated with the inhibition of human ether-a-go-go-related gene (hERG)<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> was also evaluated, and no obvious inhibition of hERG-related tail current was seen even at the high concentration of 10 μM (8.4% inhibition). These results suggest that compound <b>3</b> and its side-chain homologues represent promising drug candidates for further preclinical study.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Chemistry</h3><div class="NLM_p">The known starting material <b>6</b><a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> was first transformed to alkyne <b>8</b> through a Sonogashira coupling reaction with ethynyltrimethylsilane, followed by deprotection with tetrabutylammonium fluoride (TBAF) to remove the trimethylsilyl (TMS) group (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). Nitro compounds <b>15</b> and <b>16</b> were synthesized by monoprotection of diols <b>9</b> and <b>10</b>, followed by conversion of the remaining free hydroxyl groups to nitro groups through iodides <b>13</b> and <b>14</b> as intermediates, respectively. Protected isoxazoles <b>18</b>–<b>20</b> were synthesized through [3 + 2]-cycloaddition reactions of alkyne <b>8</b> with nitrile oxides derived from the above nitro compounds and from their commercially available, tetrahydropyranyl-protected lower homologue <b>17</b>. Deprotection with acid of the penultimate precursors <b>18</b>–<b>20</b> yielded compounds <b>3</b>–<b>5</b> as their HCl salts.</div><figure id="sch1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm200855b/production/images/medium/jm-2011-00855b_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm200855b/production/images/large/jm-2011-00855b_0003.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm200855b/production/images/large/jm-2011-00855b_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200855b&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ethynyltrimethylsilane, CuI, PPh<sub>3</sub>, PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, Et<sub>3</sub>N; (b) (<i>n</i>-Bu)<sub>4</sub>NF, THF; (c) NaH, TBSCl, THF; (d) PPh<sub>3</sub>, imidazole, I<sub>2</sub>, Et<sub>2</sub>O/MeCN; (e) AgNO<sub>2</sub>, Et<sub>2</sub>O; (f) PhNCO, Et<sub>3</sub>N, toluene; (g) HCl, ether/MeOH.</p></p></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25678" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25678" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In spite of the plethora of antidepressant drugs on the market, there is still the need to identify improved drug therapies that have a faster onset of action and provide effective treatment of refractory depression. As is now well understood, nAChRs represent promising targets in the search for new antidepressants. Based on rational drug design principles, analogues of compound <b>1</b> bearing an isoxazole ring in place of its metabolically unstable acetylene group were designed and tested. The compounds in this series were found to be highly selective α4β2-nAChRs partial agonists. Compounds <b>3</b> and <b>5</b> exhibit excellent behavioral profiles in the mouse forced swim test, whether administered intraperitoneally or orally, consistent with the antidepressant-like efficacy of these analogues. Moreover, compound <b>3</b> exhibited no significant binding affinity for other neurotransmitter receptors or transporters, suggesting that it may be free of undesirable side effects associated with off-target activity. A preliminary ADMET study for the isoxazole <b>3</b> revealed that this compound causes no pronounced CYP450 inhibition, possesses low plasma protein binding, and has low hERG inhibitory activity. The compelling activity profile shown by the α4β2-nAChR partial agonist, isoxazole <b>3</b>, at both the pharmacological and in vivo levels recommend this compound and its analogues for further study in the quest for new antidepressant drug candidates.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37802" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37802" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> General</h3><div class="NLM_p last">Proton and carbon NMR spectra were recorded on a 300 or 400 MHz spectrometer (<sup>1</sup>H frequency). NMR chemical shifts are reported in δ (parts per million, ppm) with the δ 7.26 signal of CDCl<sub>3</sub> (<sup>1</sup>H NMR), δ 4.80 signal of D<sub>2</sub>O (<sup>1</sup>H NMR), and δ 77.2 signal of CDCl<sub>3</sub> (<sup>13</sup>C NMR) as internal standards. <sup>13</sup>C NMR spectra in D<sub>2</sub>O were not adjusted. Optical rotation was detected on an Autopol IV automatic polarimeter. Mass spectra were acquired in the electrospray ionization (ESI) mode at an ionization potential of 70 eV with a liquid chromatography–mass spectrometry (LC-MS) MSD instrument (Hewlett-Packard). Column chromatography was performed by use of Merck silica gel (40–60 mesh). Purity of the final compounds (>98%) was established by use of an Agilent 1100 high-performance liquid chromatography (HPLC) system equipped with a Synergi 4 μm Hydro-RP 80A column, with detection at 254 (and 280) nm, using a variable-wavelength detector G1314A; flow rate = 1.4 mL/min; gradient elution over a time span of 20–29 min, from 30% MeOH/H<sub>2</sub>O to 100% MeOH (both containing 0.05 vol % CF<sub>3</sub>COOH). PL-HCO<sub>3</sub> MP-Resin, StratoSphere SPE purchased from Agilent Technologies, was used to remove the extra CF<sub>3</sub>COOH (trifluoroacetic acid, TFA) and to transform the compound to its free amine form after HPLC purification.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> General Procedure for [3 + 2] Cycloaddition To Form Isoxazoles (Method A)</h3><div class="NLM_p last">To a solution of nitro compound (2.0–3.0 equiv) and alkyne <b>8</b> (1.0 equiv) in dry toluene (0.2 M in alkyne) were added phenyl isocyanate (1.0 equiv) and triethylamine (1.0 equiv). The reaction mixture was stirred at 60 °C for 24–48 h. After the reaction mixture was cooled to room temperature, it was diluted with water and stirred vigorously for 2 h. The mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub>, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was purified by column chromatography with hexane/EtOAc (1:1) to give the isoxazoles in yields of 50–80%.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> General Procedure for Deprotection of N-Boc Precursors To Afford Amines as Hydrochloride Salts (Method B)</h3><div class="NLM_p last">To a solution of N-Boc-protected precursor (1.0 equiv) in MeOH was added 2 N anhydrous HCl/ether (1 mL) under argon protection at room temperature. The mixture was stirred overnight. After the solvent was evaporated, the residue was dissolved in distilled water (about 20–30 mL), the solution was filtered over a cotton plug, and the water was removed under reduced pressure at 35 °C. The crude product was purified by HPLC (see HPLC conditions below), and the resulting TFA salt was treated with AAA resin to afford the free amine. This material was dissolved in MeOH and treated again with 2 N anhydrous HCl/ether (1 mL) under argon protection at room temperature. The mixture was stirred overnight. After the solvent was evaporated, the residue was dissolved in distilled water (about 20–30 mL), the solution was filtered over a cotton plug, and water was removed under reduced pressure at 35 °C. Pure HCl salt was obtained after lyophilization.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Preparative HPLC Conditions (H<sub>2</sub>O/MeCN System, Gradient A)</h3><div class="NLM_p last">An ACE AQ 150 × 21.2 mm column was used with UV detection at both 254 and 280 nm and a flow rate of 17.0 mL/min. The gradient was 8–100% acetonitrile in water (both containing 0.05 vol % CF<sub>3</sub>COOH) in 25 min, isocratic 100% acetonitrile for another 5 min, return to 8% acetonitrile in the next 5 min, and final equilibration at 8% acetonitrile for the final 5 min.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Preparative HPLC Conditions (H<sub>2</sub>O/MeOH System, Gradient B)</h3><div class="NLM_p">An ACE AQ 150 × 21.2 mm column was used with UV detection at both 254 and 280 nm and a flow rate of 17.0 mL/min. The gradient was 8–100% MeOH in water (both containing 0.05 vol % CF<sub>3</sub>COOH) in 25 min, isocratic 100% MeOH for another 5 min, return to 8% MeOH in the next 5 min, and final equilibration at 8% MeOH for the final 5 min.</div><div id="sec4_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> 3-[5-(5-[(<i>S</i>)-2-Azetidinylmethoxy]-3-pyridyl)-3-isoxazolyl]-1-propanol Hydrochloride (<b>3</b>)</h4><div class="NLM_p last">Method B was used. Yield 63% (white solid); purity 98.8%; <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ 8.93 (s, 1H), 8.68 (s, 1H), 8.59 (m, 1H), 7.11 (s, 1H), 5.00 (m, 1H), 4.66 (m, 2H), 4.13 (m, 2H), 3.64 (t, <i>J</i> = 6.4 Hz, 2H), 2.83 (t, <i>J</i> = 7.6 Hz, 2H), 2.72 (m, 2H), 1.95 (m, 2H); <sup>13</sup>C NMR (100 MHz, D<sub>2</sub>O) δ 165.5, 162.4, 156.3, 131.6, 130.0, 127.6, 127.5, 104.2, 67.7, 60.2, 58.2, 43.4, 29.2, 21.5, 19.9; LC-MS <i>m</i>/<i>z</i> 290.2 (M + H)<sup>+</sup>; [α]<sub class="stack">D</sub><sup class="stack">24</sup> = −5.2 (<i>c</i> = 0.37, MeOH).</div></div><div id="sec4_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> 5-(5-[(<i>S</i>)-2-Azetidinylmethoxy]-3-pyridyl)-3-isoxazolylmethanol Hydrochloride (<b>4</b>)</h4><div class="NLM_p last">Method B was used. Yield 46% (white solid); purity 99.0%; <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ 8.93 (s, 1H), 8.66 (d, <i>J</i> = 2.4 Hz, 1H), 8.50 (s, 1H), 7.16 (s, 1H), 5.04 (m, 1H), 4.82 (m, 2H), 4.65 (d, <i>J</i> = 4.0 Hz, 2H), 4.16 (m, 2H), 2.76 (m, 2H); <sup>13</sup>C NMR (100 MHz, D<sub>2</sub>O) δ 165.0, 163.5, 156.6, 132.3, 130.8, 127.8, 127.6, 103.4, 68.1, 58.6, 55.2, 43.8, 20.3; LC-MS <i>m</i>/<i>z</i> 262.1 (M + H)<sup>+</sup>; [α]<sub class="stack">D</sub><sup class="stack">24</sup> = −2.2 (<i>c</i> = 0.64, MeOH). Anal. Calcd. for C<sub>13</sub>H<sub>15</sub>N<sub>3</sub>O<sub>3</sub>·2.05HCl: C, 46.47; H, 5.11; N, 12.51; Cl, 21.63. Found: C, 46.41; H, 4.95; N, 12.36; Cl, 21.83.</div></div><div id="sec4_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> 2-[5-(5-[(<i>S</i>)-2-Azetidinylmethoxy]-3-pyridyl)-3-isoxazolyl]ethanol Hydrochloride (<b>5</b>)</h4><div class="NLM_p last">Method B was used. Yield 68% (white solid); purity 98.9%; <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ 8.91 (s, 1H), 8.67 (s, 1H), 8.58 (s, 1H), 7.12 (s, 1H), 4.98 (m, 1H), 4.64 (m, 2H), 4.11 (m, 2H), 3.91 (t, <i>J</i> = 6.0 Hz, 2H), 2.97 (t, <i>J</i> = 6.0 Hz, 2H), 2.71 (m, 2H); <sup>13</sup>C NMR (100 MHz, D<sub>2</sub>O) δ 164.1, 163.3, 157.0, 132.4, 130.7, 128.3, 128.2, 105.0, 68.4, 59.7, 58.9, 44.1, 28.7, 20.6; LC-MS <i>m</i>/<i>z</i> 276.1 (M + H)<sup>+</sup>; [α]<sub class="stack">D</sub><sup class="stack">24</sup> = −5.7 (<i>c</i> = 0.65, MeOH).</div></div><div id="sec4_5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> 3-[1-(<i>tert</i>-Butoxycarbonyl)-(<i>S</i>)-2-azetidinylmethoxy]-5-[(trimethylsilyl)ethynyl]pyridine (<b>7</b>)</h4><div class="NLM_p last">To a stirred solution of starting material <b>6</b> (550 mg, 1.62 mmol), PPh<sub>3</sub> (139 mg, 0.53 mmol), and CuI (137 mg, 0.72 mmol) in triethylamine (7.0 mL) was added PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (112 mg, 0.16 mmol). The mixture was stirred at room temperature for 20 min under argon, and then ethynyltrimethylsilane (0.68 mL, 4.8 mmol) was added. The reaction mixture was stirred at 60 °C for 24 h, quenched with saturated aqueous NH<sub>4</sub>Cl solution, and extracted with CH<sub>2</sub>Cl<sub>2</sub>. The organic phase was dried over anhydrous MgSO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was purified by column chromatography with hexane/EtOAc (10:1–2:1) to give the trimethylsilylalkyne <b>7</b> (560 mg, 97%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.13 (m, 2H), 7.17 (s, 1H), 4.36 (m, 1H), 4.19 (m, 1H), 3.97 (m, 1H), 3.73 (t, <i>J</i> = 7.6 Hz, 2H), 2.15 (m, 2H), 1.26 (s, 9H), 0.09 (s, 9H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 156.0, 154.3, 144.9, 138.1, 123.1, 120.3, 101.2, 97.9, 79.6, 65.6, 59.9, 46.8, 28.3, 18.9, −0.3.</div></div><div id="sec4_5_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> 3-[1-(<i>tert</i>-Butoxycarbonyl)-(<i>S</i>)-2-azetidinylmethoxy]-5-ethynylpyridine (<b>8</b>)</h4><div class="NLM_p last">To a solution of trimethylsilylalkyne <b>7</b> (160 mg, 0.444 mmol) in 14 mL of anhydrous THF at 0 °C was added 1.0 M tetrabutylammonium fluoride in THF (1.3 mL, 1.3 mmol). The mixture was stirred at 0 °C for 1 h, quenched with saturated aqueous NH<sub>4</sub>Cl solution, and extracted with CH<sub>2</sub>Cl<sub>2</sub>. The organic phase was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was purified by chromatography with hexane/EtOAc (1:1) to give alkyne <b>8</b> as an oil (125 mg, 98%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.24 (m, 2H), 7.27 (s, 1H), 4.46 (m, 1H), 4.30 (m, 1H), 4.06 (m, 1H), 3.82 (t, <i>J</i> = 7.5 Hz, 2H), 3.18 (s, 1H), 2.24 (m, 2H), 1.35 (s, 9H).</div></div><div id="sec4_5_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 3-(<i>tert</i>-Butyldimethylsilyloxy)-1-propanol (<b>11</b>)</h4><div class="NLM_p last">To a solution of 1,3-propanediol (1.0 mL, 14 mmol) in anhydrous tetrahydrofuran (THF) (30 mL) was added NaH (60% dispersion in mineral oil, 560 mg, 14 mmol) in one portion at 0 °C under Ar. The reaction mixture was allowed to warm to room temperature, and after it was stirred at room temperature for 30 min, <i>tert</i>-butyldimethylsilyl chloride (2.1 g, 14 mmol) was added. The mixture was set aside for 2 days before it was quenched by additon of saturated aqueous NH<sub>4</sub>Cl solution. The mixture was extracted with EtOAc (3 times), and the combined organic layers were washed with brine. After being dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, the solvent was removed. The residue was purified by column chromatography with hexane/EtOAc (4:1) to afford compound <b>11</b> (1.28 g, 48%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.80 (m, 4H), 2.66 (br s, 1H), 1.76 (quint, <i>J</i> = 5.6 Hz, 2H), 0.89 (s, 9H), 0.06 (s, 6H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 63.0, 62.5, 34.4, 26.1, 18.4, 5.3.</div></div><div id="sec4_5_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 4-(<i>tert</i>-Butyldimethylsilyloxy)-1-butanol (<b>12</b>)</h4><div class="NLM_p last">Following the same procedure as for the preparation of compound <b>11</b>, compound <b>12</b> was obtained in a yield of 71% as a pale yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.66 (m, 4H), 2.47 (br s, 1H), 1.63 (m, 4H), 0.90 (s, 9H), 0.07 (s, 6H).</div></div><div id="sec4_5_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 1-(<i>tert</i>-Butyldimethylsilyloxy)-3-iodopropane (<b>13</b>)</h4><div class="NLM_p last">To a solution of compound <b>11</b> (2.80 g, 14.7 mmol), Ph<sub>3</sub>P (4.63 g, 17.6 mmol), and imidazole (2.00 g, 29.4 mmol) in ether/MeCN (1:1, 80 mL) was added I<sub>2</sub> (4.67 g, 18.4 mmol) at 0 °C. The mixture was allowed to stand at room temperature overnight, before it was quenched with saturated NaHSO<sub>3</sub> solution. The product was extracted with hexane/EtOAc (4:1), and the organic layer was washed with brine and dried over Na<sub>2</sub>SO<sub>4</sub>. After concentration, the residue was purified by column chromatography with hexane/EtOAc (10:1) to afford compound <b>13</b> (1.83 g, 41%) as a pale yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.67 (t, <i>J</i> = 6.0 Hz, 2H), 3.28 (t, <i>J</i> = 6.8 Hz, 2H), 1.99 (m, 2H), 0.90 (s, 9H), 0.07 (s, 6H).</div></div><div id="sec4_5_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 1-(<i>tert</i>-Butyldimethylsilyloxy)-4-iodobutane (<b>14</b>)</h4><div class="NLM_p last">The same procedure was followed as for the preparation of compound <b>13</b>. Crude compound <b>14</b> was obtained as a pale yellow oil and used directly in the next step without further purification.</div></div><div id="sec4_5_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 1-(<i>tert</i>-Butyldimethylsilyloxy)-3-nitropropane (<b>15</b>)</h4><div class="NLM_p last">To a solution of compound <b>13</b> (300 mg, 1.0 mmol) in ether (7 mL) in a bottle wrapped with aluminum foil was added AgNO<sub>2</sub> (purchased from Aldrich, 170 mg, 1.1 mmol) in one portion. The mixture was stirred at room temperature for 2 days. After filtration followed by solvent removal, the crude compound <b>15</b> (174 mg, 79%) was obtained as a colorless oil and used directly in the next step without further purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 4.50 (t, <i>J</i> = 6.8 Hz, 2H), 3.71 (t, <i>J</i> = 6.0 Hz, 2H), 2.18 (m, 2H), 0.88 (s, 9H), 0.05 (s, 6H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 72.8, 59.4, 30.4, 26.0, 18.4, 5.4.</div></div><div id="sec4_5_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 1-(<i>tert</i>-Butyldimethylsilyloxy)-4-nitrobutane (<b>16</b>)</h4><div class="NLM_p last">The same procedure was followed as for the preparation of compound <b>15</b>. Compound <b>16</b> was obtained (yield 34% over two steps) as a pale yellow oil.</div></div><div id="sec4_5_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 3-[1-(<i>tert</i>-Butoxycarbonyl)-(<i>S</i>)-2-azetidinylmethoxy]-5-[3-[(2-<i>tert</i>-butyldimethylsilyloxy)ethyl]-5-isoxazolyl]pyridine (<b>18</b>)</h4><div class="NLM_p last">Method A was followed. Yield 54% (pale yellow oil); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.47 (m, 2H), 7.59 (s, 1H), 6.56 (s, 1H), 4.53 (m, 1H), 4.39 (m, 1H), 4.16 (m, 1H), 3.89 (m, 4H), 2.92 (t, <i>J</i> = 6.0 Hz, 2H), 2.30 (m, 2H), 1.39 (s, 9H), 0.84 (s, 9H), 0.03 (s, 6H).</div></div><div id="sec4_5_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 3-[1-(<i>tert</i>-Butoxycarbonyl)-(<i>S</i>)-2-azetidinylmethoxy]-5-[3-[(3-<i>tert</i>-butyldimethylsilyloxy)propyl]-5-isoxazolyl]pyridine (<b>19</b>)</h4><div class="NLM_p last">Method A was followed. Yield 59% (pale yellow oil); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.54 (s, 1H), 8.32 (s, 1H), 7.55 (s, 1H), 6.45 (s, 1H), 4.48 (m, 1H), 4.34 (m, 1H), 4.13 (dd, <i>J</i> = 4.0, 12.0 Hz, 1H), 3.83 (t, <i>J</i> = 6.0 Hz, 2H), 3.64 (t, <i>J</i> = 6.0 Hz, 2H), 2.74 (t, <i>J</i> = 6.0 Hz, 2H), 2.27 (m, 2H), 1.86 (m, 2H), 1.34 (s, 9H), 0.83 (s, 9H), −0.01 (s, 6H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 166.5, 164.6, 156.2, 155.3, 139.6, 139.4, 124.3, 117.5, 100.8, 79.8, 68.9, 62.1, 60.1, 47.2, 31.2, 28.3, 26.0, 22.7, 19.1, 18.3.</div></div><div id="sec4_5_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 3-[1-(<i>tert</i>-Butoxycarbonyl)-(<i>S</i>)-2-azetidinylmethoxy]-5-[3-[(tetrahydro-2<i>H</i>-pyran-2-yloxy)methyl]-5-isoxazolyl]pyridine (<b>20</b>)</h4><div class="NLM_p last">Method A was followed. Yield 89% (pale yellow oil); <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.42 (s, 1H), 8.18 (s, 1H), 7.43 (s, 1H), 6.56 (s, 1H), 4.60 (m, 1H), 4.47 (m, 1H), 4.35 (m, 1H), 4.22 (m, 1H), 4.02 (m, 1H), 3.99 (m, 1H), 3.69 (m, 3H), 3.36 (m, 1H), 2.14 (m, 2H), 1.66–1.41 (m, 6H), 1.20 (s, 9H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 166.7, 162.1, 155.8, 154.9, 139.5, 139.0, 123.7, 117.1, 100.3, 98.0, 79.3, 68.6, 61.8, 59.9, 59.8, 30.0, 28.6, 25.0, 18.9, 18.8.</div></div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> In Vitro Studies</h3><div class="NLM_p last">For experimental details of the [<sup>3</sup>H]epibatidine competition study: please refer to the PDSP web site: <a href="http://pdsp.med.unc.edu/" class="extLink">http://pdsp.med.unc.edu/</a>.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Cell Lines and Culture</h3><div class="NLM_p">Cell lines naturally or heterologously expressing specific, functional, human nAChR subtypes were used. The human clonal cell line TE671/RD naturally expresses human muscle-type a1*-nAChRs, containing α1, β1, γ, and δ subunits, with function detectable by <sup>86</sup>Rb<sup>+</sup> efflux assays.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> The human neuroblastoma cell line SH-SY5Y naturally expresses autonomic α3β4*-nAChRs, containing α3, β4, probably α5, and sometimes β2 subunits, and also displays function detectable by <sup>86</sup>Rb<sup>+</sup> efflux assays.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(38)</a> SH-SY5Y cells also express homopentameric α7-nAChR; however, their function is not detected in the <sup>86</sup>Rb<sup>+</sup> efflux assay under the conditions used. SH-EP1 human epithelial cells stably transfected with human α4 and β2 subunits (SH-EP1-hα4β2 cells) have been established and characterized with both ion flux and radioligand binding assays.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(39)</a> SH-EP1-hα4β2 cells have further been shown to express a mixture of high- and low-sensitivity α4β2 nAChRs, for which the ratio of functional expression on the cell surface can be approximated by the response to a fully efficacious dose of compound <b>1</b>, which is fully efficacious at high-sensitivity α4β2 nAChR and negligibly efficacious at low-sensitivity α4β2.</div><div class="NLM_p last">TE671/RD, SH-SY5Y, and transfected SH-EP1 cell lines were maintained as low passage number (1–26 from our frozen stocks) cultures to ensure stable expression of native or heterologously expressed nAChRs as previously described.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Cells were passaged once a week by splitting just-confluent cultures 1/300 (TE671/RD), 1/10 (SH-SY5Y), or 1/40 (transfected SH-EP1) in serum-supplemented medium to maintain log-phase growth.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> <sup>86</sup>Rb<sup>+</sup> Efflux Assays</h3><div class="NLM_p">Function of nAChR subtypes was investigated by use of an established <sup>86</sup>Rb<sup>+</sup> efflux assay protocol.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> The assay is specific for nAChR function under the conditions used, for example, giving identical results in the presence of 100 nM atropine to exclude possible contributions of muscarinic acetylcholine receptors. Cells harvested at confluence from 100 mm plates under a stream of fresh medium only (SH-SY5Y cells) or after mild trypsinization (Irvine Scientific; for TE671/RD or transfected SH-EP1 cells) were then suspended in complete medium and evenly seeded at a density of 1.25–2 confluent 100 mm plates per 24-well plate (Falcon; ∼100–125 mg of total cell protein per well in a 500 μL volume; poly <span class="smallcaps smallerCapital">l</span>-lysine-coated for SH-SY5Y cells). After cells had adhered generally overnight, but no sooner than 4 h later, the medium was removed and replaced with 250 μL per well of complete medium supplemented with ∼350 000 cpm of <sup>86</sup>Rb<sup>+</sup> (NEN; counted at 40% efficiency by Cerenkov counting and the Packard TriCarb 1900 liquid scintillation analyzer). After at least 4 h and typically overnight, <sup>86</sup>Rb<sup>+</sup> efflux was measured by the “flip-plate” technique.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(39)</a> Briefly, after aspiration of the bulk of <sup>86</sup>Rb<sup>+</sup> loading medium from each well of the “cell plate,” each well containing cells was rinsed with 2 mL of fresh <sup>86</sup>Rb<sup>+</sup> efflux buffer [130 mM NaCl, 5.4 mM KCl, 2 mM CaCl<sub>2</sub>, 5 mM glucose, and 50 mM <i>N</i>-(2-hydroxyethyl)piperazine-<i>N</i>′-2-ethanesulfonic acid (HEPES), pH 7.4] to remove extracellular <sup>86</sup>Rb<sup>+</sup>. Following removal of residual rinse buffer by aspiration, the flip-plate technique was used again to simultaneously introduce 1.5 mL of fresh efflux buffer containing drugs of choice at indicated final concentrations from a 24-well “efflux/drug plate” into the wells of the cell plate. After a 9.5 min incubation, the solution was “flipped” back into the efflux/drug plate, and any remaining buffer in the cell plate was removed by aspiration. Ten minutes after the initiation of the first drug treatment, a second efflux/drug plate was used to reintroduce the same concentrations of drugs of choice with the addition of an ∼EC<sub>90</sub> concentration of the full agonist carbamylcholine for 5 min (∼EC<sub>90</sub> concentrations were 200 μM for SH-EP1-hα4β2 cells, 2 mM for SHSY5Y cells, and 464 mM for TE671/RD cells). The second drug treatment was then flipped back into its drug plate, and the remaining cells in the cell plate were lysed and suspended by addition of 1.5 mL of 0.1 M NaOH and 0.1% sodium dodecyl sulfate to each well. Suspensions in each well were then subjected to Cerenkov counting (Wallac Micobeta Trilux 1450; 25% efficiency) after placement of inserts (Wallac 1450-109) into each well to minimize cross-talk between wells.</div><div class="NLM_p">For quality control and normalization purposes, the sum of <sup>86</sup>Rb<sup>+</sup> in cell plates and efflux/drug plates was defined to confirm material balance (i.e., that the sum of <sup>86</sup>Rb<sup>+</sup> released into the efflux/drug plates and <sup>86</sup>Rb<sup>+</sup> remaining in the cell plate were the same for each well). Similarly, the sum of <sup>86</sup>Rb<sup>+</sup> in cell plates and efflux/drug plates also determined the efficiency of <sup>86</sup>Rb<sup>+</sup> loading (the percentage of applied <sup>86</sup>Rb<sup>+</sup> actually loaded into cells). Furthermore, the sum of <sup>86</sup>Rb<sup>+</sup> in cell plates and the second efflux/drug plates defined the amount of intracellular <sup>86</sup>Rb<sup>+</sup> available at the start of the second, 5-min assay and was used to normalize nAChR function assessed.</div><div class="NLM_p">For each experiment, in one set of control samples, total <sup>86</sup>Rb<sup>+</sup> efflux was assessed in the presence of a fully efficacious concentration of carbamylcholine alone (1 mM for SH-EP1-hα4β2 and TE671/RD cells, 3 mM for SH-SY5Y cells). Nonspecific <sup>86</sup>Rb<sup>+</sup> efflux in another set of control samples was measured either in the presence of the fully efficacious concentration of carbamylcholine plus 100 μM mecamylamine, which gave full block of agonist-induced and spontaneous nAChR-mediated ion flux, or in the presence of efflux buffer alone. Both determinations of nonspecific efflux were equivalent. Specific efflux was then taken as the difference in control samples between total and nonspecific <sup>86</sup>Rb<sup>+</sup> efflux. The same approaches were used to define total, nonspecific, and specific ion flux responses in samples subjected to the second, 5-min exposure to test drug with or without carbamylcholine at its ∼EC<sub>90</sub> concentration. For the purpose of determining the approximate ratio of high- and low-sensitivity α4β2 nAChRs for a given experiment, a fully efficacious dose of 1 μM compound <b>1</b> was used for quality control.</div><div class="NLM_p">Intrinsic agonist activity of test drugs was ascertained during the first 9.5 min of the initial 10 min exposure period by use of samples containing test drug only at different concentrations and was normalized, after subtraction of nonspecific efflux, to specific efflux in carbamylcholine control samples. Specific <sup>86</sup>Rb<sup>+</sup> efflux elicited by test drug as a percentage of specific efflux in carbamylcholine controls was the same in these samples whether measured in absolute terms or as a percentage of loaded <sup>86</sup>Rb<sup>+</sup>. Even in samples previously giving an efflux response during the initial 10-min exposure to a partial or full agonist, residual intracellular <sup>86</sup>Rb<sup>+</sup> was adequate to allow assessment of nAChR function in the secondary, 5-min assay. However, care was needed to ensure that data were normalized to the amount of intracellular <sup>86</sup>Rb<sup>+</sup> available at the time of the assay, as absolute levels of total, nonspecific, or specific efflux varied in cells partially depleted of intracellular <sup>86</sup>Rb<sup>+</sup> due to action of any agonist present during the 10-min drug exposure period. That is, calculations of specific efflux as a percentage of loaded <sup>86</sup>Rb<sup>+</sup> were typically corrected for any variation in the electrochemical gradient of <sup>86</sup>Rb<sup>+</sup> created by intracellular ion depletion after the first (agonism/pretreatment) drug treatment.</div><div class="NLM_p last">Ion flux assays (<i>n</i> ≥ 3 separate studies for each drug and cell line combination) were fit to the Hill equation, <i>F</i> ═ <i>F</i><sub>max</sub>/[1 + (<i>X</i>/EC<sub>50</sub>)<i><sup>n</sup></i>], where <i>F</i> is the percentage of control, <i>F</i><sub>max</sub>, for EC<sub>50</sub> (<i>n</i> > 0 for agonists) or IC<sub>50</sub> (<i>n</i> < 0 for antagonists) values, by use of Prism 4 (GraphPad, San Diego, CA). Most ion flux data were fit by allowing maximum and minimum ion flux values to be determined by curve fitting, but in some cases, where antagonists or agonists had weak functional potency, minimum ion flux was set at 0% of control or maximum ion flux was set at 100% of control, respectively.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> General Procedures for Behavioral Studies</h3><div id="sec4_9_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> Animals</h4><div class="NLM_p last">BALB/cJ male mice (8–10 weeks old at testing) were obtained from Jackson Laboratory (Bar Harbor, ME). Mice were housed four to a cage in a colony room maintained at 22 ± 2 °C on a 12 h light–dark cycle. All animal experiments were conducted in accordance with the NIH Guide for the Care and Use of Laboratory Animals and the PsychoGenics Animal Care and Use Committee.</div></div><div id="sec4_9_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> Drugs</h4><div class="NLM_p last">Compounds <b>3</b>–<b>5</b> were synthesized according to procedures described in the text, and sertraline was purchased from Toronto Research Chemicals (Ontario, Canada). All compounds were dissolved in injectable water and administered by intraperitoneal (IP) injection or oral gavage (PO) in a volume of 10 mL/kg.</div></div><div id="sec4_9_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> Mouse Forced Swim Test</h4><div class="NLM_p last">Procedures were based on those previously described.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Mice were individually placed into clear glass cylinders (15 cm tall × 10 cm wide, 1 L beakers) containing 23 ± 1 °C water 12 cm deep (approximately 800 mL). Mice were administered vehicle, the SSRI sertraline (10 or 20 mg/kg) as a positive control, or compounds <b>3</b>–<b>5</b>. Thirty minutes following IP or PO administration, mice were placed in the water, and the time the animal spent immobile was recorded over a 6-min trial. Immobility was defined as the postural position of floating in the water.</div></div><div id="sec4_9_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> Statistical Analysis</h4><div class="NLM_p last">Data were analyzed with analysis of variance (ANOVA) with treatment group (vehicle, sertraline, compounds <b>3</b>–<b>5)</b> as the between-group variable and total time immobile in seconds (over the 6-min trial) as the dependent variable. Significant main effects were followed up with the post hoc Newman–Keuls test.</div></div><div id="sec4_9_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> β2* nAchR ex Vivo Receptor Occupancy</h4><div class="NLM_p last">Compound <b>3</b>, <b>4</b>, and <b>5</b> (3 mg/kg) or water was administered 30 min before brain collection (the same time point as in forced swim testing) for analysis of β2 nAChR occupancy in the thalamus (for compound <b>3</b> and <b>5</b>, <i>n</i> = 3; for compound <b>4</b>, <i>n</i> = 4) as described before.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(40)</a></div></div></div></div><div class="NLM_back"><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32033" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32033" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alan P. Kozikowski</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Program, Department of Medicinal Chemistry and Pharmacognosy, University of Illinois at Chicago, 833 South Wood Street, Chicago, Illinois 60612, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#086367726163677f69487d616b266d6c7d"><span class="__cf_email__" data-cfemail="3e555144575551495f7e4b575d105b5a4b">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jianhua Liu</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Program, Department of Medicinal Chemistry and Pharmacognosy, University of Illinois at Chicago, 833 South Wood Street, Chicago, Illinois 60612, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Li-Fang Yu</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Program, Department of Medicinal Chemistry and Pharmacognosy, University of Illinois at Chicago, 833 South Wood Street, Chicago, Illinois 60612, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">J. Brek Eaton</span> - <span class="hlFld-Affiliation affiliation">Division of Neurobiology, Barrow Neurological Institute, 350 West Thomas Road, Phoenix, Arizona 85013, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Barbara Caldarone</span> - <span class="hlFld-Affiliation affiliation">PsychoGenics, Inc., 765 Old Saw Mill River Road, Tarrytown, New York 10591, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Katie Cavino</span> - <span class="hlFld-Affiliation affiliation">PsychoGenics, Inc., 765 Old Saw Mill River Road, Tarrytown, New York 10591, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christina Ruiz</span> - <span class="hlFld-Affiliation affiliation">PsychoGenics, Inc., 765 Old Saw Mill River Road, Tarrytown, New York 10591, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew Terry</span> - <span class="hlFld-Affiliation affiliation">PsychoGenics, Inc., 765 Old Saw Mill River Road, Tarrytown, New York 10591, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Allison Fedolak</span> - <span class="hlFld-Affiliation affiliation">PsychoGenics, Inc., 765 Old Saw Mill River Road, Tarrytown, New York 10591, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daguang Wang</span> - <span class="hlFld-Affiliation affiliation">PsychoGenics, Inc., 765 Old Saw Mill River Road, Tarrytown, New York 10591, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Afshin Ghavami</span> - <span class="hlFld-Affiliation affiliation">PsychoGenics, Inc., 765 Old Saw Mill River Road, Tarrytown, New York 10591, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David A. Lowe</span> - <span class="hlFld-Affiliation affiliation">PsychoGenics, Inc., 765 Old Saw Mill River Road, Tarrytown, New York 10591, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dani Brunner</span> - <span class="hlFld-Affiliation affiliation">PsychoGenics, Inc., 765 Old Saw Mill River Road, Tarrytown, New York 10591, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Psychiatry, Columbia University, NYSPI, 1051 Riverside Drive, New York, New York 10032</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ronald J. Lukas</span> - <span class="hlFld-Affiliation affiliation">Division of Neurobiology, Barrow Neurological Institute, 350 West Thomas Road, Phoenix, Arizona 85013, United States</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="testing" data-doi="10.1021/jm200855b" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i40">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05776" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05776" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This research was supported by Award U19MH085193 from the National Institute of Mental Health. The Phoenix research component was also supported in part by the Barrow Neurological Foundation and was conducted in part in the Charlotte and Harold Simensky Neurochemistry of Alzheimer’s Disease Laboratory. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Mental Health or the National Institutes of Health. We thank the PDSP program for performing binding affinity assays. We thank Dr. Werner Tueckmantel of PsychoGenics, Inc. for his assistance in proofreading the manuscript.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i41" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i41"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i42" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i42"> Abbreviations:</h2><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">blood–brain barrier</p></td></tr><tr><td class="NLM_term">HS</td><td class="NLM_def"><p class="first last">high-sensitivity</p></td></tr><tr><td class="NLM_term">nAChR(s)</td><td class="NLM_def"><p class="first last">nicotinic acetylcholine receptor(s)</p></td></tr><tr><td class="NLM_term">PPB</td><td class="NLM_def"><p class="first last">plasma protein binding</p></td></tr><tr><td class="NLM_term">ADMET</td><td class="NLM_def"><p class="first last">absorption, distribution, metabolism, excretion, and toxicity</p></td></tr><tr><td class="NLM_term">HDAC</td><td class="NLM_def"><p class="first last">histone deacetylases</p></td></tr><tr><td class="NLM_term">NMDA</td><td class="NLM_def"><p class="first last"><i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartic acid</p></td></tr><tr><td class="NLM_term">SSRI</td><td class="NLM_def"><p class="first last">selective serotonin reuptake inhibitor</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human ether-a-go-go-related gene</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i43">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27434" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27434" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 40 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">World Health Organization</span><span class="NLM_x">. </span> <span class="citation_source-book">Mental health and development: targeting people with mental health conditions as a vulnerable group</span>. <span class="NLM_publisher-name">WHO Press</span>: <span class="NLM_publisher-loc">Geneva, Switzerland</span>,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=World+Health+Organization&title=Mental+health+and+development%3A+targeting+people+with+mental+health+conditions+as+a+vulnerable+group"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3D%26btitle%3DMental%2520health%2520and%2520development%253A%2520targeting%2520people%2520with%2520mental%2520health%2520conditions%2520as%2520a%2520vulnerable%2520group%26pub%3DWHO%2520Press%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Henn, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vollmayr, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartorius, A.</span><span> </span><span class="NLM_article-title">Mechanisms of depression: the role of neurogenesis</span> <span class="citation_source-journal">Drug Discovery Today: Dis. Mech.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">407</span><span class="NLM_x">–</span> <span class="NLM_lpage">411</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm200855b&amp;key=10.1016%2Fj.ddmec.2004.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm200855b&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVOmtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2004&pages=407-411&author=F.+Hennauthor=B.+Vollmayrauthor=A.+Sartorius&title=Mechanisms+of+depression%3A+the+role+of+neurogenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of depression: the role of neurogenesis</span></div><div class="casAuthors">Henn, Fritz; Vollmayr, Barbara; Sartorius, Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today: Disease Mechanisms</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">407-411</span>CODEN:
                <span class="NLM_cas:coden">DDTDAO</span>;
        ISSN:<span class="NLM_cas:issn">1740-6765</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The behavioral changes in depression can relate to alterations in hippocampal function.  A variety of inputs to the hippocampus can effect mood, including norepinephrine (NE), serotonin (5HT) and cortisol, all factors activated by stress.  These are thought to act through activation of CREB and neurotrophins such as BDNF.  Stress was shown to decrease hippocampal neurogenesis and most antidepressants increase neurogenesis, leading to the hypothesis that changes in the rate of new neuron formation might underlie depressive illnesses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1cZS3WiwZirVg90H21EOLACvtfcHk0ljEjcOUvBT41Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVOmtbk%253D&md5=1d0994df3b20b84496c49770384c4781</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.ddmec.2004.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ddmec.2004.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DHenn%26aufirst%3DF.%26aulast%3DVollmayr%26aufirst%3DB.%26aulast%3DSartorius%26aufirst%3DA.%26atitle%3DMechanisms%2520of%2520depression%253A%2520the%2520role%2520of%2520neurogenesis%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Dis.%2520Mech.%26date%3D2004%26volume%3D1%26spage%3D407%26epage%3D411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">World Health Organization</span><span class="NLM_x">. </span> <span class="citation_source-book">Global health risks: mortality and burden of disease attributable to selected major risks</span>. <span class="NLM_publisher-name">WHO Press</span>: <span class="NLM_publisher-loc">Geneva, Switzerland</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=World+Health+Organization&title=Global+health+risks%3A+mortality+and+burden+of+disease+attributable+to+selected+major+risks"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3D%26btitle%3DGlobal%2520health%2520risks%253A%2520mortality%2520and%2520burden%2520of%2520disease%2520attributable%2520to%2520selected%2520major%2520risks%26pub%3DWHO%2520Press%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Reeves, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladner, M. E.</span><span> </span><span class="NLM_article-title">Antidepressant-induced suicidality: an update</span> <span class="citation_source-journal">CNS Neurosci. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">227</span><span class="NLM_x">–</span> <span class="NLM_lpage">234</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm200855b&amp;key=20553304" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm200855b&amp;key=1%3ACAS%3A280%3ADC%252BC3cnmsl2ntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=227-234&author=R.+R.+Reevesauthor=M.+E.+Ladner&title=Antidepressant-induced+suicidality%3A+an+update"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Antidepressant-induced suicidality: an update</span></div><div class="casAuthors">Reeves Roy R; Ladner Mark E</div><div class="citationInfo"><span class="NLM_cas:title">CNS neuroscience & therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">227-34</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Evidence suggests that antidepressant treatment may in some cases result in worsening depression and increased risk of suicidality in pediatric and adolescent patients.  The United States Food and Drug Administration requires that antidepressants carry a black box warning regarding such a risk in patients up to age 24.  Many studies of antidepressant-induced suicidality among adults have also reported an increased risk, while several other investigations involving that population have not supported such a finding.  This article provides an update of the controversy surrounding antidepressants as a potential cause of suicidal ideations or behavior.  Antidepressant-induced suicidality appears to be an uncommon occurrence but also a legitimate phenomenon.  Close monitoring and a follow-up care should be provided for patients after initiation of a new antidepressant.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQpaJAtPTO0M8AKB7Fa-xrUfW6udTcc2eaIzZ6ULtFOu7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cnmsl2ntg%253D%253D&md5=0380a35990856318143fc5b8dcb4c884</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReeves%26aufirst%3DR.%2BR.%26aulast%3DLadner%26aufirst%3DM.%2BE.%26atitle%3DAntidepressant-induced%2520suicidality%253A%2520an%2520update%26jtitle%3DCNS%2520Neurosci.%2520Ther.%26date%3D2010%26volume%3D16%26spage%3D227%26epage%3D234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Berton, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nestler, E. J.</span><span> </span><span class="NLM_article-title">New approaches to antidepressant drug discovery: beyond monoamines</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">137</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm200855b&amp;key=10.1038%2Fnrn1846" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm200855b&amp;key=16429123" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm200855b&amp;key=1%3ACAS%3A528%3ADC%252BD28XlvV2qug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=137-151&author=O.+Bertonauthor=E.+J.+Nestler&title=New+approaches+to+antidepressant+drug+discovery%3A+beyond+monoamines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">New approaches to antidepressant drug discovery: beyond monoamines</span></div><div class="casAuthors">Berton, Olivier; Nestler, Eric J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">137-151</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  All available antidepressant medications are based on serendipitous discoveries of the clin. efficacy of two classes of antidepressants more than 50 years ago.  These tricyclic and monoamine oxidase inhibitor antidepressants were subsequently found to promote serotonin or noradrenaline function in the brain.  Newer agents are more specific but have the same core mechanisms of action in promoting these monoamine neurotransmitters.  This is unfortunate, because only ∼50% of individuals with depression show full remission in response to these mechanisms.  This review summarizes the obstacles that have hindered the development of non-monoamine-based antidepressants, and provides a progress report on some of the most promising current strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPjIkAa3yd1rVg90H21EOLACvtfcHk0lhvuMkUOHuSIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlvV2qug%253D%253D&md5=78c0c58b7fd7cebfcdfe15e30eaa0c54</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrn1846&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn1846%26sid%3Dliteratum%253Aachs%26aulast%3DBerton%26aufirst%3DO.%26aulast%3DNestler%26aufirst%3DE.%2BJ.%26atitle%3DNew%2520approaches%2520to%2520antidepressant%2520drug%2520discovery%253A%2520beyond%2520monoamines%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2006%26volume%3D7%26spage%3D137%26epage%3D151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Zheng, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yap, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, Z. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, Z. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y. Z.</span><span> </span><span class="NLM_article-title">Therapeutic targets: progress of their exploration and investigation of their characteristics</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">259</span><span class="NLM_x">–</span> <span class="NLM_lpage">279</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2006&pages=259-279&author=C.+J.+Zhengauthor=L.+Y.+Hanauthor=C.+W.+Yapauthor=Z.+L.+Jiauthor=Z.+W.+Caoauthor=Y.+Z.+Chen&title=Therapeutic+targets%3A+progress+of+their+exploration+and+investigation+of+their+characteristics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DC.%2BJ.%26aulast%3DHan%26aufirst%3DL.%2BY.%26aulast%3DYap%26aufirst%3DC.%2BW.%26aulast%3DJi%26aufirst%3DZ.%2BL.%26aulast%3DCao%26aufirst%3DZ.%2BW.%26aulast%3DChen%26aufirst%3DY.%2BZ.%26atitle%3DTherapeutic%2520targets%253A%2520progress%2520of%2520their%2520exploration%2520and%2520investigation%2520of%2520their%2520characteristics%26jtitle%3DPharmacol.%2520Rev.%26date%3D2006%26volume%3D58%26spage%3D259%26epage%3D279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Abel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zukin, R. S.</span><span> </span><span class="NLM_article-title">Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">64</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm200855b&amp;key=10.1016%2Fj.coph.2007.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm200855b&amp;key=18206423" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm200855b&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVOgu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=57-64&author=T.+Abelauthor=R.+S.+Zukin&title=Epigenetic+targets+of+HDAC+inhibition+in+neurodegenerative+and+psychiatric+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders</span></div><div class="casAuthors">Abel, Ted; Zukin, R. Suzanne</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-64</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Epigenetic chromatin remodeling and modifications of DNA represent central mechanisms for regulation of gene expression during brain development and in memory formation.  Emerging evidence implicates epigenetic modifications in disorders of synaptic plasticity and cognition.  This review focuses on recent findings that HDAC inhibitors can ameliorate deficits in synaptic plasticity, cognition, and stress-related behaviors in a wide range of neurol. and psychiatric disorders including Huntington's disease, Parkinson's disease, anxiety and mood disorders, Rubinstein-Taybi syndrome, and Rett syndrome.  These agents may prove useful in the clinic for the treatment of the cognitive impairments that are central elements of many neurodevelopmental, neurol., and psychiatric disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo70UH4lz6tXbVg90H21EOLACvtfcHk0lhvuMkUOHuSIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVOgu78%253D&md5=eda84c14cd5138b12b69ce51684459fd</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2007.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2007.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DAbel%26aufirst%3DT.%26aulast%3DZukin%26aufirst%3DR.%2BS.%26atitle%3DEpigenetic%2520targets%2520of%2520HDAC%2520inhibition%2520in%2520neurodegenerative%2520and%2520psychiatric%2520disorders%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2008%26volume%3D8%26spage%3D57%26epage%3D64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Schroeder, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crusio, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akbarian, S.</span><span> </span><span class="NLM_article-title">Antidepressant-like effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">55</span><span class="NLM_x">–</span> <span class="NLM_lpage">64</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm200855b&amp;key=10.1016%2Fj.biopsych.2006.06.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm200855b&amp;key=16945350" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm200855b&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmsFKrur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2007&pages=55-64&author=F.+A.+Schroederauthor=C.+L.+Linauthor=W.+E.+Crusioauthor=S.+Akbarian&title=Antidepressant-like+effects+of+the+histone+deacetylase+inhibitor%2C+sodium+butyrate%2C+in+the+mouse"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Antidepressant-Like Effects of the Histone Deacetylase Inhibitor, Sodium Butyrate, in the Mouse</span></div><div class="casAuthors">Schroeder, Frederick A.; Lin, Cong Lily; Crusio, Wim E.; Akbarian, Schahram</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-64</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Chromatin remodeling, including changes in histone acetylation, might play a role in the pathophysiol. and treatment of depression.  We investigated whether the histone deacetylase inhibitor sodium butyrate (SB) administered as single drug or in combination with the selective serotonin reuptake inhibitor (SSRI) fluoxetine exerts antidepressant-like effects in mice.  Mice (C57BL/6J) received injections of SB, fluoxetine, or a combination of both drugs either acutely or chronically for a period of 28 days and were subjected to a battery of tests to measure anxiety and behavioral despair.  Histone acetylation and expression of brain-derived neurotrophic factor (BDNF) were monitored in hippocampus and frontal cortex.  Co-treatment with SB and fluoxetine resulted in a significant 20-40% decrease in immobility scores in the tail suspension test (TST), a measure for behavioral despair, both acutely and chronically.  In contrast, decreased immobility after single drug regimens was limited either to the acute (fluoxetine) or chronic (SB) paradigm.  Systemic injection of SB induced short-lasting histone hyperacetylation in hippocampus and frontal cortex.  Among the four treatment paradigms that resulted in improved immobility scores in the TST, three were assocd. with a transient, at least 50% increase in BDNF transcript in frontal cortex, whereas changes in hippocampus were less consistent.  The histone deacetylase inhibitor SB exerts antidepressant-like effects in the mouse.  The therapeutic benefits and mol. actions of histone modifying drugs, including co-treatment with SSRIs and other newer generation antidepressant medications, warrant further exploration in exptl. models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHGR19kvoLIrVg90H21EOLACvtfcHk0liXjGHeqjWyCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmsFKrur0%253D&md5=a7337d9513d437a344bdc0374db1fac1</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2006.06.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2006.06.036%26sid%3Dliteratum%253Aachs%26aulast%3DSchroeder%26aufirst%3DF.%2BA.%26aulast%3DLin%26aufirst%3DC.%2BL.%26aulast%3DCrusio%26aufirst%3DW.%2BE.%26aulast%3DAkbarian%26aufirst%3DS.%26atitle%3DAntidepressant-like%2520effects%2520of%2520the%2520histone%2520deacetylase%2520inhibitor%252C%2520sodium%2520butyrate%252C%2520in%2520the%2520mouse%26jtitle%3DBiol.%2520Psychiatry%26date%3D2007%26volume%3D62%26spage%3D55%26epage%3D64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Miyamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mishina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nabeshima, T.</span><span> </span><span class="NLM_article-title">Lower sensitivity to stress and altered monoaminergic neuronal function in mice lacking the NMDA receptor epsilon 4 subunit</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2335</span><span class="NLM_x">–</span> <span class="NLM_lpage">2342</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm200855b&amp;key=11896172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm200855b&amp;key=1%3ACAS%3A528%3ADC%252BD38XisVGit7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2002&pages=2335-2342&author=Y.+Miyamotoauthor=K.+Yamadaauthor=Y.+Nodaauthor=H.+Moriauthor=M.+Mishinaauthor=T.+Nabeshima&title=Lower+sensitivity+to+stress+and+altered+monoaminergic+neuronal+function+in+mice+lacking+the+NMDA+receptor+epsilon+4+subunit"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Lower sensitivity to stress and altered monoaminergic neuronal function in mice lacking the NMDA receptor ε4 subunit</span></div><div class="casAuthors">Miyamoto, Yoshiaki; Yamada, Kiyofumi; Noda, Yukihiro; Mori, Hisashi; Mishina, Masayoshi; Nabeshima, Toshitaka</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2335-2342</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">NMDA receptors, an ionotropic subtype of glutamate receptors (GluRs), play an important role in excitatory neurotransmission, synaptic plasticity, and brain development.  They are composed of the GluRζ subunit (NR1) combined with any one of four GluRε subunits (GluRε1-GluRε4; NR2A-NR2D).  Although the GluRζ subunit exists in the majority of the CNS throughout all stages of development, the GluRε subunits are expressed in distinct temporal and spatial patterns.  In the present study, we investigated neuronal functions in mice lacking the embryonic GluRε4 subunit.  GluRε4 mutant mice exhibited redns. of [3H]MK-801 binding and 45Ca2+ uptake through the NMDA receptors.  The expression of GluRζ subunit protein, but not GluRε1 and GluRε2 subunit proteins, was reduced in the frontal cortex and striatum of the mutant mice.  A postmortem examn. in GluRε4 mutant mice revealed that tissue contents of norepinephrine, dopamine, serotonin, and their metabolites were reduced in the hippocampus and that dopamine, as well as serotonin, metab. was upregulated in the frontal cortex, striatum, hippocampus, and thalamus.  To clarify the phenotypical influences of the alteration in neuronal functions, performances in various behavioral tests were examd.  GluRε4 mutant mice showed reduced spontaneous locomotor activity in a novel environment and less sensitivity to stress induced by the elevated plus-maze, light-dark box, and forced swimming tests.  These findings suggest that GluRε4 mutant mice have dysfunctional NMDA receptors and altered emotional behavior probably caused by changes in monoaminergic neuronal activities in adulthood.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgUqNdgZA1frVg90H21EOLACvtfcHk0liXjGHeqjWyCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XisVGit7s%253D&md5=17535ed0fe971b546afbdc1b26d43c16</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMiyamoto%26aufirst%3DY.%26aulast%3DYamada%26aufirst%3DK.%26aulast%3DNoda%26aufirst%3DY.%26aulast%3DMori%26aufirst%3DH.%26aulast%3DMishina%26aufirst%3DM.%26aulast%3DNabeshima%26aufirst%3DT.%26atitle%3DLower%2520sensitivity%2520to%2520stress%2520and%2520altered%2520monoaminergic%2520neuronal%2520function%2520in%2520mice%2520lacking%2520the%2520NMDA%2520receptor%2520epsilon%25204%2520subunit%26jtitle%3DJ.%2520Neurosci.%26date%3D2002%26volume%3D22%26spage%3D2335%26epage%3D2342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Shytle, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silver, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehan, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanberg, P. R.</span><span> </span><span class="NLM_article-title">Nicotinic acetylcholine receptors as targets for antidepressants</span> <span class="citation_source-journal">Mol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">525</span><span class="NLM_x">–</span> <span class="NLM_lpage">535</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm200855b&amp;key=10.1038%2Fsj.mp.4001035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm200855b&amp;key=12140772" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm200855b&amp;key=1%3ACAS%3A528%3ADC%252BD38XlsFWrsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2002&pages=525-535&author=R.+D.+Shytleauthor=A.+A.+Silverauthor=R.+J.+Lukasauthor=M.+B.+Newmanauthor=D.+V.+Sheehanauthor=P.+R.+Sanberg&title=Nicotinic+acetylcholine+receptors+as+targets+for+antidepressants"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinic acetylcholine receptors as targets for antidepressants</span></div><div class="casAuthors">Shytle, R. D.; Silver, A. A.; Lukas, R. J.; Newman, M. B.; Sheehan, D. V.; Sanberg, P. R.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Psychiatry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">525-535</span>CODEN:
                <span class="NLM_cas:coden">MOPSFQ</span>;
        ISSN:<span class="NLM_cas:issn">1359-4184</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  While the monoamine deficiency hypothesis of depression is still most commonly used to explain the actions of antidepressant drugs, a growing body of evidence has accumulated that is not adequately explained by the hypothesis.  This article draws attention to contributions from another apparently common pharmacol. property of antidepressant medications - the inhibition of nicotinic acetylcholine receptors (nAChR).  Evidence is presented suggesting the hypercholinergic neurotransmission, which is assocd. with depressed mood states, may be mediated through excessive neuronal nicotinic receptor activation and that the therapeutic actions of many antidepressants may be, in part, mediated through inhibition of these receptors.  In support of this hypothesis, preliminary evidence is presented suggesting that the potent, centrally acting nAChR antagonist, mecamylamine, which is devoid of monoamine reuptake inhibition, may reduce symptoms of depression and mood instability in patients with comorbid depression and bipolar disorder.  If this hypothesis is supported by further preclin. and clin. research, nicotinic acetylcholine receptor antagonists may represent a novel class of therapeutic agents for treating mood disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-iysHOoVi_LVg90H21EOLACvtfcHk0lgo4aAU3X3MSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlsFWrsb0%253D&md5=1c15fa7b0b0779aa69198a24c8546726</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fsj.mp.4001035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.mp.4001035%26sid%3Dliteratum%253Aachs%26aulast%3DShytle%26aufirst%3DR.%2BD.%26aulast%3DSilver%26aufirst%3DA.%2BA.%26aulast%3DLukas%26aufirst%3DR.%2BJ.%26aulast%3DNewman%26aufirst%3DM.%2BB.%26aulast%3DSheehan%26aufirst%3DD.%2BV.%26aulast%3DSanberg%26aufirst%3DP.%2BR.%26atitle%3DNicotinic%2520acetylcholine%2520receptors%2520as%2520targets%2520for%2520antidepressants%26jtitle%3DMol.%2520Psychiatry%26date%3D2002%26volume%3D7%26spage%3D525%26epage%3D535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Buckley, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surowy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curzon, P.</span><span> </span><span class="NLM_article-title">Mechanism of action of A-85380 in an animal model of depression</span> <span class="citation_source-journal">Prog. Neuropsychopharmacol. Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">723</span><span class="NLM_x">–</span> <span class="NLM_lpage">730</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm200855b&amp;key=10.1016%2Fj.pnpbp.2004.05.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm200855b&amp;key=15276699" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm200855b&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtVansLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2004&pages=723-730&author=M.+J.+Buckleyauthor=C.+Surowyauthor=M.+Meyerauthor=P.+Curzon&title=Mechanism+of+action+of+A-85380+in+an+animal+model+of+depression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of action of A-85380 in an animal model of depression</span></div><div class="casAuthors">Buckley, Michael J.; Surowy, Carol; Meyer, Michael; Curzon, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neuro-Psychopharmacology & Biological Psychiatry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">723-730</span>CODEN:
                <span class="NLM_cas:coden">PNPPD7</span>;
        ISSN:<span class="NLM_cas:issn">0278-5846</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A role for neuronal nicotinic receptor (NNR) activation in animal models of depression has been established.  In order to det. the mechanism by which NNR ligands exert their antidepressant effects, expts. using different NNR receptor antagonists in both the mouse and the rat forced swim test (RFST) were performed.  In the mouse forced swim test (MFST), A-85380 (0.62 μmol/kg=0.14 mg/kg, i.p.), an NNR agonist, increased swim distance when administered 15 min prior to test.  This effect was blocked by pre-treatment with mecamylamine (1.5 μmol/kg=0.3 mg/kg, i.p.), suggesting that an NNR mechanism is involved.  Further, chlorisondamine at a non-central nervous system (CNS) penetrating dose (1.6 μmol/kg=1 mg/kg, i.p.) did not antagonize A-85380 in this model, thus implicating central rather than peripheral nicotinic receptors.  Dihydro-β-erythroidine (DHβE, 0.3 μmol/kg=0.1 mg/kg, i.p.) pre-treatment also blocked this effect, indicating that the α4β2 receptor subtype may be involved in A-85380-induced antidepressant effects.  Finally, methiothepin (0.33 μmol/kg=0.14 mg/kg, i.p.) pre-treatment antagonized this effect, suggesting serotonergic involvement.  In the rat modified forced swim test, sub-acute administration of A-85380 (0.62 μmol/kg, i.p.) increased swimming behavior and decreased immobility.  Climbing behavior was unaffected.  In contrast, desipramine treatment (33 μmol/kg=10 mg/kg, i.p.) resulted in an increase in climbing behavior with no effect on swimming.  This behavioral profile has been shown to be more typical of serotonergic rather than noradrenergic antidepressants, suggesting that A-85380 exerts its effects via NNR activation of serotonergic systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpat5Oy_ll2BbVg90H21EOLACvtfcHk0lgo4aAU3X3MSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtVansLY%253D&md5=441e1ee97e800531a136c4003ada9028</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.pnpbp.2004.05.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pnpbp.2004.05.012%26sid%3Dliteratum%253Aachs%26aulast%3DBuckley%26aufirst%3DM.%2BJ.%26aulast%3DSurowy%26aufirst%3DC.%26aulast%3DMeyer%26aufirst%3DM.%26aulast%3DCurzon%26aufirst%3DP.%26atitle%3DMechanism%2520of%2520action%2520of%2520A-85380%2520in%2520an%2520animal%2520model%2520of%2520depression%26jtitle%3DProg.%2520Neuropsychopharmacol.%2520Biol.%2520Psychiatry%26date%3D2004%26volume%3D28%26spage%3D723%26epage%3D730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Ferguson, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodkin, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lloyd, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menzaghi, F.</span><span> </span><span class="NLM_article-title">Antidepressant-like effects of the subtype-selective nicotinic acetylcholine receptor agonist, SIB-1508Y, in the learned helplessness rat model of depression</span> <span class="citation_source-journal">Psychopharmacology (Berlin)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">152</span><span class="NLM_x">, </span> <span class="NLM_fpage">295</span><span class="NLM_x">–</span> <span class="NLM_lpage">303</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm200855b&amp;key=10.1007%2Fs002130000531" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm200855b&amp;key=11105940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm200855b&amp;key=1%3ACAS%3A528%3ADC%252BD3cXosVKrs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=2000&pages=295-303&author=S.+M.+Fergusonauthor=J.+D.+Brodkinauthor=G.+K.+Lloydauthor=F.+Menzaghi&title=Antidepressant-like+effects+of+the+subtype-selective+nicotinic+acetylcholine+receptor+agonist%2C+SIB-1508Y%2C+in+the+learned+helplessness+rat+model+of+depression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Antidepressant-like effects of the subtype-selective nicotinic acetylcholine receptor agonist, SIB-1508Y, in the learned helplessness rat model of depression</span></div><div class="casAuthors">Ferguson, Susan M.; Brodkin, Jesse D.; Lloyd, G. Kenneth; Menzaghi, Frederique</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">152</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">295-303</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Rationale: Epidemiol. studies of smokers suggest that there is a link between nicotine and depression.  Nonetheless, few studies have examd. the potential use of nicotinic ligands in the treatment of depression.  Objectives: The goal of this study was to evaluate the effects of SIB-1508Y, a novel subtype-selective ligand for high affinity nicotinic acetylcholine receptors (nAChRs), in the learned helplessness model of depression in rats.  Methods: In this model, exposure to inescapable foot-shock produces a lasting deficit in escape responses emitted in a subsequent conditioned avoidance procedure (learned helplessness).  The effect of SIB-1508Y on learned helplessness was compared to the clin. used antidepressants, imipramine and fluoxetine, and the non-selective nAChR ligand, nicotine.  Results: Similarly to imipramine and fluoxetine, subchronic treatment (5 days) with SIB-1508Y reversed the escape deficit in the learned helplessness model in a dose dependent manner.  The effect of SIB-1508Y on learned helplessness was still apparent 1 wk following drug administration and was also maintained after 4 wk of daily administration.  In contrast, while nicotine was able to attenuate the learned helplessness deficit, this trend only reached statistical significance after chronic administration.  The non-competitive ion channel blocker mecamylamine increased escape failures when administered alone and blocked the effects of SIB-1508Y but not imipramine.  SIB-1508Y also produced an increase in avoidance responding, which suggests an enhancement of learning.  Conclusion: These results not only suggest a role for nAChRs in the development of a depressive-like syndrome, but also that subtype-selective nAChR agonists, such as SIB-1508Y, may offer a novel therapeutic approach to the treatment of depression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIrOZoKkV0KbVg90H21EOLACvtfcHk0lgo4aAU3X3MSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXosVKrs7s%253D&md5=e666d9ee7d29027f862915024bd27f52</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1007%2Fs002130000531&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002130000531%26sid%3Dliteratum%253Aachs%26aulast%3DFerguson%26aufirst%3DS.%2BM.%26aulast%3DBrodkin%26aufirst%3DJ.%2BD.%26aulast%3DLloyd%26aufirst%3DG.%2BK.%26aulast%3DMenzaghi%26aufirst%3DF.%26atitle%3DAntidepressant-like%2520effects%2520of%2520the%2520subtype-selective%2520nicotinic%2520acetylcholine%2520receptor%2520agonist%252C%2520SIB-1508Y%252C%2520in%2520the%2520learned%2520helplessness%2520rat%2520model%2520of%2520depression%26jtitle%3DPsychopharmacology%2520%2528Berlin%2529%26date%3D2000%26volume%3D152%26spage%3D295%26epage%3D303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Rabenstein, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldarone, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picciotto, M. R.</span><span> </span><span class="NLM_article-title">The nicotinic antagonist mecamylamine has antidepressant-like effects in wild-type but not beta2- or alpha7-nicotinic acetylcholine receptor subunit knockout mice</span> <span class="citation_source-journal">Psychopharmacology (Berlin)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">189</span><span class="NLM_x">, </span> <span class="NLM_fpage">395</span><span class="NLM_x">–</span> <span class="NLM_lpage">401</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm200855b&amp;key=10.1007%2Fs00213-006-0568-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm200855b&amp;key=17016705" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm200855b&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1WltrfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=189&publication_year=2006&pages=395-401&author=R.+L.+Rabensteinauthor=B.+J.+Caldaroneauthor=M.+R.+Picciotto&title=The+nicotinic+antagonist+mecamylamine+has+antidepressant-like+effects+in+wild-type+but+not+beta2-+or+alpha7-nicotinic+acetylcholine+receptor+subunit+knockout+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The nicotinic antagonist mecamylamine has antidepressant-like effects in wild-type but not β2- or α7-nicotinic acetylcholine receptor subunit knockout mice</span></div><div class="casAuthors">Rabenstein, R. L.; Caldarone, B. J.; Picciotto, M. R.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">189</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">395-401</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">Increases in cholinergic transmission are linked to depression in human subjects and animal models.  We therefore examd. the effect of decreasing nicotinic acetylcholine receptor (nAChR) activity in tests of antidepressant efficacy using C57BL/6J mice.  We detd. whether the noncompetitive nAChR antagonist mecamylamine had antidepressant-like effects in the forced swim test (FST) and tail suspension test (TST).  These expts. were repeated in mice lacking either the β2- or α7-nAChR subunits to identify the nAChR subunits involved in mediating the antidepressant response to mecamylamine.  Adult mice on the C57BL/6J background were acutely administered mecamylamine i.p. 30 min before testing in the FST or TST.  A dose-response study showed that mecamylamine significantly decreased immobility time in the TST at the 1.0-mg/kg dose but did not alter baseline locomotor activity.  The competitive nAChR antagonist dihydro-β-erythroidine, but not the blood-brain barrier impermeant antagonist hexamethonium, also decreased immobility in the TST.  One milligram per kg of mecamylamine also significantly decreased time immobile in the FST whereas both β2- and α7-knockout mice were insensitive to the effects of mecamylamine in the FST.  Decreased activity of central nAChRs has antidepressant-like effects in both the TST and FST and these effects are dependent on both β2 and α7 subunits.  Therefore, compds. that decrease nAChR activity may be attractive new candidates for development as antidepressants in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4zVDjRJ7VULVg90H21EOLACvtfcHk0ljMFNJeqZu2hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1WltrfK&md5=b99a73e6e5569f34c9d45c79c50cb540</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1007%2Fs00213-006-0568-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-006-0568-z%26sid%3Dliteratum%253Aachs%26aulast%3DRabenstein%26aufirst%3DR.%2BL.%26aulast%3DCaldarone%26aufirst%3DB.%2BJ.%26aulast%3DPicciotto%26aufirst%3DM.%2BR.%26atitle%3DThe%2520nicotinic%2520antagonist%2520mecamylamine%2520has%2520antidepressant-like%2520effects%2520in%2520wild-type%2520but%2520not%2520beta2-%2520or%2520alpha7-nicotinic%2520acetylcholine%2520receptor%2520subunit%2520knockout%2520mice%26jtitle%3DPsychopharmacology%2520%2528Berlin%2529%26date%3D2006%26volume%3D189%26spage%3D395%26epage%3D401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Caldarone, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrist, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleary, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beech, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picciotto, M. R.</span><span> </span><span class="NLM_article-title">High-affinity nicotinic acetylcholine receptors are required for antidepressant effects of amitriptyline on behavior and hippocampal cell proliferation</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">657</span><span class="NLM_x">–</span> <span class="NLM_lpage">664</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm200855b&amp;key=10.1016%2Fj.biopsych.2004.08.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm200855b&amp;key=15522249" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm200855b&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptFOmtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2004&pages=657-664&author=B.+J.+Caldaroneauthor=A.+Harristauthor=M.+A.+Clearyauthor=R.+D.+Beechauthor=S.+L.+Kingauthor=M.+R.+Picciotto&title=High-affinity+nicotinic+acetylcholine+receptors+are+required+for+antidepressant+effects+of+amitriptyline+on+behavior+and+hippocampal+cell+proliferation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">High-affinity nicotinic acetylcholine receptors are required for antidepressant effects of amitriptyline on behavior and hippocampal cell proliferation</span></div><div class="casAuthors">Caldarone, Barbara J.; Harrist, Alexia; Cleary, Muriel A.; Beech, Robert D.; King, Sarah L.; Picciotto, Marina R.</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">657-664</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A wide variety of antidepressants act as noncompetitive antagonists of nicotinic acetylcholine receptors (nAChRs), but the relationship between this antagonism and the therapeutic effects of antidepressants is unknown.  Antidepressant properties of the noncompetitive nAChR antagonist mecamylamine in the forced swim test were tested alone and in combination with the tricyclic antidepressant amitriptyline.  Mice lacking high-affinity nAChRs were tested in three behavioral models to det. whether these receptors are required for behavioral effects of amitriptyline in common models of antidepressant action.  Finally, the brains of wild-type and knockout animals treated with amitriptyline were examd. to det. whether high-affinity nAChRs are required for antidepressant-induced increases in hippocampal cell proliferation.  Inhibition of nAChRs by mecamylamine had antidepressant-like effects in the forced swim test and potentiated the antidepressant activity of amitriptyline when the two drugs were used in combination.  Mice lacking high-affinity nAChRs showed no behavioral response to amitriptyline.  Finally, after chronic treatment with amitriptyline, nAChR knockout mice did not show the increase in hippocampal cell proliferation seen in wild-type mice.  These data support the hypothesis that antagonism of nAChRs is an essential component of the therapeutic action of antidepressants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbp5wZl3o94bVg90H21EOLACvtfcHk0ljMFNJeqZu2hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptFOmtrc%253D&md5=90c1ee0ae0910945d98113e7eb9d7b9e</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2004.08.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2004.08.010%26sid%3Dliteratum%253Aachs%26aulast%3DCaldarone%26aufirst%3DB.%2BJ.%26aulast%3DHarrist%26aufirst%3DA.%26aulast%3DCleary%26aufirst%3DM.%2BA.%26aulast%3DBeech%26aufirst%3DR.%2BD.%26aulast%3DKing%26aufirst%3DS.%2BL.%26aulast%3DPicciotto%26aufirst%3DM.%2BR.%26atitle%3DHigh-affinity%2520nicotinic%2520acetylcholine%2520receptors%2520are%2520required%2520for%2520antidepressant%2520effects%2520of%2520amitriptyline%2520on%2520behavior%2520and%2520hippocampal%2520cell%2520proliferation%26jtitle%3DBiol.%2520Psychiatry%26date%3D2004%26volume%3D56%26spage%3D657%26epage%3D664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Picciotto, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lena, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bessis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lallemand, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Novere, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincent, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pich, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brulet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Changeux, J. P.</span><span> </span><span class="NLM_article-title">Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">374</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">67</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=374&publication_year=1995&pages=65-67&author=M.+R.+Picciottoauthor=M.+Zoliauthor=C.+Lenaauthor=A.+Bessisauthor=Y.+Lallemandauthor=N.+Le+Novereauthor=P.+Vincentauthor=E.+M.+Pichauthor=P.+Bruletauthor=J.+P.+Changeux&title=Abnormal+avoidance+learning+in+mice+lacking+functional+high-affinity+nicotine+receptor+in+the+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPicciotto%26aufirst%3DM.%2BR.%26aulast%3DZoli%26aufirst%3DM.%26aulast%3DLena%26aufirst%3DC.%26aulast%3DBessis%26aufirst%3DA.%26aulast%3DLallemand%26aufirst%3DY.%26aulast%3DLe%2BNovere%26aufirst%3DN.%26aulast%3DVincent%26aufirst%3DP.%26aulast%3DPich%26aufirst%3DE.%2BM.%26aulast%3DBrulet%26aufirst%3DP.%26aulast%3DChangeux%26aufirst%3DJ.%2BP.%26atitle%3DAbnormal%2520avoidance%2520learning%2520in%2520mice%2520lacking%2520functional%2520high-affinity%2520nicotine%2520receptor%2520in%2520the%2520brain%26jtitle%3DNature%26date%3D1995%26volume%3D374%26spage%3D65%26epage%3D67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Romanelli, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gratteri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guandalini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonaccini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gualtieri, F.</span><span> </span><span class="NLM_article-title">Central nicotinic receptors: structure, function, ligands, and therapeutic potential</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">746</span><span class="NLM_x">–</span> <span class="NLM_lpage">767</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=746-767&author=M.+N.+Romanelliauthor=P.+Gratteriauthor=L.+Guandaliniauthor=E.+Martiniauthor=C.+Bonacciniauthor=F.+Gualtieri&title=Central+nicotinic+receptors%3A+structure%2C+function%2C+ligands%2C+and+therapeutic+potential"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRomanelli%26aufirst%3DM.%2BN.%26aulast%3DGratteri%26aufirst%3DP.%26aulast%3DGuandalini%26aufirst%3DL.%26aulast%3DMartini%26aufirst%3DE.%26aulast%3DBonaccini%26aufirst%3DC.%26aulast%3DGualtieri%26aufirst%3DF.%26atitle%3DCentral%2520nicotinic%2520receptors%253A%2520structure%252C%2520function%252C%2520ligands%252C%2520and%2520therapeutic%2520potential%26jtitle%3DChemMedChem%26date%3D2007%26volume%3D2%26spage%3D746%26epage%3D767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Gotti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clementi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fornari, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaimarri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guiducci, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manfredi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moretti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedrazzi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pucci, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoli, M.</span><span> </span><span class="NLM_article-title">Structural and functional diversity of native brain neuronal nicotinic receptors</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">703</span><span class="NLM_x">–</span> <span class="NLM_lpage">711</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2009&pages=703-711&author=C.+Gottiauthor=F.+Clementiauthor=A.+Fornariauthor=A.+Gaimarriauthor=S.+Guiducciauthor=I.+Manfrediauthor=M.+Morettiauthor=P.+Pedrazziauthor=L.+Pucciauthor=M.+Zoli&title=Structural+and+functional+diversity+of+native+brain+neuronal+nicotinic+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGotti%26aufirst%3DC.%26aulast%3DClementi%26aufirst%3DF.%26aulast%3DFornari%26aufirst%3DA.%26aulast%3DGaimarri%26aufirst%3DA.%26aulast%3DGuiducci%26aufirst%3DS.%26aulast%3DManfredi%26aufirst%3DI.%26aulast%3DMoretti%26aufirst%3DM.%26aulast%3DPedrazzi%26aufirst%3DP.%26aulast%3DPucci%26aufirst%3DL.%26aulast%3DZoli%26aufirst%3DM.%26atitle%3DStructural%2520and%2520functional%2520diversity%2520of%2520native%2520brain%2520neuronal%2520nicotinic%2520receptors%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2009%26volume%3D78%26spage%3D703%26epage%3D711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Zwart, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carbone, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moroni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bermudez, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mogg, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folly, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broad, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinz, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sher, E.</span><span> </span><span class="NLM_article-title">Sazetidine-A is a potent and selective agonist at native and recombinant alpha 4 beta 2 nicotinic acetylcholine receptors</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">1838</span><span class="NLM_x">–</span> <span class="NLM_lpage">1843</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2008&pages=1838-1843&author=R.+Zwartauthor=A.+L.+Carboneauthor=M.+Moroniauthor=I.+Bermudezauthor=A.+J.+Moggauthor=E.+A.+Follyauthor=L.+M.+Broadauthor=A.+C.+Williamsauthor=D.+Zhangauthor=C.+Dingauthor=B.+A.+Heinzauthor=E.+Sher&title=Sazetidine-A+is+a+potent+and+selective+agonist+at+native+and+recombinant+alpha+4+beta+2+nicotinic+acetylcholine+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZwart%26aufirst%3DR.%26aulast%3DCarbone%26aufirst%3DA.%2BL.%26aulast%3DMoroni%26aufirst%3DM.%26aulast%3DBermudez%26aufirst%3DI.%26aulast%3DMogg%26aufirst%3DA.%2BJ.%26aulast%3DFolly%26aufirst%3DE.%2BA.%26aulast%3DBroad%26aufirst%3DL.%2BM.%26aulast%3DWilliams%26aufirst%3DA.%2BC.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DDing%26aufirst%3DC.%26aulast%3DHeinz%26aufirst%3DB.%2BA.%26aulast%3DSher%26aufirst%3DE.%26atitle%3DSazetidine-A%2520is%2520a%2520potent%2520and%2520selective%2520agonist%2520at%2520native%2520and%2520recombinant%2520alpha%25204%2520beta%25202%2520nicotinic%2520acetylcholine%2520receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2008%26volume%3D73%26spage%3D1838%26epage%3D1843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Xiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musachio, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, Z. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chellappan, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellar, K. J.</span><span> </span><span class="NLM_article-title">Sazetidine-A, a novel ligand that desensitizes alpha4beta2 nicotinic acetylcholine receptors without activating them</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">1454</span><span class="NLM_x">–</span> <span class="NLM_lpage">1460</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2006&pages=1454-1460&author=Y.+Xiaoauthor=H.+Fanauthor=J.+L.+Musachioauthor=Z.+L.+Weiauthor=S.+K.+Chellappanauthor=A.+P.+Kozikowskiauthor=K.+J.+Kellar&title=Sazetidine-A%2C+a+novel+ligand+that+desensitizes+alpha4beta2+nicotinic+acetylcholine+receptors+without+activating+them"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DFan%26aufirst%3DH.%26aulast%3DMusachio%26aufirst%3DJ.%2BL.%26aulast%3DWei%26aufirst%3DZ.%2BL.%26aulast%3DChellappan%26aufirst%3DS.%2BK.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26aulast%3DKellar%26aufirst%3DK.%2BJ.%26atitle%3DSazetidine-A%252C%2520a%2520novel%2520ligand%2520that%2520desensitizes%2520alpha4beta2%2520nicotinic%2520acetylcholine%2520receptors%2520without%2520activating%2520them%26jtitle%3DMol.%2520Pharmacol.%26date%3D2006%26volume%3D70%26spage%3D1454%26epage%3D1460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eaton, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajjuri, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chellappan, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karadi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldarone, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manzano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuen, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, R. J.</span><span> </span><span class="NLM_article-title">Chemistry and pharmacology of nicotinic ligands based on 6-[5-(azetidin-2-ylmethoxy)pyridin-3-yl]hex-5-yn-1-ol (AMOP-H-OH) for possible use in depression</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1279</span><span class="NLM_x">–</span> <span class="NLM_lpage">1291</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=1279-1291&author=A.+P.+Kozikowskiauthor=J.+B.+Eatonauthor=K.+M.+Bajjuriauthor=S.+K.+Chellappanauthor=Y.+Chenauthor=S.+Karadiauthor=R.+Heauthor=B.+Caldaroneauthor=M.+Manzanoauthor=P.+W.+Yuenauthor=R.+J.+Lukas&title=Chemistry+and+pharmacology+of+nicotinic+ligands+based+on+6-%5B5-%28azetidin-2-ylmethoxy%29pyridin-3-yl%5Dhex-5-yn-1-ol+%28AMOP-H-OH%29+for+possible+use+in+depression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26aulast%3DEaton%26aufirst%3DJ.%2BB.%26aulast%3DBajjuri%26aufirst%3DK.%2BM.%26aulast%3DChellappan%26aufirst%3DS.%2BK.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DKaradi%26aufirst%3DS.%26aulast%3DHe%26aufirst%3DR.%26aulast%3DCaldarone%26aufirst%3DB.%26aulast%3DManzano%26aufirst%3DM.%26aulast%3DYuen%26aufirst%3DP.%2BW.%26aulast%3DLukas%26aufirst%3DR.%2BJ.%26atitle%3DChemistry%2520and%2520pharmacology%2520of%2520nicotinic%2520ligands%2520based%2520on%25206-%255B5-%2528azetidin-2-ylmethoxy%2529pyridin-3-yl%255Dhex-5-yn-1-ol%2520%2528AMOP-H-OH%2529%2520for%2520possible%2520use%2520in%2520depression%26jtitle%3DChemMedChem%26date%3D2009%26volume%3D4%26spage%3D1279%26epage%3D1291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eaton, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldarone, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span> </span><span class="NLM_article-title">Chemistry and pharmacological characterization of novel nitrogen analogues of AMOP-H-OH (Sazetidine-A, 6-[5-(azetidin-2-ylmethoxy)pyridin-3-yl]hex-5-yn-1-ol) as alpha4beta2-nicotinic acetylcholine receptor-selective partial agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">6973</span><span class="NLM_x">–</span> <span class="NLM_lpage">6985</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100765u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=6973-6985&author=J.+Liuauthor=J.+B.+Eatonauthor=B.+Caldaroneauthor=R.+J.+Lukasauthor=A.+P.+Kozikowski&title=Chemistry+and+pharmacological+characterization+of+novel+nitrogen+analogues+of+AMOP-H-OH+%28Sazetidine-A%2C+6-%5B5-%28azetidin-2-ylmethoxy%29pyridin-3-yl%5Dhex-5-yn-1-ol%29+as+alpha4beta2-nicotinic+acetylcholine+receptor-selective+partial+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm100765u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100765u%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DEaton%26aufirst%3DJ.%2BB.%26aulast%3DCaldarone%26aufirst%3DB.%26aulast%3DLukas%26aufirst%3DR.%2BJ.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DChemistry%2520and%2520pharmacological%2520characterization%2520of%2520novel%2520nitrogen%2520analogues%2520of%2520AMOP-H-OH%2520%2528Sazetidine-A%252C%25206-%255B5-%2528azetidin-2-ylmethoxy%2529pyridin-3-yl%255Dhex-5-yn-1-ol%2529%2520as%2520alpha4beta2-nicotinic%2520acetylcholine%2520receptor-selective%2520partial%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D6973%26epage%3D6985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Tapadar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luchini, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billadeau, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span> </span><span class="NLM_article-title">Isoxazole moiety in the linker region of HDAC inhibitors adjacent to the Zn-chelating group: effects on HDAC biology and antiproliferative activity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">3023</span><span class="NLM_x">–</span> <span class="NLM_lpage">3026</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm200855b&amp;key=10.1016%2Fj.bmcl.2009.04.058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm200855b&amp;key=19419863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm200855b&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtVersrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=3023-3026&author=S.+Tapadarauthor=R.+Heauthor=D.+N.+Luchiniauthor=D.+D.+Billadeauauthor=A.+P.+Kozikowski&title=Isoxazole+moiety+in+the+linker+region+of+HDAC+inhibitors+adjacent+to+the+Zn-chelating+group%3A+effects+on+HDAC+biology+and+antiproliferative+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Isoxazole moiety in the linker region of HDAC inhibitors adjacent to the Zn-chelating group: Effects on HDAC biology and antiproliferative activity</span></div><div class="casAuthors">Tapadar, Subhasish; He, Rong; Luchini, Doris N.; Billadeau, Daniel D.; Kozikowski, Alan P.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3023-3026</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of hydroxamic acid based histone deacetylase inhibitors 6-15, contg. an isoxazole moiety adjacent to the Zn-chelating hydroxamic acid, is reported herein.  Some of these compds. showed nanomolar activity in the HDAC isoform inhibitory assay and exhibited micromolar inhibitory activity against five pancreatic cancer cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrta5zk6I47pLVg90H21EOLACvtfcHk0lj70UkA-tKFSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtVersrs%253D&md5=affc37e7890fc939db595fa48397390c</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.04.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.04.058%26sid%3Dliteratum%253Aachs%26aulast%3DTapadar%26aufirst%3DS.%26aulast%3DHe%26aufirst%3DR.%26aulast%3DLuchini%26aufirst%3DD.%2BN.%26aulast%3DBilladeau%26aufirst%3DD.%2BD.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DIsoxazole%2520moiety%2520in%2520the%2520linker%2520region%2520of%2520HDAC%2520inhibitors%2520adjacent%2520to%2520the%2520Zn-chelating%2520group%253A%2520effects%2520on%2520HDAC%2520biology%2520and%2520antiproliferative%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D3023%26epage%3D3026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Huang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brun, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franzblau, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span> </span><span class="NLM_article-title">Searching for new cures for tuberculosis: design, synthesis, and biological evaluation of 2-methylbenzothiazoles</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6757</span><span class="NLM_x">–</span> <span class="NLM_lpage">6767</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901112f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6757-6767&author=Q.+Huangauthor=J.+Maoauthor=B.+Wanauthor=Y.+Wangauthor=R.+Brunauthor=S.+G.+Franzblauauthor=A.+P.+Kozikowski&title=Searching+for+new+cures+for+tuberculosis%3A+design%2C+synthesis%2C+and+biological+evaluation+of+2-methylbenzothiazoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm901112f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901112f%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DMao%26aufirst%3DJ.%26aulast%3DWan%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DFranzblau%26aufirst%3DS.%2BG.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DSearching%2520for%2520new%2520cures%2520for%2520tuberculosis%253A%2520design%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%25202-methylbenzothiazoles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6757%26epage%3D6767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Lilienkampf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pieroni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franzblau, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span> </span><span class="NLM_article-title">Rational design of 5-phenyl-3-isoxazolecarboxylic acid ethyl esters as growth inhibitors of <i>Mycobacterium tuberculosis</i>: a potent and selective series for further drug development</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">678</span><span class="NLM_x">–</span> <span class="NLM_lpage">688</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901273n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=678-688&author=A.+Lilienkampfauthor=M.+Pieroniauthor=B.+Wanauthor=Y.+Wangauthor=S.+G.+Franzblauauthor=A.+P.+Kozikowski&title=Rational+design+of+5-phenyl-3-isoxazolecarboxylic+acid+ethyl+esters+as+growth+inhibitors+of+Mycobacterium+tuberculosis%3A+a+potent+and+selective+series+for+further+drug+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm901273n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901273n%26sid%3Dliteratum%253Aachs%26aulast%3DLilienkampf%26aufirst%3DA.%26aulast%3DPieroni%26aufirst%3DM.%26aulast%3DWan%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DFranzblau%26aufirst%3DS.%2BG.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DRational%2520design%2520of%25205-phenyl-3-isoxazolecarboxylic%2520acid%2520ethyl%2520esters%2520as%2520growth%2520inhibitors%2520of%2520Mycobacterium%2520tuberculosis%253A%2520a%2520potent%2520and%2520selective%2520series%2520for%2520further%2520drug%2520development%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D678%26epage%3D688" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Wei, Z. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petukhov, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bizik, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teixeira, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercola, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpe, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glazer, R. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span> </span><span class="NLM_article-title">Isoxazolyl-serine-based agonists of peroxisome proliferator-activated receptor: design, synthesis, and effects on cardiomyocyte differentiation</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">16714</span><span class="NLM_x">–</span> <span class="NLM_lpage">16715</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja046386l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2004&pages=16714-16715&author=Z.+L.+Weiauthor=P.+A.+Petukhovauthor=F.+Bizikauthor=J.+C.+Teixeiraauthor=M.+Mercolaauthor=E.+A.+Volpeauthor=R.+I.+Glazerauthor=T.+M.+Willsonauthor=A.+P.+Kozikowski&title=Isoxazolyl-serine-based+agonists+of+peroxisome+proliferator-activated+receptor%3A+design%2C+synthesis%2C+and+effects+on+cardiomyocyte+differentiation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fja046386l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja046386l%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DZ.%2BL.%26aulast%3DPetukhov%26aufirst%3DP.%2BA.%26aulast%3DBizik%26aufirst%3DF.%26aulast%3DTeixeira%26aufirst%3DJ.%2BC.%26aulast%3DMercola%26aufirst%3DM.%26aulast%3DVolpe%26aufirst%3DE.%2BA.%26aulast%3DGlazer%26aufirst%3DR.%2BI.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DIsoxazolyl-serine-based%2520agonists%2520of%2520peroxisome%2520proliferator-activated%2520receptor%253A%2520design%252C%2520synthesis%252C%2520and%2520effects%2520on%2520cardiomyocyte%2520differentiation%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2004%26volume%3D126%26spage%3D16714%26epage%3D16715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Gotti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clementi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fornari, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaimarri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guiducci, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manfredi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moretti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedrazzi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pucci, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoli, M.</span><span> </span><span class="NLM_article-title">Structural and functional diversity of native brain neuronal nicotinic receptors</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">703</span><span class="NLM_x">–</span> <span class="NLM_lpage">711</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2009&pages=703-711&author=C.+Gottiauthor=F.+Clementiauthor=A.+Fornariauthor=A.+Gaimarriauthor=S.+Guiducciauthor=I.+Manfrediauthor=M.+Morettiauthor=P.+Pedrazziauthor=L.+Pucciauthor=M.+Zoli&title=Structural+and+functional+diversity+of+native+brain+neuronal+nicotinic+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGotti%26aufirst%3DC.%26aulast%3DClementi%26aufirst%3DF.%26aulast%3DFornari%26aufirst%3DA.%26aulast%3DGaimarri%26aufirst%3DA.%26aulast%3DGuiducci%26aufirst%3DS.%26aulast%3DManfredi%26aufirst%3DI.%26aulast%3DMoretti%26aufirst%3DM.%26aulast%3DPedrazzi%26aufirst%3DP.%26aulast%3DPucci%26aufirst%3DL.%26aulast%3DZoli%26aufirst%3DM.%26atitle%3DStructural%2520and%2520functional%2520diversity%2520of%2520native%2520brain%2520neuronal%2520nicotinic%2520receptors%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2009%26volume%3D78%26spage%3D703%26epage%3D711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Nicolazzo, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, W. N.</span><span> </span><span class="NLM_article-title">Methods to assess drug permeability across the blood-brain barrier</span> <span class="citation_source-journal">J. Pharm. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">281</span><span class="NLM_x">–</span> <span class="NLM_lpage">293</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm200855b&amp;key=10.1211%2Fjpp.58.3.0001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm200855b&amp;key=16536894" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm200855b&amp;key=1%3ACAS%3A528%3ADC%252BD28XpsFKgsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2006&pages=281-293&author=J.+A.+Nicolazzoauthor=S.+A.+Charmanauthor=W.+N.+Charman&title=Methods+to+assess+drug+permeability+across+the+blood-brain+barrier"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Methods to assess drug permeability across the blood-brain barrier</span></div><div class="casAuthors">Nicolazzo, Joseph A.; Charman, Susan A.; Charman, William N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">281-293</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Press</span>)
        </div><div class="casAbstract">A review.  Much research has focussed on the development of novel therapeutic agents to target various central nervous system disorders, however less attention has been given to detg. the potential of such agents to permeate the blood-brain barrier (BBB), a factor that will ultimately govern the effectiveness of these agents in man.  In order to assess the potential for novel compds. to permeate the BBB, various in-vitro, in-vivo and in-silico methods may be employed.  Although in-vitro models (such as primary cell culture and immortalized cell lines) are useful as a screening method and can appropriately rank compds. in order of BBB permeability, they often correlate poorly to in-vivo brain uptake due to down-regulation of some BBB-specific transporters.  In-vivo models (such as the internal carotid artery single injection or perfusion, i.v. bolus injection, brain efflux index and intracerebral microdialysis) provide more accurate information regarding brain uptake, and these can be complemented with novel imaging techniques (such as magnetic resonance imaging and positron emission tomog.), although such methods are not suited to high-throughput permeability assessment.  This paper reviews current methods used for assessing BBB permeability and highlights the particular advantages and disadvantages assocd. with each method, with a particular focus on methods suitable for moderate- to high-throughput screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvRYDVgPWxirVg90H21EOLACvtfcHk0liXhS9vnnfxCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpsFKgsrs%253D&md5=32914c526d7600d0af89f03bad207cef</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1211%2Fjpp.58.3.0001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1211%252Fjpp.58.3.0001%26sid%3Dliteratum%253Aachs%26aulast%3DNicolazzo%26aufirst%3DJ.%2BA.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DCharman%26aufirst%3DW.%2BN.%26atitle%3DMethods%2520to%2520assess%2520drug%2520permeability%2520across%2520the%2520blood-brain%2520barrier%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D2006%26volume%3D58%26spage%3D281%26epage%3D293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Fan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unwalla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerns, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diller, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humblet, C.</span><span> </span><span class="NLM_article-title">Insights for predicting blood-brain barrier penetration of CNS targeted molecules using QSPR approaches</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1123</span><span class="NLM_x">–</span> <span class="NLM_lpage">1133</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci900384c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm200855b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtFektb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2010&pages=1123-1133&author=Y.+Fanauthor=R.+Unwallaauthor=R.+A.+Dennyauthor=L.+Diauthor=E.+H.+Kernsauthor=D.+J.+Dillerauthor=C.+Humblet&title=Insights+for+predicting+blood-brain+barrier+penetration+of+CNS+targeted+molecules+using+QSPR+approaches"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Insights for Predicting Blood-Brain Barrier Penetration of CNS Targeted Molecules Using QSPR Approaches</span></div><div class="casAuthors">Fan, Yi; Unwalla, Rayomand; Denny, Rajiah A.; Di, Li; Kerns, Edward H.; Diller, David J.; Humblet, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1123-1133</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Due to the high attrition rate of central nervous system drug candidates during clin. trials, the assessment of blood-brain barrier (BBB) penetration in early research is particularly important.  A genetic approxn. (GA)-based regression model was developed for predicting in vivo blood-brain partitioning data, expressed as log BB (log[brain]/[blood]).  The model was built using an inhouse data set of 193 compds. assembled from 22 different therapeutic projects.  The final model (cross-validated r2 = 0.72) with five mol. descriptors was selected based on validation using several large internal and external test sets.  We demonstrate the potential utility of the model by applying it to a set of literature reported secretase inhibitors.  In addn., we describe a rule-based approach for rapid assessment of brain penetration with several simple mol. descriptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoimKmKOsuC7Vg90H21EOLACvtfcHk0ljedL7r8DfAhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtFektb4%253D&md5=e826f236637d324f641f7f6511f9b7f6</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fci900384c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci900384c%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DY.%26aulast%3DUnwalla%26aufirst%3DR.%26aulast%3DDenny%26aufirst%3DR.%2BA.%26aulast%3DDi%26aufirst%3DL.%26aulast%3DKerns%26aufirst%3DE.%2BH.%26aulast%3DDiller%26aufirst%3DD.%2BJ.%26aulast%3DHumblet%26aufirst%3DC.%26atitle%3DInsights%2520for%2520predicting%2520blood-brain%2520barrier%2520penetration%2520of%2520CNS%2520targeted%2520molecules%2520using%2520QSPR%2520approaches%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2010%26volume%3D50%26spage%3D1123%26epage%3D1133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Romanelli, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gratteri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guandalini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonaccini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gualtieri, F.</span><span> </span><span class="NLM_article-title">Central nicotinic receptors: structure, function, ligands, and therapeutic potential</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">746</span><span class="NLM_x">–</span> <span class="NLM_lpage">767</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=746-767&author=M.+N.+Romanelliauthor=P.+Gratteriauthor=L.+Guandaliniauthor=E.+Martiniauthor=C.+Bonacciniauthor=F.+Gualtieri&title=Central+nicotinic+receptors%3A+structure%2C+function%2C+ligands%2C+and+therapeutic+potential"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRomanelli%26aufirst%3DM.%2BN.%26aulast%3DGratteri%26aufirst%3DP.%26aulast%3DGuandalini%26aufirst%3DL.%26aulast%3DMartini%26aufirst%3DE.%26aulast%3DBonaccini%26aufirst%3DC.%26aulast%3DGualtieri%26aufirst%3DF.%26atitle%3DCentral%2520nicotinic%2520receptors%253A%2520structure%252C%2520function%252C%2520ligands%252C%2520and%2520therapeutic%2520potential%26jtitle%3DChemMedChem%26date%3D2007%26volume%3D2%26spage%3D746%26epage%3D767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Lukas, R. J.; Fryer, J. D.; Eaton, J. B.; Gentry, C. L.</span><span> </span><span class="NLM_article-title">Some methods for studies of nicotinic acetylcholine receptor pharmacology</span>. In  <span class="citation_source-book">Nicotinic Receptors and the Nervous System</span>; <span class="NLM_contrib-group">Levin, E. D.</span>, Ed.; <span class="NLM_publisher-name">CRC Press</span>: <span class="NLM_publisher-loc">Boca Raton, FL</span>,<span class="NLM_x"> </span><span class="NLM_year">2002</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&pages=3-27&author=R.+J.+Lukas&author=J.+D.+Fryer&author=J.+B.+Eaton&author=C.+L.+Gentryauthor=E.+D.+Levin&title=Nicotinic+Receptors+and+the+Nervous+System"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DLukas%26aufirst%3DR.%2BJ.%26atitle%3DSome%2520methods%2520for%2520studies%2520of%2520nicotinic%2520acetylcholine%2520receptor%2520pharmacology%26btitle%3DNicotinic%2520Receptors%2520and%2520the%2520Nervous%2520System%26aulast%3DLevin%26aufirst%3DE.%2BD.%26pub%3DCRC%2520Press%26date%3D2002%26spage%3D3%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Paterson, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Min, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hackett, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanania, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldarone, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghavami, A.</span><span> </span><span class="NLM_article-title">The high-affinity nAChR partial agonists varenicline and sazetidine-A exhibit reinforcing properties in rats</span> <span class="citation_source-journal">Prog. Neuropsychopharmacol. Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1455</span><span class="NLM_x">–</span> <span class="NLM_lpage">1464</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm200855b&amp;key=10.1016%2Fj.pnpbp.2010.07.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm200855b&amp;key=20708056" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm200855b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsV2jtrnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2010&pages=1455-1464&author=N.+E.+Patersonauthor=W.+Minauthor=A.+Hackettauthor=D.+Loweauthor=T.+Hananiaauthor=B.+Caldaroneauthor=A.+Ghavami&title=The+high-affinity+nAChR+partial+agonists+varenicline+and+sazetidine-A+exhibit+reinforcing+properties+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">The high-affinity nAChR partial agonists varenicline and sazetidine-A exhibit reinforcing properties in rats</span></div><div class="casAuthors">Paterson, Neil E.; Min, Wenzhong; Hackett, Adrian; Lowe, David; Hanania, Taleen; Caldarone, Barbara; Ghavami, Afshin</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neuro-Psychopharmacology & Biological Psychiatry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1455-1464</span>CODEN:
                <span class="NLM_cas:coden">PNPPD7</span>;
        ISSN:<span class="NLM_cas:issn">0278-5846</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Varenicline (Chantix, Champix) is a nicotinic acetylcholine receptor (nAChR) partial agonist clin. approved for smoking cessation, yet its potential abuse liability properties have not been fully characterized.  The nAChR ligand sazetidine-A has been reported as a selective full or partial agonist at α4β2* nAChR subtypes in in vitro studies.  In the present studies, varenicline, sazetidine-A and nicotine exhibited inverted U-shaped dose-response functions under fixed-ratio (peak responding at 30, 60 and 10-30 μg/kg/inf, resp.) or progressive-ratio (peak responding at 30-60, 30-100 and 30 μg/kg/inf, resp.) schedules in rats trained to self-administer nicotine.  Varenicline (ED50 0.2 mg/kg) and sazetidine-A (ED50 0.44 mg/kg) fully substituted for nicotine (ED50 0.09 mg/kg) in rats trained to discriminate nicotine (0.4 mg/kg, i.p.) from saline.  The reinforcing and discriminative stimulus (DS) properties of sazetidine-A, varenicline and nicotine were attenuated by acute pretreatment with the non-selective neuronal non-competitive nAChR antagonist mecamylamine or the α4* nAChR-selective antagonist dihydro-β-erythroidine, but not by the α7 nAChR subtype antagonist methyllycaconitine.  Drug-naive rats acquired stable self-administration of varenicline (30 μg/kg/inf), and sazetidine-A (60 μg/kg/inf), at doses that supported peak responding under a fixed-ratio 3 schedule in nicotine-trained rats.  Nonetheless, self-administration and re-acquisition of varenicline and sazetidine-A were less robust than nicotine.  Thus, partial activation of α4β2* nAChRs by varenicline or sazetidine-A is sufficient to mimic the DS and reinforcing properties of nicotine in nicotine-experienced rats, although the reinforcing properties of partial agonists are diminished in nicotine-naive rats.  Future studies should assess nicotine withdrawal measures in animals chronically exposed to varenicline or sazetidine-A.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGor9g7aPkUlPbVg90H21EOLACvtfcHk0ljedL7r8DfAhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsV2jtrnI&md5=22e90c57dd320216c0a745bfd7e424bf</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.pnpbp.2010.07.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pnpbp.2010.07.037%26sid%3Dliteratum%253Aachs%26aulast%3DPaterson%26aufirst%3DN.%2BE.%26aulast%3DMin%26aufirst%3DW.%26aulast%3DHackett%26aufirst%3DA.%26aulast%3DLowe%26aufirst%3DD.%26aulast%3DHanania%26aufirst%3DT.%26aulast%3DCaldarone%26aufirst%3DB.%26aulast%3DGhavami%26aufirst%3DA.%26atitle%3DThe%2520high-affinity%2520nAChR%2520partial%2520agonists%2520varenicline%2520and%2520sazetidine-A%2520exhibit%2520reinforcing%2520properties%2520in%2520rats%26jtitle%3DProg.%2520Neuropsychopharmacol.%2520Biol.%2520Psychiatry%26date%3D2010%26volume%3D34%26spage%3D1455%26epage%3D1464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Turner, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castellano, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blendy, J. A.</span><span> </span><span class="NLM_article-title">Nicotinic partial agonists varenicline and sazetidine-A have differential effects on affective behavior</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">334</span><span class="NLM_x">, </span> <span class="NLM_fpage">665</span><span class="NLM_x">–</span> <span class="NLM_lpage">672</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm200855b&amp;key=10.1124%2Fjpet.110.166280" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm200855b&amp;key=20435920" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm200855b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1Kisb%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=334&publication_year=2010&pages=665-672&author=J.+R.+Turnerauthor=L.+M.+Castellanoauthor=J.+A.+Blendy&title=Nicotinic+partial+agonists+varenicline+and+sazetidine-A+have+differential+effects+on+affective+behavior"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinic partial agonists varenicline and sazetidine-A have differential effects on affective behavior</span></div><div class="casAuthors">Turner, Jill R.; Castellano, Laura M.; Blendy, Julie A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">334</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">665-672</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Clin. and preclin. studies suggest that nicotinic acetylcholine receptors are involved in affective disorders; therefore, the potential therapeutic value of nicotinic partial agonists as treatments of these disorders is of growing interest.  This study evaluated the effects of acute and chronic administration of nicotine and the α4β2 nicotinic partial agonists varenicline and sazetidine-A in mouse models of anxiety and depression.  Acutely, only nicotine and varenicline had anxiolytic effects in the marble-burying test and in the novelty-induced hypophagia (NIH) test.  In contrast, in animal models of antidepressant efficacy, such as the forced swim and the tail suspension test, only acute sazetidine-A had significant antidepressant-like effects.  The NIH test provides an anxiety-related measure that is sensitive to the effects of chronic but not acute antidepressant treatment.  Chronic nicotine and chronic sazetidine-A treatment were effective in this paradigm, but varenicline was ineffective.  These results suggest that the partial agonists varenicline and sazetidine-A may have diverse therapeutic benefits in affective disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogo1Sj2UHr5bVg90H21EOLACvtfcHk0ljedL7r8DfAhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1Kisb%252FE&md5=79c7a0573c7aea5e0bb72ab5d5a4e05d</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1124%2Fjpet.110.166280&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.110.166280%26sid%3Dliteratum%253Aachs%26aulast%3DTurner%26aufirst%3DJ.%2BR.%26aulast%3DCastellano%26aufirst%3DL.%2BM.%26aulast%3DBlendy%26aufirst%3DJ.%2BA.%26atitle%3DNicotinic%2520partial%2520agonists%2520varenicline%2520and%2520sazetidine-A%2520have%2520differential%2520effects%2520on%2520affective%2520behavior%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2010%26volume%3D334%26spage%3D665%26epage%3D672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eaton, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajjuri, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chellappan, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karadi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldarone, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manzano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuen, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, R. J.</span><span> </span><span class="NLM_article-title">Chemistry and pharmacology of nicotinic ligands based on 6-[5-(azetidin-2-ylmethoxy)pyridin-3-yl]hex-5-yn-1-ol (AMOP-H-OH) for possible use in depression</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1279</span><span class="NLM_x">–</span> <span class="NLM_lpage">1291</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=1279-1291&author=A.+P.+Kozikowskiauthor=J.+B.+Eatonauthor=K.+M.+Bajjuriauthor=S.+K.+Chellappanauthor=Y.+Chenauthor=S.+Karadiauthor=R.+Heauthor=B.+Caldaroneauthor=M.+Manzanoauthor=P.+W.+Yuenauthor=R.+J.+Lukas&title=Chemistry+and+pharmacology+of+nicotinic+ligands+based+on+6-%5B5-%28azetidin-2-ylmethoxy%29pyridin-3-yl%5Dhex-5-yn-1-ol+%28AMOP-H-OH%29+for+possible+use+in+depression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26aulast%3DEaton%26aufirst%3DJ.%2BB.%26aulast%3DBajjuri%26aufirst%3DK.%2BM.%26aulast%3DChellappan%26aufirst%3DS.%2BK.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DKaradi%26aufirst%3DS.%26aulast%3DHe%26aufirst%3DR.%26aulast%3DCaldarone%26aufirst%3DB.%26aulast%3DManzano%26aufirst%3DM.%26aulast%3DYuen%26aufirst%3DP.%2BW.%26aulast%3DLukas%26aufirst%3DR.%2BJ.%26atitle%3DChemistry%2520and%2520pharmacology%2520of%2520nicotinic%2520ligands%2520based%2520on%25206-%255B5-%2528azetidin-2-ylmethoxy%2529pyridin-3-yl%255Dhex-5-yn-1-ol%2520%2528AMOP-H-OH%2529%2520for%2520possible%2520use%2520in%2520depression%26jtitle%3DChemMedChem%26date%3D2009%26volume%3D4%26spage%3D1279%26epage%3D1291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Porsolt, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jalfre, M.</span><span> </span><span class="NLM_article-title">Behavioral despair in mice: a primary screening test for antidepressants</span> <span class="citation_source-journal">Arch. Int. Pharmacodyn. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">229</span><span class="NLM_x">, </span> <span class="NLM_fpage">327</span><span class="NLM_x">–</span> <span class="NLM_lpage">336</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm200855b&amp;key=596982" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm200855b&amp;key=1%3ACAS%3A528%3ADyaE1cXktlKgsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=229&publication_year=1977&pages=327-336&author=R.+D.+Porsoltauthor=A.+Bertinauthor=M.+Jalfre&title=Behavioral+despair+in+mice%3A+a+primary+screening+test+for+antidepressants"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Behavioral despair in mice:  a primary screening test for antidepressants</span></div><div class="casAuthors">Porsolt, R. D.; Bertin, A.; Jalfre, M.</div><div class="citationInfo"><span class="NLM_cas:title">Archives Internationales de Pharmacodynamie et de Therapie</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">229</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">327-36</span>CODEN:
                <span class="NLM_cas:coden">AIPTAK</span>;
        ISSN:<span class="NLM_cas:issn">0003-9780</span>.
    </div><div class="casAbstract">A depressed state can be induced in mice by forcing them to swim in a narrow cylinder from which they cannot escape.  After a brief period of vigorous activity the mice adopt a characteristic immobile posture which is readily identifiable.  Immobility was reduced by tricyclic antidepressants, monoamine oxidase inhibitors and atypical antidepressants, as well as by electroconvulsive shock.  Psychostimulants also reduced immobility but in contrast to antidepressants caused marked motor stimulation.  Immobility was not affected by minor or major tranquilizers.  These findings, closely parallel to those previously reported in rats, suggest that the procedure is selectively senstitive to antidepressant treatments.  The mouse procedure is, however, more rapid and less costly than that with rats and is thus more suitable for the primary screening of antidepressant drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3THea0LRwE7Vg90H21EOLACvtfcHk0ljbkIJOu77hFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXktlKgsbs%253D&md5=70dd5706992ee8151a9801a2aeb42961</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPorsolt%26aufirst%3DR.%2BD.%26aulast%3DBertin%26aufirst%3DA.%26aulast%3DJalfre%26aufirst%3DM.%26atitle%3DBehavioral%2520despair%2520in%2520mice%253A%2520a%2520primary%2520screening%2520test%2520for%2520antidepressants%26jtitle%3DArch.%2520Int.%2520Pharmacodyn.%2520Ther.%26date%3D1977%26volume%3D229%26spage%3D327%26epage%3D336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="note"><p class="first last">Preliminary ADMET studies were carried out by Cerep, Inc.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Jamieson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moir, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wishart, G.</span><span> </span><span class="NLM_article-title">Medicinal chemistry of hERG optimizations: Highlights and hang-ups</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">5029</span><span class="NLM_x">–</span> <span class="NLM_lpage">5046</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060379l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm200855b&amp;key=1%3ACAS%3A528%3ADC%252BD28Xns1WqsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=5029-5046&author=C.+Jamiesonauthor=E.+M.+Moirauthor=Z.+Rankovicauthor=G.+Wishart&title=Medicinal+chemistry+of+hERG+optimizations%3A+Highlights+and+hang-ups"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemistry of hERG optimizations: Highlights and hang-ups</span></div><div class="casAuthors">Jamieson, Craig; Moir, Elizabeth M.; Rankovic, Zoran; Wishart, Grant</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5029-5046</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  A brief summary of the in silico, in vitro, and in vivo approaches employed to measure blockade of hERG and QT prolongation is detailed.  The discussion aims to summarize the approaches engaged to circumvent activity at hERG, identified through an extensive literature survey.  The optimizations are recorded as pairs of compds., which have been categorized in terms of the tactics employed to diminish hERG activity. Examn. of the properties of the compds. within each category has enabled formulation os some empirical guidelines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqv6eM5w53KebVg90H21EOLACvtfcHk0ljbkIJOu77hFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xns1WqsL8%253D&md5=117c84a010f877c835b7dbc945996b92</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm060379l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060379l%26sid%3Dliteratum%253Aachs%26aulast%3DJamieson%26aufirst%3DC.%26aulast%3DMoir%26aufirst%3DE.%2BM.%26aulast%3DRankovic%26aufirst%3DZ.%26aulast%3DWishart%26aufirst%3DG.%26atitle%3DMedicinal%2520chemistry%2520of%2520hERG%2520optimizations%253A%2520Highlights%2520and%2520hang-ups%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D5029%26epage%3D5046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Lin, N.-H.; He, Y.; Li, Y.; Holladay, M. W.; Ryther, K.</span><span> </span><span class="NLM_article-title">3-Pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission</span>. U.S. Patent 5629325, May 13,<span class="NLM_x"> </span><span class="NLM_year">1997</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&author=N.-H.+Lin&author=Y.+He&author=Y.+Li&author=M.+W.+Holladay&author=K.+Ryther&title=3-Pyridyloxymethyl+heterocyclic+ether+compounds+useful+in+controlling+chemical+synaptic+transmission"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DN.-H.%26atitle%3D3-Pyridyloxymethyl%2520heterocyclic%2520ether%2520compounds%2520useful%2520in%2520controlling%2520chemical%2520synaptic%2520transmission%26date%3D1997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Lukas, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norman, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucero, L.</span><span> </span><span class="NLM_article-title">Characterization of nicotinic acetylcholine receptors expressed by cells of the SH-SY5Y human neuroblastoma clonal line</span> <span class="citation_source-journal">Mol. Cell Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm200855b&amp;key=10.1006%2Fmcne.1993.1001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm200855b&amp;key=19912902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm200855b&amp;key=1%3ACAS%3A528%3ADyaK3sXit1Khs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1993&pages=1-12&author=R.+J.+Lukasauthor=S.+A.+Normanauthor=L.+Lucero&title=Characterization+of+nicotinic+acetylcholine+receptors+expressed+by+cells+of+the+SH-SY5Y+human+neuroblastoma+clonal+line"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of nicotinic acetylcholine receptors expressed by cells of the SH-SY5Y human neuroblastoma clonal line</span></div><div class="casAuthors">Lukas, Ronald J.; Norman, Sylvia A.; Lucero, Linda</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Neuroscience</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-12</span>CODEN:
                <span class="NLM_cas:coden">MOCNED</span>;
        ISSN:<span class="NLM_cas:issn">1044-7431</span>.
    </div><div class="casAbstract">Radioligand binding studies show that cells of the SH-SY5Y human neuroblastoma clonal line express a single class of neuronal/nicotinic α-bungarotoxin binding sites (nBgtS).  These sites are defined by their ability to bind radioiodinated α-bungarotoxin (Bgt) with high affinity (KD = 4 nM) and nicotinic ligands with lower (μM) affinities.  Radioligand binding studies also show that SH-SY5Y cells express high affinity specific binding sites for 3H-labeled acetylcholine that could reflect interactions with two classes of sites (KD' = 1 nM, KD' = 100 nM).  These sites are distinguished from nBgtS by their insensitivity to blockade by Bgt and by their ability to bind other nicotinic agonists with high (nM) affinity.  86Rb+ efflux studies indicate that SH-SY5Y cells express functional nicotinic acetylcholine receptor (nAChR) ion channels that, like radioagonist binding sites, are insensitive to blockade by Bgt.  However, there are far more functional nAChR than high affinity radioagonist binding sites.  Functional nAChR have a pharmacol. profile expected of ganglia-type receptors composed of nAChR alpha3 and beta4 subunits.  Northern blot anal. indicates that genes corresponding to human alpha3, alpha5, beta2, and beta4 subunits are expressed by SH-SY5Y cells.  The authors conclude that SH-SY5Y cells express at least two members of the nAChR family (nBgtS and ganglia-type nAChR) and that high affinity radioagonist binding sites are a subset of functional ganglia-type nAChR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonLYzJClIqI7Vg90H21EOLACvtfcHk0ljbkIJOu77hFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXit1Khs7g%253D&md5=f71050efab7399610c03f3d9e262660a</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1006%2Fmcne.1993.1001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fmcne.1993.1001%26sid%3Dliteratum%253Aachs%26aulast%3DLukas%26aufirst%3DR.%2BJ.%26aulast%3DNorman%26aufirst%3DS.%2BA.%26aulast%3DLucero%26aufirst%3DL.%26atitle%3DCharacterization%2520of%2520nicotinic%2520acetylcholine%2520receptors%2520expressed%2520by%2520cells%2520of%2520the%2520SH-SY5Y%2520human%2520neuroblastoma%2520clonal%2520line%26jtitle%3DMol.%2520Cell%2520Neurosci.%26date%3D1993%26volume%3D4%26spage%3D1%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Eaton, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeder, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fryer, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buhlman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, Y. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinlein, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, R. J.</span><span> </span><span class="NLM_article-title">Characterization of human alpha 4 beta 2-nicotinic acetylcholine receptors stably and heterologously expressed in native nicotinic receptor-null SH-EP1 human epithelial cells</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">1283</span><span class="NLM_x">–</span> <span class="NLM_lpage">1294</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2003&pages=1283-1294&author=J.+B.+Eatonauthor=J.+H.+Pengauthor=K.+M.+Schroederauthor=A.+A.+Georgeauthor=J.+D.+Fryerauthor=C.+Krishnanauthor=L.+Buhlmanauthor=Y.+P.+Kuoauthor=O.+Steinleinauthor=R.+J.+Lukas&title=Characterization+of+human+alpha+4+beta+2-nicotinic+acetylcholine+receptors+stably+and+heterologously+expressed+in+native+nicotinic+receptor-null+SH-EP1+human+epithelial+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEaton%26aufirst%3DJ.%2BB.%26aulast%3DPeng%26aufirst%3DJ.%2BH.%26aulast%3DSchroeder%26aufirst%3DK.%2BM.%26aulast%3DGeorge%26aufirst%3DA.%2BA.%26aulast%3DFryer%26aufirst%3DJ.%2BD.%26aulast%3DKrishnan%26aufirst%3DC.%26aulast%3DBuhlman%26aufirst%3DL.%26aulast%3DKuo%26aufirst%3DY.%2BP.%26aulast%3DSteinlein%26aufirst%3DO.%26aulast%3DLukas%26aufirst%3DR.%2BJ.%26atitle%3DCharacterization%2520of%2520human%2520alpha%25204%2520beta%25202-nicotinic%2520acetylcholine%2520receptors%2520stably%2520and%2520heterologously%2520expressed%2520in%2520native%2520nicotinic%2520receptor-null%2520SH-EP1%2520human%2520epithelial%2520cells%26jtitle%3DMol.%2520Pharmacol.%26date%3D2003%26volume%3D64%26spage%3D1283%26epage%3D1294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Caldarone, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paterson, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manzano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedolak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavino, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanania, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chellappan, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picciotto, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghavami, A.</span><span> </span><span class="NLM_article-title">Dissociation between duration of action in the forced swim test in mice and nicotinic acetylcholine receptor occupancy with sazetidine, varenicline, and 5-I-A85380</span> <span class="citation_source-journal">Psychopharmacology (Berlin)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">217</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">–</span> <span class="NLM_lpage">210</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm200855b&amp;key=10.1007%2Fs00213-011-2271-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm200855b&amp;key=21487659" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm200855b&amp;key=1%3ACAS%3A528%3ADC%252BC3MXksFymt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=217&publication_year=2011&pages=199-210&author=B.+J.+Caldaroneauthor=D.+Wangauthor=N.+E.+Patersonauthor=M.+Manzanoauthor=A.+Fedolakauthor=K.+Cavinoauthor=M.+Kwanauthor=T.+Hananiaauthor=S.+K.+Chellappanauthor=A.+P.+Kozikowskiauthor=B.+Olivierauthor=M.+R.+Picciottoauthor=A.+Ghavami&title=Dissociation+between+duration+of+action+in+the+forced+swim+test+in+mice+and+nicotinic+acetylcholine+receptor+occupancy+with+sazetidine%2C+varenicline%2C+and+5-I-A85380"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Dissociation between duration of action in the forced swim test in mice and nicotinic acetylcholine receptor occupancy with sazetidine, varenicline, and 5-I-A85380</span></div><div class="casAuthors">Caldarone, Barbara J.; Wang, Daguang; Paterson, Neil E.; Manzano, Michael; Fedolak, Allison; Cavino, Katie; Kwan, Mei; Hanania, Taleen; Chellappan, Sheela K.; Kozikowski, Alan P.; Olivier, Berend; Picciotto, Marina R.; Ghavami, Afshin</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Heidelberg, Germany)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">217</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">199-210</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Rationale: Nicotinic acetylcholine receptor (nAChR) agonists, partial agonists, and antagonists have antidepressant-like effects in rodents and reduce symptoms of depression in humans.  Objectives: The study detd. whether the antidepressant-like effect of the nAChR β2* partial agonist sazetidine-A (sazetidine) in the forced swim test was due to activation or desensitization of β2* nAChRs.  The study also detd. if sazetidine's behavioral responses in the forced swim test corresponded to β2* nAChRs receptor occupancy and drug bioavailability.  Results: Acute antidepressant-like effects in the forced swim test were seen with sazetidine and the full β2* agonist 5-I-A8350 (BALB/cJ mice) and the less selective β2* partial agonist varenicline in C57BL/6J but not BALB/cJ mice.  The role of β2* nAChRs was confirmed by results showing: (1) reversal of sazetidine's antidepressant-like effects in the forced swim test by nAChR antagonists mecamylamine and dihydro-β-erythroidine; (2) absence of sazetidine's effect in mice lacking the β2 subunit of the nAChR; and (3) a high correspondence between behaviorally active doses of sazetidine and β2* receptor occupancy. β2* receptor occupancy following acute sazetidine, varenicline, and 5-I-A8350 lasted beyond the duration of action in the forced swim test.  Sazetidine's long lasting receptor occupancy did not diminish behavioral efficacy in the forced swim test following repeated dosing.  Conclusions: Results demonstrate that activation of a small population of β2* nAChRs (10-40%) is sufficient to elicit sazetidine's antidepressant-like actions without producing tolerance and suggest that ligands that activate β2* nAChRs would be promising targets for the development of a new class of antidepressant.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriIAbTX2Qb67Vg90H21EOLACvtfcHk0ljWFlMlX10KvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXksFymt7g%253D&md5=794495af9e8426b2ab966c35efa35c54</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1007%2Fs00213-011-2271-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-011-2271-y%26sid%3Dliteratum%253Aachs%26aulast%3DCaldarone%26aufirst%3DB.%2BJ.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DPaterson%26aufirst%3DN.%2BE.%26aulast%3DManzano%26aufirst%3DM.%26aulast%3DFedolak%26aufirst%3DA.%26aulast%3DCavino%26aufirst%3DK.%26aulast%3DKwan%26aufirst%3DM.%26aulast%3DHanania%26aufirst%3DT.%26aulast%3DChellappan%26aufirst%3DS.%2BK.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26aulast%3DOlivier%26aufirst%3DB.%26aulast%3DPicciotto%26aufirst%3DM.%2BR.%26aulast%3DGhavami%26aufirst%3DA.%26atitle%3DDissociation%2520between%2520duration%2520of%2520action%2520in%2520the%2520forced%2520swim%2520test%2520in%2520mice%2520and%2520nicotinic%2520acetylcholine%2520receptor%2520occupancy%2520with%2520sazetidine%252C%2520varenicline%252C%2520and%25205-I-A85380%26jtitle%3DPsychopharmacology%2520%2528Berlin%2529%26date%3D2011%26volume%3D217%26spage%3D199%26epage%3D210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':[],'ref36':['cit36'],'ref37':['cit37'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 55 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Ramakrishna Nirogi, Abdul Rasheed Mohammed, Anil K. Shinde, Srinivasa Rao Ravella, Narsimha Bogaraju, Ramkumar Subramanian, Venkat Reddy Mekala, Raghava Choudary Palacharla, Nageswararao Muddana, Jagadeesh Babu Thentu, Gopinadh Bhyrapuneni, Renny Abraham, <span class="NLM_string-name hlFld-ContribAuthor">Venkat Jasti</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Development of 3-(6-Chloropyridine-3-yloxymethyl)-2-azabicyclo[3.1.0]hexane Hydrochloride (SUVN-911): A Novel, Potent, Selective, and Orally Active Neuronal Nicotinic Acetylcholine α4β2 Receptor Antagonist for the Treatment of Depression. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (6)
                                     , 2833-2853. <a href="https://doi.org/10.1021/acs.jmedchem.9b00790" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00790</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00790&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00790%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BDevelopment%252Bof%252B3-%2525286-Chloropyridine-3-yloxymethyl%252529-2-azabicyclo%25255B3.1.0%25255Dhexane%252BHydrochloride%252B%252528SUVN-911%252529%25253A%252BA%252BNovel%25252C%252BPotent%25252C%252BSelective%25252C%252Band%252BOrally%252BActive%252BNeuronal%252BNicotinic%252BAcetylcholine%252B%2525CE%2525B14%2525CE%2525B22%252BReceptor%252BAntagonist%252Bfor%252Bthe%252BTreatment%252Bof%252BDepression%26aulast%3DNirogi%26aufirst%3DRamakrishna%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D24052019%26date%3D21022020%26date%3D06022020%26volume%3D63%26issue%3D6%26spage%3D2833%26epage%3D2853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Sovan
Sundar Giri, <span class="NLM_string-name hlFld-ContribAuthor">Rai-Shung Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Copper-Catalyzed [4+2]-Cycloadditions of Isoxazoles with 2-Alkynylbenzaldehydes To Access Distinct α-Carbonylnaphthalene Derivatives: C(3,4)- versus C(4,5)-Regioselectivity at Isoxazoles. </span><span class="cited-content_cbyCitation_journal-name">ACS Catalysis</span><span> <strong>2019,</strong> <em>9 </em>
                                    (8)
                                     , 7328-7334. <a href="https://doi.org/10.1021/acscatal.9b02323" title="DOI URL">https://doi.org/10.1021/acscatal.9b02323</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscatal.9b02323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscatal.9b02323%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Catalysis%26atitle%3DCopper-Catalyzed%252B%25255B4%25252B2%25255D-Cycloadditions%252Bof%252BIsoxazoles%252Bwith%252B2-Alkynylbenzaldehydes%252BTo%252BAccess%252BDistinct%252B%2525CE%2525B1-Carbonylnaphthalene%252BDerivatives%25253A%252BC%2525283%25252C4%252529-%252Bversus%252BC%2525284%25252C5%252529-Regioselectivity%252Bat%252BIsoxazoles%26aulast%3DGiri%26aufirst%3DSovan%2BSundar%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D04062019%26date%3D11072019%26date%3D17072019%26date%3D15072019%26volume%3D9%26issue%3D8%26spage%3D7328%26epage%3D7334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xuejian Xia, Qiongqiong Zhu, Jing Wang, Jie Chen, Weiguo Cao, Bo Zhu, <span class="NLM_string-name hlFld-ContribAuthor">Xiaoyu Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Direct Asymmetric Vinylogous Mannich Addition of 3,5-Disubstituted-4-nitroisoxazoles to Isatin-Derived Imines Catalyzed by a Bifunctional Phase-Transfer-Catalyst. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>83 </em>
                                    (23)
                                     , 14617-14625. <a href="https://doi.org/10.1021/acs.joc.8b02439" title="DOI URL">https://doi.org/10.1021/acs.joc.8b02439</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.8b02439&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.8b02439%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DDirect%252BAsymmetric%252BVinylogous%252BMannich%252BAddition%252Bof%252B3%25252C5-Disubstituted-4-nitroisoxazoles%252Bto%252BIsatin-Derived%252BImines%252BCatalyzed%252Bby%252Ba%252BBifunctional%252BPhase-Transfer-Catalyst%26aulast%3DXia%26aufirst%3DXuejian%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D20092018%26date%3D15112018%26date%3D09112018%26volume%3D83%26issue%3D23%26spage%3D14617%26epage%3D14625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Darius J.  Faizi</span>, <span class="hlFld-ContribAuthor ">Adena  Issaian</span>, <span class="hlFld-ContribAuthor ">Ashlee J.  Davis</span>, and <span class="hlFld-ContribAuthor ">Suzanne A.  Blum</span>  . </span><span class="cited-content_cbyCitation_article-title">Catalyst-Free Synthesis of Borylated Lactones from Esters via Electrophilic Oxyboration. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2016,</strong> <em>138 </em>
                                    (7)
                                     , 2126-2129. <a href="https://doi.org/10.1021/jacs.5b12989" title="DOI URL">https://doi.org/10.1021/jacs.5b12989</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.5b12989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.5b12989%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DCatalyst-Free%252BSynthesis%252Bof%252BBorylated%252BLactones%252Bfrom%252BEsters%252Bvia%252BElectrophilic%252BOxyboration%26aulast%3DFaizi%26aufirst%3DDarius%2BJ.%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D11122015%26date%3D16022016%26date%3D24022016%26date%3D05022016%26volume%3D138%26issue%3D7%26spage%3D2126%26epage%3D2129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kim N.  Tu</span>, <span class="hlFld-ContribAuthor ">Joshua J.  Hirner</span>, and <span class="hlFld-ContribAuthor ">Suzanne A.  Blum</span>  . </span><span class="cited-content_cbyCitation_article-title">Oxyboration with and without a Catalyst: Borylated Isoxazoles via B–O σ-Bond Addition. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2016,</strong> <em>18 </em>
                                    (3)
                                     , 480-483. <a href="https://doi.org/10.1021/acs.orglett.5b03530" title="DOI URL">https://doi.org/10.1021/acs.orglett.5b03530</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.5b03530&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.5b03530%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DOxyboration%252Bwith%252Band%252Bwithout%252Ba%252BCatalyst%25253A%252BBorylated%252BIsoxazoles%252Bvia%252BB%2525E2%252580%252593O%252B%2525CF%252583-Bond%252BAddition%26aulast%3DTu%26aufirst%3DKim%2BN.%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D12122015%26date%3D15012016%26date%3D05022016%26volume%3D18%26issue%3D3%26spage%3D480%26epage%3D483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cristiano  Bolchi</span>, <span class="hlFld-ContribAuthor ">Ermanno  Valoti</span>, <span class="hlFld-ContribAuthor ">Cecilia  Gotti</span>, <span class="hlFld-ContribAuthor ">Francesca  Fasoli</span>, <span class="hlFld-ContribAuthor ">Paola  Ruggeri</span>, <span class="hlFld-ContribAuthor ">Laura  Fumagalli</span>, <span class="hlFld-ContribAuthor ">Matteo  Binda</span>, <span class="hlFld-ContribAuthor ">Vanessa  Mucchietto</span>, <span class="hlFld-ContribAuthor ">Miriam  Sciaccaluga</span>, <span class="hlFld-ContribAuthor ">Roberta  Budriesi</span>, <span class="hlFld-ContribAuthor ">Sergio  Fucile</span>, and <span class="hlFld-ContribAuthor ">Marco  Pallavicini</span>  . </span><span class="cited-content_cbyCitation_article-title">Chemistry and Pharmacology of a Series of Unichiral Analogues of 2-(2-Pyrrolidinyl)-1,4-benzodioxane, Prolinol Phenyl Ether, and Prolinol 3-Pyridyl Ether Designed as α4β2-Nicotinic Acetylcholine Receptor Agonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (16)
                                     , 6665-6677. <a href="https://doi.org/10.1021/acs.jmedchem.5b00904" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00904</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00904&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00904%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DChemistry%252Band%252BPharmacology%252Bof%252Ba%252BSeries%252Bof%252BUnichiral%252BAnalogues%252Bof%252B2-%2525282-Pyrrolidinyl%252529-1%25252C4-benzodioxane%25252C%252BProlinol%252BPhenyl%252BEther%25252C%252Band%252BProlinol%252B3-Pyridyl%252BEther%252BDesigned%252Bas%252B%2525CE%2525B14%2525CE%2525B22-Nicotinic%252BAcetylcholine%252BReceptor%252BAgonists%26aulast%3DBolchi%26aufirst%3DCristiano%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D12062015%26date%3D18082015%26date%3D27082015%26date%3D30072015%26volume%3D58%26issue%3D16%26spage%3D6665%26epage%3D6677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li-Fang  Yu</span>, <span class="hlFld-ContribAuthor ">Han-Kun  Zhang</span>, <span class="hlFld-ContribAuthor ">Barbara J.  Caldarone</span>, <span class="hlFld-ContribAuthor ">J. Brek  Eaton</span>, <span class="hlFld-ContribAuthor ">Ronald J.  Lukas</span>, and <span class="hlFld-ContribAuthor ">Alan P.  Kozikowski</span>  . </span><span class="cited-content_cbyCitation_article-title">Recent Developments in Novel Antidepressants Targeting α4β2-Nicotinic Acetylcholine Receptors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (20)
                                     , 8204-8223. <a href="https://doi.org/10.1021/jm401937a" title="DOI URL">https://doi.org/10.1021/jm401937a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401937a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401937a%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252BDevelopments%252Bin%252BNovel%252BAntidepressants%252BTargeting%252B%2525CE%2525B14%2525CE%2525B22-Nicotinic%252BAcetylcholine%252BReceptors%26aulast%3DYu%26aufirst%3DLi-Fang%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D17122013%26date%3D02072014%26date%3D23102014%26date%3D05062014%26volume%3D57%26issue%3D20%26spage%3D8204%26epage%3D8223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yunkyung  Jeong</span>, <span class="hlFld-ContribAuthor ">Bom-I  Kim</span>, <span class="hlFld-ContribAuthor ">Jae Kyun  Lee</span>, and <span class="hlFld-ContribAuthor ">Jae-Sang  Ryu</span>  . </span><span class="cited-content_cbyCitation_article-title">Direct Synthesis of 4-Fluoroisoxazoles through Gold-Catalyzed Cascade Cyclization–Fluorination of 2-Alkynone O-Methyl Oximes. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2014,</strong> <em>79 </em>
                                    (14)
                                     , 6444-6455. <a href="https://doi.org/10.1021/jo5008702" title="DOI URL">https://doi.org/10.1021/jo5008702</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo5008702&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo5008702%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DDirect%252BSynthesis%252Bof%252B4-Fluoroisoxazoles%252Bthrough%252BGold-Catalyzed%252BCascade%252BCyclization%2525E2%252580%252593Fluorination%252Bof%252B2-Alkynone%252BO-Methyl%252BOximes%26aulast%3DJeong%26aufirst%3DYunkyung%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D18042014%26date%3D07072014%26date%3D18072014%26date%3D30062014%26volume%3D79%26issue%3D14%26spage%3D6444%26epage%3D6455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher B.  Marotta</span>, <span class="hlFld-ContribAuthor ">Iva  Rreza</span>, <span class="hlFld-ContribAuthor ">Henry A.  Lester</span>, and <span class="hlFld-ContribAuthor ">Dennis A.  Dougherty</span>. </span><span class="cited-content_cbyCitation_article-title">Selective Ligand Behaviors Provide New Insights into Agonist Activation of Nicotinic Acetylcholine Receptors. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2014,</strong> <em>9 </em>
                                    (5)
                                     , 1153-1159. <a href="https://doi.org/10.1021/cb400937d" title="DOI URL">https://doi.org/10.1021/cb400937d</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cb400937d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcb400937d%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DSelective%252BLigand%252BBehaviors%252BProvide%252BNew%252BInsights%252Binto%252BAgonist%252BActivation%252Bof%252BNicotinic%252BAcetylcholine%252BReceptors%26aulast%3DMarotta%26aufirst%3DChristopher%2BB.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D20122013%26date%3D24022014%26date%3D05032014%26date%3D16052014%26date%3D24022014%26volume%3D9%26issue%3D5%26spage%3D1153%26epage%3D1159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Han-Kun  Zhang</span>, <span class="hlFld-ContribAuthor ">Li-Fang  Yu</span>, <span class="hlFld-ContribAuthor ">J. Brek  Eaton</span>, <span class="hlFld-ContribAuthor ">Paul  Whiteaker</span>, <span class="hlFld-ContribAuthor ">Oluseye K.  Onajole</span>, <span class="hlFld-ContribAuthor ">Taleen  Hanania</span>, <span class="hlFld-ContribAuthor ">Daniela  Brunner</span>, <span class="hlFld-ContribAuthor ">Ronald J.  Lukas</span>, and <span class="hlFld-ContribAuthor ">Alan P.  Kozikowski</span>  . </span><span class="cited-content_cbyCitation_article-title">Chemistry, Pharmacology, and Behavioral Studies Identify Chiral Cyclopropanes as Selective α4β2-Nicotinic Acetylcholine Receptor Partial Agonists Exhibiting an Antidepressant Profile. Part II. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (13)
                                     , 5495-5504. <a href="https://doi.org/10.1021/jm400510u" title="DOI URL">https://doi.org/10.1021/jm400510u</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm400510u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm400510u%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DChemistry%25252C%252BPharmacology%25252C%252Band%252BBehavioral%252BStudies%252BIdentify%252BChiral%252BCyclopropanes%252Bas%252BSelective%252B%2525CE%2525B14%2525CE%2525B22-Nicotinic%252BAcetylcholine%252BReceptor%252BPartial%252BAgonists%252BExhibiting%252Ban%252BAntidepressant%252BProfile.%252BPart%252BII%26aulast%3DZhang%26aufirst%3DHan-Kun%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D08042013%26date%3D26062013%26date%3D11072013%26date%3D04062013%26volume%3D56%26issue%3D13%26spage%3D5495%26epage%3D5504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li-Fang  Yu</span>, <span class="hlFld-ContribAuthor ">J. Brek  Eaton</span>, <span class="hlFld-ContribAuthor ">Allison  Fedolak</span>, <span class="hlFld-ContribAuthor ">Han-Kun  Zhang</span>, <span class="hlFld-ContribAuthor ">Taleen  Hanania</span>, <span class="hlFld-ContribAuthor ">Dani  Brunner</span>, <span class="hlFld-ContribAuthor ">Ronald J.  Lukas</span>, and <span class="hlFld-ContribAuthor ">Alan P.  Kozikowski</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Highly Potent and Selective α4β2-Nicotinic Acetylcholine Receptor (nAChR) Partial Agonists Containing an Isoxazolylpyridine Ether Scaffold that Demonstrate Antidepressant-like Activity. Part II. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (22)
                                     , 9998-10009. <a href="https://doi.org/10.1021/jm301177j" title="DOI URL">https://doi.org/10.1021/jm301177j</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm301177j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm301177j%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BHighly%252BPotent%252Band%252BSelective%252B%2525CE%2525B14%2525CE%2525B22-Nicotinic%252BAcetylcholine%252BReceptor%252B%252528nAChR%252529%252BPartial%252BAgonists%252BContaining%252Ban%252BIsoxazolylpyridine%252BEther%252BScaffold%252Bthat%252BDemonstrate%252BAntidepressant-like%252BActivity.%252BPart%252BII%26aulast%3DYu%26aufirst%3DLi-Fang%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D09082012%26date%3D02112012%26date%3D26112012%26date%3D23102012%26volume%3D55%26issue%3D22%26spage%3D9998%26epage%3D10009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hankun  Zhang</span>, <span class="hlFld-ContribAuthor ">Werner  Tückmantel</span>, <span class="hlFld-ContribAuthor ">J. Brek  Eaton</span>, <span class="hlFld-ContribAuthor ">Po-wai  Yuen</span>, <span class="hlFld-ContribAuthor ">Li-Fang  Yu</span>, <span class="hlFld-ContribAuthor ">Krishna Mohan  Bajjuri</span>, <span class="hlFld-ContribAuthor ">Allison  Fedolak</span>, <span class="hlFld-ContribAuthor ">Daguang  Wang</span>, <span class="hlFld-ContribAuthor ">Afshin  Ghavami</span>, <span class="hlFld-ContribAuthor ">Barbara  Caldarone</span>, <span class="hlFld-ContribAuthor ">Neil E.  Paterson</span>, <span class="hlFld-ContribAuthor ">David A.  Lowe</span>, <span class="hlFld-ContribAuthor ">Daniela  Brunner</span>, <span class="hlFld-ContribAuthor ">Ronald J.  Lukas</span>, and <span class="hlFld-ContribAuthor ">Alan P.  Kozikowski</span>  . </span><span class="cited-content_cbyCitation_article-title">Chemistry and Behavioral Studies Identify Chiral Cyclopropanes as Selective α4β2-Nicotinic Acetylcholine Receptor Partial Agonists Exhibiting an Antidepressant Profile. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (2)
                                     , 717-724. <a href="https://doi.org/10.1021/jm201157c" title="DOI URL">https://doi.org/10.1021/jm201157c</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm201157c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm201157c%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DChemistry%252Band%252BBehavioral%252BStudies%252BIdentify%252BChiral%252BCyclopropanes%252Bas%252BSelective%252B%2525CE%2525B14%2525CE%2525B22-Nicotinic%252BAcetylcholine%252BReceptor%252BPartial%252BAgonists%252BExhibiting%252Ban%252BAntidepressant%252BProfile%26aulast%3DZhang%26aufirst%3DHankun%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D30082011%26date%3D10012012%26date%3D26012012%26date%3D15122011%26volume%3D55%26issue%3D2%26spage%3D717%26epage%3D724" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ziru  Yu</span>, <span class="hlFld-ContribAuthor ">Dewen  Kong</span>, <span class="hlFld-ContribAuthor ">Yu  Liang</span>, <span class="hlFld-ContribAuthor ">Xiaoyue  Zhao</span>, <span class="hlFld-ContribAuthor ">Guanhua  Du</span>. </span><span class="cited-content_cbyCitation_article-title">Protective effects of VMY-2-95 on corticosterone-induced injuries in mice and cellular models. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2021,</strong> <em>11 </em>
                                    (7)
                                     , 1903-1913. <a href="https://doi.org/10.1016/j.apsb.2021.03.002" title="DOI URL">https://doi.org/10.1016/j.apsb.2021.03.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2021.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2021.03.002%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DProtective%252Beffects%252Bof%252BVMY-2-95%252Bon%252Bcorticosterone-induced%252Binjuries%252Bin%252Bmice%252Band%252Bcellular%252Bmodels%26aulast%3DYu%26aufirst%3DZiru%26date%3D2021%26volume%3D11%26issue%3D7%26spage%3D1903%26epage%3D1913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liangkui  Li</span>, <span class="hlFld-ContribAuthor ">Shiqing  Huang</span>, <span class="hlFld-ContribAuthor ">Kuantao  Mao</span>, <span class="hlFld-ContribAuthor ">Leiyang  Lv</span>, <span class="hlFld-ContribAuthor ">Zhiping  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of isoxazoles via cyclization of β-fluoro enones with sodium azide. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2021,</strong> <em>71 </em>, 153052. <a href="https://doi.org/10.1016/j.tetlet.2021.153052" title="DOI URL">https://doi.org/10.1016/j.tetlet.2021.153052</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2021.153052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2021.153052%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DSynthesis%252Bof%252Bisoxazoles%252Bvia%252Bcyclization%252Bof%252B%2525CE%2525B2-fluoro%252Benones%252Bwith%252Bsodium%252Bazide%26aulast%3DLi%26aufirst%3DLiangkui%26date%3D2021%26volume%3D71%26spage%3D153052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Prasanta  Das</span>, <span class="hlFld-ContribAuthor ">Sarah  Boone</span>, <span class="hlFld-ContribAuthor ">Dipanwita  Mitra</span>, <span class="hlFld-ContribAuthor ">Lindsay  Turner</span>, <span class="hlFld-ContribAuthor ">Ritesh  Tandon</span>, <span class="hlFld-ContribAuthor ">Drazen  Raucher</span>, <span class="hlFld-ContribAuthor ">Ashton T.  Hamme</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of fluoro-substituted spiro-isoxazolines as potential anti-viral and anti-cancer agents. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2020,</strong> <em>10 </em>
                                    (50)
                                     , 30223-30237. <a href="https://doi.org/10.1039/D0RA06148D" title="DOI URL">https://doi.org/10.1039/D0RA06148D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0RA06148D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0RA06148D%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bfluoro-substituted%252Bspiro-isoxazolines%252Bas%252Bpotential%252Banti-viral%252Band%252Banti-cancer%252Bagents%26aulast%3DDas%26aufirst%3DPrasanta%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D50%26spage%3D30223%26epage%3D30237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Afzal  Shaik</span>, <span class="hlFld-ContribAuthor ">Richie R.  Bhandare</span>, <span class="hlFld-ContribAuthor ">Kishor  Palleapati</span>, <span class="hlFld-ContribAuthor ">Srinath  Nissankararao</span>, <span class="hlFld-ContribAuthor ">Venkata  Kancharlapalli</span>, <span class="hlFld-ContribAuthor ">Shahanaaz  Shaik</span>. </span><span class="cited-content_cbyCitation_article-title">Antimicrobial, Antioxidant, and Anticancer Activities of Some Novel Isoxazole Ring Containing Chalcone and Dihydropyrazole Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (5)
                                     , 1047. <a href="https://doi.org/10.3390/molecules25051047" title="DOI URL">https://doi.org/10.3390/molecules25051047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25051047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25051047%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DAntimicrobial%25252C%252BAntioxidant%25252C%252Band%252BAnticancer%252BActivities%252Bof%252BSome%252BNovel%252BIsoxazole%252BRing%252BContaining%252BChalcone%252Band%252BDihydropyrazole%252BDerivatives%26aulast%3DShaik%26aufirst%3DAfzal%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D5%26spage%3D1047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sakkani  Nagaraju</span>, <span class="hlFld-ContribAuthor ">Kota  Sathish</span>, <span class="hlFld-ContribAuthor ">Neeli  Satyanarayana</span>, <span class="hlFld-ContribAuthor ">Banoth  Paplal</span>, <span class="hlFld-ContribAuthor ">Dhurke  Kashinath</span>. </span><span class="cited-content_cbyCitation_article-title">Regioselective synthesis of spiro isoxazole‐oxindole‐tetrahydrothiophene hybrids
              via
              cascade reactions under catalyst‐free conditions. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2020,</strong> <em>57 </em>
                                    (1)
                                     , 469-476. <a href="https://doi.org/10.1002/jhet.3803" title="DOI URL">https://doi.org/10.1002/jhet.3803</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.3803&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.3803%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DRegioselective%252Bsynthesis%252Bof%252Bspiro%252Bisoxazole%2525E2%252580%252590oxindole%2525E2%252580%252590tetrahydrothiophene%252Bhybrids%252Bvia%252Bcascade%252Breactions%252Bunder%252Bcatalyst%2525E2%252580%252590free%252Bconditions%26aulast%3DNagaraju%26aufirst%3DSakkani%26date%3D2020%26date%3D2019%26volume%3D57%26issue%3D1%26spage%3D469%26epage%3D476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manuela M.  Laikowski</span>, <span class="hlFld-ContribAuthor ">Fávero  Reisdorfer</span>, <span class="hlFld-ContribAuthor ">Sidnei  Moura</span>. </span><span class="cited-content_cbyCitation_article-title">NAChR α4β2 Subtype and their Relation with Nicotine Addiction, Cognition, Depression and Hyperactivity Disorder. </span><span class="cited-content_cbyCitation_journal-name">Current Medicinal Chemistry</span><span> <strong>2019,</strong> <em>26 </em>
                                    (20)
                                     , 3792-3811. <a href="https://doi.org/10.2174/0929867325666180410105135" title="DOI URL">https://doi.org/10.2174/0929867325666180410105135</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/0929867325666180410105135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F0929867325666180410105135%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Medicinal%2520Chemistry%26atitle%3DNAChR%252B%2525CE%2525B14%2525CE%2525B22%252BSubtype%252Band%252Btheir%252BRelation%252Bwith%252BNicotine%252BAddiction%25252C%252BCognition%25252C%252BDepression%252Band%252BHyperactivity%252BDisorder%26aulast%3DLaikowski%26aufirst%3DManuela%2BM.%26date%3D2019%26volume%3D26%26issue%3D20%26spage%3D3792%26epage%3D3811" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hamza  Tachallait</span>, <span class="hlFld-ContribAuthor ">Mohsine  Driowya</span>, <span class="hlFld-ContribAuthor ">Eleuterio  Álvarez</span>, <span class="hlFld-ContribAuthor ">Rachid  Benhida</span>, <span class="hlFld-ContribAuthor ">Khalid  Bougrin</span>. </span><span class="cited-content_cbyCitation_article-title">Water Promoted One-pot Three-Step Synthesis of Novel N-Saccharin Isoxazolines/Isoxazoles Using KI/Oxone Under Ultrasonic Activation. </span><span class="cited-content_cbyCitation_journal-name">Current Organic Chemistry</span><span> <strong>2019,</strong> <em>23 </em>
                                    (11)
                                     , 1270-1281. <a href="https://doi.org/10.2174/1385272823666190621115726" title="DOI URL">https://doi.org/10.2174/1385272823666190621115726</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1385272823666190621115726&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1385272823666190621115726%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Organic%2520Chemistry%26atitle%3DWater%252BPromoted%252BOne-pot%252BThree-Step%252BSynthesis%252Bof%252BNovel%252BN-Saccharin%252BIsoxazolines%25252FIsoxazoles%252BUsing%252BKI%25252FOxone%252BUnder%252BUltrasonic%252BActivation%26aulast%3DTachallait%26aufirst%3DHamza%26date%3D2019%26volume%3D23%26issue%3D11%26spage%3D1270%26epage%3D1281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fausto M.  Güiza</span>, <span class="hlFld-ContribAuthor ">Yenny Bueno  Duarte</span>, <span class="hlFld-ContribAuthor ">Stelia C.  Mendez-Sanchez</span>, <span class="hlFld-ContribAuthor ">Arnold R. Romero  Bohórquez</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and in vitro evaluation of substituted tetrahydroquinoline-isoxazole hybrids as anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2019,</strong> <em>28 </em>
                                    (8)
                                     , 1182-1196. <a href="https://doi.org/10.1007/s00044-019-02363-z" title="DOI URL">https://doi.org/10.1007/s00044-019-02363-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-019-02363-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-019-02363-z%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DSynthesis%252Band%252Bin%252Bvitro%252Bevaluation%252Bof%252Bsubstituted%252Btetrahydroquinoline-isoxazole%252Bhybrids%252Bas%252Banticancer%252Bagents%26aulast%3DG%25C3%25BCiza%26aufirst%3DFausto%2BM.%26date%3D2019%26date%3D2019%26volume%3D28%26issue%3D8%26spage%3D1182%26epage%3D1196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuang  Chen</span>, <span class="hlFld-ContribAuthor ">Guan-Lian  Wang</span>, <span class="hlFld-ContribAuthor ">Sheng-Wen  Xu</span>, <span class="hlFld-ContribAuthor ">Min-Yi  Tian</span>, <span class="hlFld-ContribAuthor ">Min  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiong-Li  Liu</span>, <span class="hlFld-ContribAuthor ">Wei-Cheng  Yuan</span>. </span><span class="cited-content_cbyCitation_article-title">Regio- and stereoselective [3 + 2] cycloaddition reaction: access to isoxazole-dispirobisoxindoles featuring three contiguous stereocenters. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2019,</strong> <em>17 </em>
                                    (27)
                                     , 6551-6556. <a href="https://doi.org/10.1039/C9OB01203F" title="DOI URL">https://doi.org/10.1039/C9OB01203F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9OB01203F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9OB01203F%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DRegio-%252Band%252Bstereoselective%252B%25255B3%252B%25252B%252B2%25255D%252Bcycloaddition%252Breaction%25253A%252Baccess%252Bto%252Bisoxazole-dispirobisoxindoles%252Bfeaturing%252Bthree%252Bcontiguous%252Bstereocenters%26aulast%3DChen%26aufirst%3DShuang%26date%3D2019%26date%3D2019%26volume%3D17%26issue%3D27%26spage%3D6551%26epage%3D6556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pierrick  Bruyat</span>, <span class="hlFld-ContribAuthor ">Ludovic  Jean</span>, <span class="hlFld-ContribAuthor ">Pierre-Yves  Renard</span>. </span><span class="cited-content_cbyCitation_article-title">Regioselective Solid-Phase Synthesis of Peptide Analogues Containing 3,4- or 3,5-Disubstituted Isoxazole as
              s-cis
              or
              s-trans
              Peptide Bond Mimics. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>2019 </em>
                                    (20)
                                     , 3134-3141. <a href="https://doi.org/10.1002/ejoc.201900378" title="DOI URL">https://doi.org/10.1002/ejoc.201900378</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201900378&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201900378%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DRegioselective%252BSolid-Phase%252BSynthesis%252Bof%252BPeptide%252BAnalogues%252BContaining%252B3%25252C4-%252Bor%252B3%25252C5-Disubstituted%252BIsoxazole%252Bas%252Bs-cis%252Bor%252Bs-trans%252BPeptide%252BBond%252BMimics%26aulast%3DBruyat%26aufirst%3DPierrick%26date%3D2019%26date%3D2019%26volume%3D2019%26issue%3D20%26spage%3D3134%26epage%3D3141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ashish  Bhatt</span>, <span class="hlFld-ContribAuthor ">Rajesh K.  Singh</span>, <span class="hlFld-ContribAuthor ">Ravi  Kant</span>. </span><span class="cited-content_cbyCitation_article-title">Trichloroisocyanuric acid mediated one-pot synthesis of 3,5-diarylisoxazoles from
              α,β
              -unsaturated ketones. </span><span class="cited-content_cbyCitation_journal-name">Synthetic Communications</span><span> <strong>2019,</strong> <em>49 </em>
                                    (8)
                                     , 1083-1091. <a href="https://doi.org/10.1080/00397911.2019.1590848" title="DOI URL">https://doi.org/10.1080/00397911.2019.1590848</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00397911.2019.1590848&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00397911.2019.1590848%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthetic%2520Communications%26atitle%3DTrichloroisocyanuric%252Bacid%252Bmediated%252Bone-pot%252Bsynthesis%252Bof%252B3%25252C5-diarylisoxazoles%252Bfrom%252B%2525CE%2525B1%25252C%2525CE%2525B2%252B-unsaturated%252Bketones%26aulast%3DBhatt%26aufirst%3DAshish%26date%3D2019%26date%3D2019%26volume%3D49%26issue%3D8%26spage%3D1083%26epage%3D1091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ashish  Bhatt</span>, <span class="hlFld-ContribAuthor ">Rajesh K.  Singh</span>, <span class="hlFld-ContribAuthor ">Ravi  Kant</span>. </span><span class="cited-content_cbyCitation_article-title">A convenient one-pot synthesis of 3,5-diarylisoxazoles via oxidative cyclisation using catalytic CuBr2 and oxone. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2019,</strong> <em>60 </em>
                                    (16)
                                     , 1143-1147. <a href="https://doi.org/10.1016/j.tetlet.2019.03.044" title="DOI URL">https://doi.org/10.1016/j.tetlet.2019.03.044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2019.03.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2019.03.044%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DA%252Bconvenient%252Bone-pot%252Bsynthesis%252Bof%252B3%25252C5-diarylisoxazoles%252Bvia%252Boxidative%252Bcyclisation%252Busing%252Bcatalytic%252BCuBr2%252Band%252Boxone%26aulast%3DBhatt%26aufirst%3DAshish%26date%3D2019%26volume%3D60%26issue%3D16%26spage%3D1143%26epage%3D1147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Subas Chandra  Sahoo</span>, <span class="hlFld-ContribAuthor ">Subhas Chandra  Pan</span>. </span><span class="cited-content_cbyCitation_article-title">Catalytic Enantioselective Synthesis of 3,4,5-Trisubstituted Isoxazoline
              N
              -Oxides and Regioselective Synthesis of 3,4,5-Trisubstituted Isoxazoles. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>2019 </em>
                                    (6)
                                     , 1385-1389. <a href="https://doi.org/10.1002/ejoc.201801693" title="DOI URL">https://doi.org/10.1002/ejoc.201801693</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201801693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201801693%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DCatalytic%252BEnantioselective%252BSynthesis%252Bof%252B3%25252C4%25252C5-Trisubstituted%252BIsoxazoline%252BN%252B-Oxides%252Band%252BRegioselective%252BSynthesis%252Bof%252B3%25252C4%25252C5-Trisubstituted%252BIsoxazoles%26aulast%3DSahoo%26aufirst%3DSubas%2BChandra%26date%3D2019%26date%3D2019%26volume%3D2019%26issue%3D6%26spage%3D1385%26epage%3D1389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenwen  Liu</span>, <span class="hlFld-ContribAuthor ">Huan  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaokang  Li</span>, <span class="hlFld-ContribAuthor ">Yixiang  Xu</span>, <span class="hlFld-ContribAuthor ">Jian  Zhang</span>, <span class="hlFld-ContribAuthor ">Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Qi  Gong</span>, <span class="hlFld-ContribAuthor ">Xiaoxia  Qiu</span>, <span class="hlFld-ContribAuthor ">Jin  Zhu</span>, <span class="hlFld-ContribAuthor ">Fei  Mao</span>, <span class="hlFld-ContribAuthor ">Haiyan  Zhang</span>, <span class="hlFld-ContribAuthor ">Jian  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and evaluation of vilazodone-tacrine hybrids as multitarget-directed ligands against depression with cognitive impairment. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (12)
                                     , 3117-3125. <a href="https://doi.org/10.1016/j.bmc.2018.04.037" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.04.037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.04.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.04.037%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bevaluation%252Bof%252Bvilazodone-tacrine%252Bhybrids%252Bas%252Bmultitarget-directed%252Bligands%252Bagainst%252Bdepression%252Bwith%252Bcognitive%252Bimpairment%26aulast%3DLiu%26aufirst%3DWenwen%26date%3D2018%26volume%3D26%26issue%3D12%26spage%3D3117%26epage%3D3125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Neetu  Agrawal</span>, <span class="hlFld-ContribAuthor ">Pradeep  Mishra</span>. </span><span class="cited-content_cbyCitation_article-title">The synthetic and therapeutic expedition of isoxazole and its analogs. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2018,</strong> <em>27 </em>
                                    (5)
                                     , 1309-1344. <a href="https://doi.org/10.1007/s00044-018-2152-6" title="DOI URL">https://doi.org/10.1007/s00044-018-2152-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-018-2152-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-018-2152-6%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DThe%252Bsynthetic%252Band%252Btherapeutic%252Bexpedition%252Bof%252Bisoxazole%252Band%252Bits%252Banalogs%26aulast%3DAgrawal%26aufirst%3DNeetu%26date%3D2018%26date%3D2018%26volume%3D27%26issue%3D5%26spage%3D1309%26epage%3D1344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bing  Lin</span>, <span class="hlFld-ContribAuthor ">Wen-Hui  Zhang</span>, <span class="hlFld-ContribAuthor ">Dan-Dan  Wang</span>, <span class="hlFld-ContribAuthor ">Yi  Gong</span>, <span class="hlFld-ContribAuthor ">Qi-Di  Wei</span>, <span class="hlFld-ContribAuthor ">Xiong-Li  Liu</span>, <span class="hlFld-ContribAuthor ">Ting-Ting  Feng</span>, <span class="hlFld-ContribAuthor ">Ying  Zhou</span>, <span class="hlFld-ContribAuthor ">Wei-Cheng  Yuan</span>. </span><span class="cited-content_cbyCitation_article-title">3-Methyl-4-nitro-5-isatylidenyl-isoxazoles as 1,3-dipolarophiles for synthesis of polycyclic 3,3′-pyrrolidinyl-dispirooxindoles and their biological evaluation for anticancer activities. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2017,</strong> <em>73 </em>
                                    (34)
                                     , 5176-5188. <a href="https://doi.org/10.1016/j.tet.2017.07.011" title="DOI URL">https://doi.org/10.1016/j.tet.2017.07.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2017.07.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2017.07.011%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3D3-Methyl-4-nitro-5-isatylidenyl-isoxazoles%252Bas%252B1%25252C3-dipolarophiles%252Bfor%252Bsynthesis%252Bof%252Bpolycyclic%252B3%25252C3%2525E2%252580%2525B2-pyrrolidinyl-dispirooxindoles%252Band%252Btheir%252Bbiological%252Bevaluation%252Bfor%252Banticancer%252Bactivities%26aulast%3DLin%26aufirst%3DBing%26date%3D2017%26volume%3D73%26issue%3D34%26spage%3D5176%26epage%3D5188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Divya  Dheer</span>, <span class="hlFld-ContribAuthor ">Ravindra K.  Rawal</span>, <span class="hlFld-ContribAuthor ">Virender  Singh</span>, <span class="hlFld-ContribAuthor ">P.L.  Sangwan</span>, <span class="hlFld-ContribAuthor ">Parthasarathi  Das</span>, <span class="hlFld-ContribAuthor ">Ravi  Shankar</span>. </span><span class="cited-content_cbyCitation_article-title">β-CD/CuI catalyzed regioselective synthesis of iodo substituted 1,2,3-triazoles, imidazo[1,2-a]-pyridines and benzoimidazo[2,1-b]thiazoles in water and their functionalization. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2017,</strong> <em>73 </em>
                                    (30)
                                     , 4295-4306. <a href="https://doi.org/10.1016/j.tet.2017.05.081" title="DOI URL">https://doi.org/10.1016/j.tet.2017.05.081</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2017.05.081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2017.05.081%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3D%2525CE%2525B2-CD%25252FCuI%252Bcatalyzed%252Bregioselective%252Bsynthesis%252Bof%252Biodo%252Bsubstituted%252B1%25252C2%25252C3-triazoles%25252C%252Bimidazo%25255B1%25252C2-a%25255D-pyridines%252Band%252Bbenzoimidazo%25255B2%25252C1-b%25255Dthiazoles%252Bin%252Bwater%252Band%252Btheir%252Bfunctionalization%26aulast%3DDheer%26aufirst%3DDivya%26date%3D2017%26volume%3D73%26issue%3D30%26spage%3D4295%26epage%3D4306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">George N.  Pairas</span>, <span class="hlFld-ContribAuthor ">Fereniki  Perperopoulou</span>, <span class="hlFld-ContribAuthor ">Petros G.  Tsoungas</span>, <span class="hlFld-ContribAuthor ">George  Varvounis</span>. </span><span class="cited-content_cbyCitation_article-title">The Isoxazole Ring and Its
              N
              -Oxide: A Privileged Core Structure in Neuropsychiatric Therapeutics. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2017,</strong> <em>12 </em>
                                    (6)
                                     , 408-419. <a href="https://doi.org/10.1002/cmdc.201700023" title="DOI URL">https://doi.org/10.1002/cmdc.201700023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201700023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201700023%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DThe%252BIsoxazole%252BRing%252Band%252BIts%252BN%252B-Oxide%25253A%252BA%252BPrivileged%252BCore%252BStructure%252Bin%252BNeuropsychiatric%252BTherapeutics%26aulast%3DPairas%26aufirst%3DGeorge%2BN.%26date%3D2017%26date%3D2017%26volume%3D12%26issue%3D6%26spage%3D408%26epage%3D419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bo  Feng</span>, <span class="hlFld-ContribAuthor ">Xiao-Yang  Zhao</span>, <span class="hlFld-ContribAuthor ">Yi-Zhou  Song</span>, <span class="hlFld-ContribAuthor ">Wen-Na  Liang</span>, <span class="hlFld-ContribAuthor ">Ji-Liang  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Sarsasapogenin reverses depressive-like behaviors and nicotinic acetylcholine receptors induced by olfactory bulbectomy. </span><span class="cited-content_cbyCitation_journal-name">Neuroscience Letters</span><span> <strong>2017,</strong> <em>639 </em>, 173-178. <a href="https://doi.org/10.1016/j.neulet.2016.12.025" title="DOI URL">https://doi.org/10.1016/j.neulet.2016.12.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neulet.2016.12.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neulet.2016.12.025%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuroscience%2520Letters%26atitle%3DSarsasapogenin%252Breverses%252Bdepressive-like%252Bbehaviors%252Band%252Bnicotinic%252Bacetylcholine%252Breceptors%252Binduced%252Bby%252Bolfactory%252Bbulbectomy%26aulast%3DFeng%26aufirst%3DBo%26date%3D2017%26volume%3D639%26spage%3D173%26epage%3D178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yadong  Sun</span>, <span class="hlFld-ContribAuthor ">Ablimit  Abdukader</span>, <span class="hlFld-ContribAuthor ">Haiyan  Zhang</span>, <span class="hlFld-ContribAuthor ">Wanle  Yang</span>, <span class="hlFld-ContribAuthor ">Chenjiang  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Copper-catalyzed aerobic oxidative C–O bond formation for the synthesis of 3,5-disubstituted isoxazoles from enone oximes. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2017,</strong> <em>7 </em>
                                    (88)
                                     , 55786-55789. <a href="https://doi.org/10.1039/C7RA11436B" title="DOI URL">https://doi.org/10.1039/C7RA11436B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7RA11436B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7RA11436B%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DCopper-catalyzed%252Baerobic%252Boxidative%252BC%2525E2%252580%252593O%252Bbond%252Bformation%252Bfor%252Bthe%252Bsynthesis%252Bof%252B3%25252C5-disubstituted%252Bisoxazoles%252Bfrom%252Benone%252Boximes%26aulast%3DSun%26aufirst%3DYadong%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D88%26spage%3D55786%26epage%3D55789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Han-Kun  Zhang</span>, <span class="hlFld-ContribAuthor ">J. Brek  Eaton</span>, <span class="hlFld-ContribAuthor ">Allison  Fedolak</span>, <span class="hlFld-ContribAuthor ">Hendra  Gunosewoyo</span>, <span class="hlFld-ContribAuthor ">Oluseye K.  Onajole</span>, <span class="hlFld-ContribAuthor ">Dani  Brunner</span>, <span class="hlFld-ContribAuthor ">Ronald J.  Lukas</span>, <span class="hlFld-ContribAuthor ">Li-Fang  Yu</span>, <span class="hlFld-ContribAuthor ">Alan P.  Kozikowski</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of novel hybrids of highly potent and selective α4β2-Nicotinic acetylcholine receptor (nAChR) partial agonists. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>124 </em>, 689-697. <a href="https://doi.org/10.1016/j.ejmech.2016.09.016" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.09.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.09.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.09.016%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bhybrids%252Bof%252Bhighly%252Bpotent%252Band%252Bselective%252B%2525CE%2525B14%2525CE%2525B22-Nicotinic%252Bacetylcholine%252Breceptor%252B%252528nAChR%252529%252Bpartial%252Bagonists%26aulast%3DZhang%26aufirst%3DHan-Kun%26date%3D2016%26volume%3D124%26spage%3D689%26epage%3D697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dawei  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Chen</span>, <span class="hlFld-ContribAuthor ">Xue  Guo</span>, <span class="hlFld-ContribAuthor ">Yumin  Zhang</span>, <span class="hlFld-ContribAuthor ">Yaya  Hou</span>, <span class="hlFld-ContribAuthor ">Tianqi  Zhao</span>, <span class="hlFld-ContribAuthor ">Qiang  Gu</span>. </span><span class="cited-content_cbyCitation_article-title">An efficient solvent-free synthesis of isoxazolyl-1,4-dihydropyridines on solid support SiO2 under microwave irradiation. </span><span class="cited-content_cbyCitation_journal-name">Monatshefte für Chemie - Chemical Monthly</span><span> <strong>2016,</strong> <em>147 </em>
                                    (9)
                                     , 1605-1614. <a href="https://doi.org/10.1007/s00706-016-1657-2" title="DOI URL">https://doi.org/10.1007/s00706-016-1657-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00706-016-1657-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00706-016-1657-2%26sid%3Dliteratum%253Aachs%26jtitle%3DMonatshefte%2520f%25C3%25BCr%2520Chemie%2520-%2520Chemical%2520Monthly%26atitle%3DAn%252Befficient%252Bsolvent-free%252Bsynthesis%252Bof%252Bisoxazolyl-1%25252C4-dihydropyridines%252Bon%252Bsolid%252Bsupport%252BSiO2%252Bunder%252Bmicrowave%252Birradiation%26aulast%3DZhang%26aufirst%3DDawei%26date%3D2016%26date%3D2016%26volume%3D147%26issue%3D9%26spage%3D1605%26epage%3D1614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liang  Yu</span>, <span class="hlFld-ContribAuthor ">Xiaoke  Ma</span>, <span class="hlFld-ContribAuthor ">Long  Zhang</span>, <span class="hlFld-ContribAuthor ">Jing  Zhang</span>, <span class="hlFld-ContribAuthor ">Lin  Gao</span>. </span><span class="cited-content_cbyCitation_article-title">Prediction of new drug indications based on clinical data and network modularity. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2016,</strong> <em>6 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/srep32530" title="DOI URL">https://doi.org/10.1038/srep32530</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/srep32530&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fsrep32530%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DPrediction%252Bof%252Bnew%252Bdrug%252Bindications%252Bbased%252Bon%252Bclinical%252Bdata%252Band%252Bnetwork%252Bmodularity%26aulast%3DYu%26aufirst%3DLiang%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nikolaos  Kouvatsos</span>, <span class="hlFld-ContribAuthor ">Petros  Giastas</span>, <span class="hlFld-ContribAuthor ">Dafni  Chroni-Tzartou</span>, <span class="hlFld-ContribAuthor ">Cornelia  Poulopoulou</span>, <span class="hlFld-ContribAuthor ">Socrates J.  Tzartos</span>. </span><span class="cited-content_cbyCitation_article-title">Crystal structure of a human neuronal nAChR extracellular domain in pentameric assembly: Ligand-bound α2 homopentamer. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2016,</strong> <em>113 </em>
                                    (34)
                                     , 9635-9640. <a href="https://doi.org/10.1073/pnas.1602619113" title="DOI URL">https://doi.org/10.1073/pnas.1602619113</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.1602619113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.1602619113%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DCrystal%252Bstructure%252Bof%252Ba%252Bhuman%252Bneuronal%252BnAChR%252Bextracellular%252Bdomain%252Bin%252Bpentameric%252Bassembly%25253A%252BLigand-bound%252B%2525CE%2525B12%252Bhomopentamer%26aulast%3DKouvatsos%26aufirst%3DNikolaos%26date%3D2016%26date%3D2016%26volume%3D113%26issue%3D34%26spage%3D9635%26epage%3D9640" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dawei  Zhang</span>, <span class="hlFld-ContribAuthor ">Yumin  Zhang</span>, <span class="hlFld-ContribAuthor ">Tianqi  Zhao</span>, <span class="hlFld-ContribAuthor ">Jing  Li</span>, <span class="hlFld-ContribAuthor ">Yaya  Hou</span>, <span class="hlFld-ContribAuthor ">Qiang  Gu</span>. </span><span class="cited-content_cbyCitation_article-title">A rapid and efficient solvent-free microwave-assisted synthesis of pyrazolone derivatives containing substituted isoxazole ring. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2016,</strong> <em>72 </em>
                                    (22)
                                     , 2979-2987. <a href="https://doi.org/10.1016/j.tet.2016.04.014" title="DOI URL">https://doi.org/10.1016/j.tet.2016.04.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2016.04.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2016.04.014%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DA%252Brapid%252Band%252Befficient%252Bsolvent-free%252Bmicrowave-assisted%252Bsynthesis%252Bof%252Bpyrazolone%252Bderivatives%252Bcontaining%252Bsubstituted%252Bisoxazole%252Bring%26aulast%3DZhang%26aufirst%3DDawei%26date%3D2016%26volume%3D72%26issue%3D22%26spage%3D2979%26epage%3D2987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiong-Wei  Liu</span>, <span class="hlFld-ContribAuthor ">Zhen  Yao</span>, <span class="hlFld-ContribAuthor ">Jun  Yang</span>, <span class="hlFld-ContribAuthor ">Zhi-Yong  Chen</span>, <span class="hlFld-ContribAuthor ">Xiong-Li  Liu</span>, <span class="hlFld-ContribAuthor ">Zhi  Zhao</span>, <span class="hlFld-ContribAuthor ">Yi  Lu</span>, <span class="hlFld-ContribAuthor ">Ying  Zhou</span>, <span class="hlFld-ContribAuthor ">Yu  Cao</span>. </span><span class="cited-content_cbyCitation_article-title">1,3-Dipolar cycloaddition enabled isoxazole-fused spiropyrrolidine oxindoles syntheses from 3-methyl-4-nitro-5-alkenyl-isoxazoles and azomethine ylides. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2016,</strong> <em>72 </em>
                                    (10)
                                     , 1364-1374. <a href="https://doi.org/10.1016/j.tet.2016.01.029" title="DOI URL">https://doi.org/10.1016/j.tet.2016.01.029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2016.01.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2016.01.029%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3D1%25252C3-Dipolar%252Bcycloaddition%252Benabled%252Bisoxazole-fused%252Bspiropyrrolidine%252Boxindoles%252Bsyntheses%252Bfrom%252B3-methyl-4-nitro-5-alkenyl-isoxazoles%252Band%252Bazomethine%252Bylides%26aulast%3DLiu%26aufirst%3DXiong-Wei%26date%3D2016%26volume%3D72%26issue%3D10%26spage%3D1364%26epage%3D1374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Han-Kun  Zhang</span>, <span class="hlFld-ContribAuthor ">Hendra  Gunosewoyo</span>, <span class="hlFld-ContribAuthor ">Fan  Yan</span>, <span class="hlFld-ContribAuthor ">Jie  Tang</span>, <span class="hlFld-ContribAuthor ">Li-Fang  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Development of Antidepressant Drugs Through Targeting α4β2-Nicotinic Acetylcholine Receptors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 207-225. <a href="https://doi.org/10.1007/978-1-4939-3768-4_11" title="DOI URL">https://doi.org/10.1007/978-1-4939-3768-4_11</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-4939-3768-4_11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-4939-3768-4_11%26sid%3Dliteratum%253Aachs%26atitle%3DDevelopment%252Bof%252BAntidepressant%252BDrugs%252BThrough%252BTargeting%252B%2525CE%2525B14%2525CE%2525B22-Nicotinic%252BAcetylcholine%252BReceptors%26aulast%3DZhang%26aufirst%3DHan-Kun%26date%3D2016%26date%3D2016%26spage%3D207%26epage%3D225%26pub%3DSpringer%2520New%2520York%26atitle%3DNicotinic%252BAcetylcholine%252BReceptor%252BTechnologies%26aulast%3DLi%26aufirst%3DMing%2BD.%26date%3D2016%26volume%3D117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guorui  Cao</span>, <span class="hlFld-ContribAuthor ">Yu  Wang</span>, <span class="hlFld-ContribAuthor ">Tao  Cui</span>, <span class="hlFld-ContribAuthor ">Longjiang  Huang</span>, <span class="hlFld-ContribAuthor ">Dawei  Teng</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 3,4,5-trisubstituted isoxazoles via 1,3-dipolar cycloaddition/SO
              2
              extrusion of benzoisothiazole-2,2-dioxide-3-ylidenes with nitrile oxides. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2016,</strong> <em>6 </em>
                                    (27)
                                     , 22519-22525. <a href="https://doi.org/10.1039/C5RA26718H" title="DOI URL">https://doi.org/10.1039/C5RA26718H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5RA26718H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5RA26718H%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DSynthesis%252Bof%252B3%25252C4%25252C5-trisubstituted%252Bisoxazoles%252Bvia%252B1%25252C3-dipolar%252Bcycloaddition%25252FSO%252B2%252Bextrusion%252Bof%252Bbenzoisothiazole-2%25252C2-dioxide-3-ylidenes%252Bwith%252Bnitrile%252Boxides%26aulast%3DCao%26aufirst%3DGuorui%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D27%26spage%3D22519%26epage%3D22525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan  He</span>, <span class="hlFld-ContribAuthor ">Yu-yang  Xie</span>, <span class="hlFld-ContribAuthor ">Ying-chun  Wang</span>, <span class="hlFld-ContribAuthor ">Xiao-min  Bin</span>, <span class="hlFld-ContribAuthor ">Da-chao  Hu</span>, <span class="hlFld-ContribAuthor ">Heng-shan  Wang</span>, <span class="hlFld-ContribAuthor ">Ying-ming  Pan</span>. </span><span class="cited-content_cbyCitation_article-title">TEMPO-catalyzed synthesis of 5-substituted isoxazoles from propargylic ketones and TMSN
              3. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2016,</strong> <em>6 </em>
                                    (64)
                                     , 58988-58993. <a href="https://doi.org/10.1039/C6RA11099A" title="DOI URL">https://doi.org/10.1039/C6RA11099A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6RA11099A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6RA11099A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DTEMPO-catalyzed%252Bsynthesis%252Bof%252B5-substituted%252Bisoxazoles%252Bfrom%252Bpropargylic%252Bketones%252Band%252BTMSN%252B3%26aulast%3DHe%26aufirst%3DYan%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D64%26spage%3D58988%26epage%3D58993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zahra  Najafi</span>, <span class="hlFld-ContribAuthor ">Mohammad  Mahdavi</span>, <span class="hlFld-ContribAuthor ">Maliheh  Safavi</span>, <span class="hlFld-ContribAuthor ">Mina  Saeedi</span>, <span class="hlFld-ContribAuthor ">Heshmatollah  Alinezhad</span>, <span class="hlFld-ContribAuthor ">Mahboobeh  Pordeli</span>, <span class="hlFld-ContribAuthor ">Sussan  Kabudanian Ardestani</span>, <span class="hlFld-ContribAuthor ">Abbas  Shafiee</span>, <span class="hlFld-ContribAuthor ">Alireza  Foroumadi</span>, <span class="hlFld-ContribAuthor ">Tahmineh  Akbarzadeh</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and
              In Vitro
              Cytotoxic Activity of Novel Triazole-Isoxazole Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2015,</strong> <em>52 </em>
                                    (6)
                                     , 1743-1747. <a href="https://doi.org/10.1002/jhet.2273" title="DOI URL">https://doi.org/10.1002/jhet.2273</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.2273&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.2273%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DSynthesis%252Band%252BIn%252BVitro%252BCytotoxic%252BActivity%252Bof%252BNovel%252BTriazole-Isoxazole%252BDerivatives%26aulast%3DNajafi%26aufirst%3DZahra%26date%3D2015%26date%3D2014%26volume%3D52%26issue%3D6%26spage%3D1743%26epage%3D1747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jack L.  Brown</span>, <span class="hlFld-ContribAuthor ">Susan  Wonnacott</span>. </span><span class="cited-content_cbyCitation_article-title">Sazetidine-A Activates and Desensitizes Native α7 Nicotinic Acetylcholine Receptors. </span><span class="cited-content_cbyCitation_journal-name">Neurochemical Research</span><span> <strong>2015,</strong> <em>40 </em>
                                    (10)
                                     , 2047-2054. <a href="https://doi.org/10.1007/s11064-014-1302-6" title="DOI URL">https://doi.org/10.1007/s11064-014-1302-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11064-014-1302-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11064-014-1302-6%26sid%3Dliteratum%253Aachs%26jtitle%3DNeurochemical%2520Research%26atitle%3DSazetidine-A%252BActivates%252Band%252BDesensitizes%252BNative%252B%2525CE%2525B17%252BNicotinic%252BAcetylcholine%252BReceptors%26aulast%3DBrown%26aufirst%3DJack%2BL.%26date%3D2015%26date%3D2014%26volume%3D40%26issue%3D10%26spage%3D2047%26epage%3D2054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiong-Li  Liu</span>, <span class="hlFld-ContribAuthor ">De-Hong  Jing</span>, <span class="hlFld-ContribAuthor ">Zhen  Yao</span>, <span class="hlFld-ContribAuthor ">Wen-Hui  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiong-Wei  Liu</span>, <span class="hlFld-ContribAuthor ">Zhou-Jie  Yang</span>, <span class="hlFld-ContribAuthor ">Zhi  Zhao</span>, <span class="hlFld-ContribAuthor ">Ying  Zhou</span>, <span class="hlFld-ContribAuthor ">Xiao-Nian  Li</span>. </span><span class="cited-content_cbyCitation_article-title">DABCO-catalyzed sp3 C–H activation: rapid access to isoxazole or coumarin-fused 3-quaternary carbon oxindoles and isoxazole-fused pyrrolidinones. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2015,</strong> <em>56 </em>
                                    (41)
                                     , 5637-5645. <a href="https://doi.org/10.1016/j.tetlet.2015.08.059" title="DOI URL">https://doi.org/10.1016/j.tetlet.2015.08.059</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2015.08.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2015.08.059%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DDABCO-catalyzed%252Bsp3%252BC%2525E2%252580%252593H%252Bactivation%25253A%252Brapid%252Baccess%252Bto%252Bisoxazole%252Bor%252Bcoumarin-fused%252B3-quaternary%252Bcarbon%252Boxindoles%252Band%252Bisoxazole-fused%252Bpyrrolidinones%26aulast%3DLiu%26aufirst%3DXiong-Li%26date%3D2015%26volume%3D56%26issue%3D41%26spage%3D5637%26epage%3D5645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Songzhe  Han</span>, <span class="hlFld-ContribAuthor ">Samir Z.  Zard</span>. </span><span class="cited-content_cbyCitation_article-title">A convergent route to substituted azetidines and to Boc-protected 4-aminomethylpyrroles. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2015,</strong> <em>71 </em>
                                    (22)
                                     , 3680-3689. <a href="https://doi.org/10.1016/j.tet.2014.10.054" title="DOI URL">https://doi.org/10.1016/j.tet.2014.10.054</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2014.10.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2014.10.054%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DA%252Bconvergent%252Broute%252Bto%252Bsubstituted%252Bazetidines%252Band%252Bto%252BBoc-protected%252B4-aminomethylpyrroles%26aulast%3DHan%26aufirst%3DSongzhe%26date%3D2015%26volume%3D71%26issue%3D22%26spage%3D3680%26epage%3D3689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Santosh Kumar  Prajapti</span>, <span class="hlFld-ContribAuthor ">Shweta  Shrivastava</span>, <span class="hlFld-ContribAuthor ">Umesh  Bihade</span>, <span class="hlFld-ContribAuthor ">Ajay Kumar  Gupta</span>, <span class="hlFld-ContribAuthor ">V. G. M.  Naidu</span>, <span class="hlFld-ContribAuthor ">Uttam Chand  Banerjee</span>, <span class="hlFld-ContribAuthor ">Bathini Nagendra  Babu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of novel Δ
              2
              -isoxazoline fused cyclopentane derivatives as potential antimicrobial and anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2015,</strong> <em>6 </em>
                                    (5)
                                     , 839-845. <a href="https://doi.org/10.1039/C4MD00525B" title="DOI URL">https://doi.org/10.1039/C4MD00525B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4MD00525B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4MD00525B%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252B%2525CE%252594%252B2%252B-isoxazoline%252Bfused%252Bcyclopentane%252Bderivatives%252Bas%252Bpotential%252Bantimicrobial%252Band%252Banticancer%252Bagents%26aulast%3DPrajapti%26aufirst%3DSantosh%2BKumar%26date%3D2015%26date%3D2015%26volume%3D6%26issue%3D5%26spage%3D839%26epage%3D845" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A V  Galenko</span>, <span class="hlFld-ContribAuthor ">A F  Khlebnikov</span>, <span class="hlFld-ContribAuthor ">M S  Novikov</span>, <span class="hlFld-ContribAuthor ">V V  Pakalnis</span>, <span class="hlFld-ContribAuthor ">N V  Rostovskii</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in isoxazole chemistry. </span><span class="cited-content_cbyCitation_journal-name">Russian Chemical Reviews</span><span> <strong>2015,</strong> <em>84 </em>
                                    (4)
                                     , 335-377. <a href="https://doi.org/10.1070/RCR4503" title="DOI URL">https://doi.org/10.1070/RCR4503</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1070/RCR4503&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1070%2FRCR4503%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Chemical%2520Reviews%26atitle%3DRecent%252Badvances%252Bin%252Bisoxazole%252Bchemistry%26aulast%3DGalenko%26aufirst%3DA%2BV%26date%3D2015%26date%3D2015%26volume%3D84%26issue%3D4%26spage%3D335%26epage%3D377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">R.R.  Rajawinslin</span>, <span class="hlFld-ContribAuthor ">Mustafa J.  Raihan</span>, <span class="hlFld-ContribAuthor ">Donala  Janreddy</span>, <span class="hlFld-ContribAuthor ">Veerababurao  Kavala</span>, <span class="hlFld-ContribAuthor ">Chun-Wei  Kuo</span>, <span class="hlFld-ContribAuthor ">Ting-Shen  Kuo</span>, <span class="hlFld-ContribAuthor ">Mei-Ling  Chen</span>, <span class="hlFld-ContribAuthor ">Chiu-Hui  He</span>, <span class="hlFld-ContribAuthor ">Ching-Fa  Yao</span>. </span><span class="cited-content_cbyCitation_article-title">Selectfluor mediated one pot synthesis of cyclohexanone ring fused isoxazole derivatives. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2014,</strong> <em>70 </em>
                                    (41)
                                     , 7505-7510. <a href="https://doi.org/10.1016/j.tet.2014.08.024" title="DOI URL">https://doi.org/10.1016/j.tet.2014.08.024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2014.08.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2014.08.024%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DSelectfluor%252Bmediated%252Bone%252Bpot%252Bsynthesis%252Bof%252Bcyclohexanone%252Bring%252Bfused%252Bisoxazole%252Bderivatives%26aulast%3DRajawinslin%26aufirst%3DR.R.%26date%3D2014%26volume%3D70%26issue%3D41%26spage%3D7505%26epage%3D7510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Doo-Hee  Song</span>, <span class="hlFld-ContribAuthor ">Jae-Sang  Ryu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 3,4,5-Trisubstituted Isoxazoles through Gold-Catalyzed Cascade Cyclization-Oxidative Alkynylation and Cyclization-Fluorination of 2-Alkynone O-Methyloximes. </span><span class="cited-content_cbyCitation_journal-name">Bulletin of the Korean Chemical Society</span><span> <strong>2014,</strong> <em>35 </em>
                                    (9)
                                     , 2635-2644. <a href="https://doi.org/10.5012/bkcs.2014.35.9.2635" title="DOI URL">https://doi.org/10.5012/bkcs.2014.35.9.2635</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5012/bkcs.2014.35.9.2635&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5012%2Fbkcs.2014.35.9.2635%26sid%3Dliteratum%253Aachs%26jtitle%3DBulletin%2520of%2520the%2520Korean%2520Chemical%2520Society%26atitle%3DSynthesis%252Bof%252B3%25252C4%25252C5-Trisubstituted%252BIsoxazoles%252Bthrough%252BGold-Catalyzed%252BCascade%252BCyclization-Oxidative%252BAlkynylation%252Band%252BCyclization-Fluorination%252Bof%252B2-Alkynone%252BO-Methyloximes%26aulast%3DSong%26aufirst%3DDoo-Hee%26date%3D2014%26volume%3D35%26issue%3D9%26spage%3D2635%26epage%3D2644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li-Yang  Lu</span>, <span class="hlFld-ContribAuthor ">Hsiu-Ming  Kuo</span>, <span class="hlFld-ContribAuthor ">Hwo-Shuenn  Sheu</span>, <span class="hlFld-ContribAuthor ">Gene-Hsiang  Lee</span>, <span class="hlFld-ContribAuthor ">Chung K.  Lai</span>. </span><span class="cited-content_cbyCitation_article-title">Polarization effects in mesogenic isoxazoles and 1,3,4-oxadiazoles. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2014,</strong> <em>70 </em>
                                    (35)
                                     , 5999-6011. <a href="https://doi.org/10.1016/j.tet.2014.05.036" title="DOI URL">https://doi.org/10.1016/j.tet.2014.05.036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2014.05.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2014.05.036%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DPolarization%252Beffects%252Bin%252Bmesogenic%252Bisoxazoles%252Band%252B1%25252C3%25252C4-oxadiazoles%26aulast%3DLu%26aufirst%3DLi-Yang%26date%3D2014%26volume%3D70%26issue%3D35%26spage%3D5999%26epage%3D6011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li‐Fang  Yu</span>, <span class="hlFld-ContribAuthor ">J.  Brek Eaton</span>, <span class="hlFld-ContribAuthor ">Han‐Kun  Zhang</span>, <span class="hlFld-ContribAuthor ">Emily  Sabath</span>, <span class="hlFld-ContribAuthor ">Taleen  Hanania</span>, <span class="hlFld-ContribAuthor ">Guan‐Nan  Li</span>, <span class="hlFld-ContribAuthor ">Richard B.  Breemen</span>, <span class="hlFld-ContribAuthor ">Paul  Whiteaker</span>, <span class="hlFld-ContribAuthor ">Qiang  Liu</span>, <span class="hlFld-ContribAuthor ">Jie  Wu</span>, <span class="hlFld-ContribAuthor ">Yong‐Chang  Chang</span>, <span class="hlFld-ContribAuthor ">Ronald J.  Lukas</span>, <span class="hlFld-ContribAuthor ">Dani  Brunner</span>, <span class="hlFld-ContribAuthor ">Alan P.  Kozikowski</span>. </span><span class="cited-content_cbyCitation_article-title">The potent and selective
              α
              4
              β
              2*/
              α
              6*‐nicotinic acetylcholine receptor partial agonist 2‐[5‐[5‐((
              S
              )Azetidin‐2‐ylmethoxy)‐3‐pyridinyl]‐3‐isoxazolyl]ethanol demonstrates antidepressive‐like behavior in animal models and a favorable ADME‐tox profile. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology Research & Perspectives</span><span> <strong>2014,</strong> <em>2 </em>
                                    (2)
                                     <a href="https://doi.org/10.1002/prp2.26" title="DOI URL">https://doi.org/10.1002/prp2.26</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/prp2.26&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fprp2.26%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520Research%2520%2526%2520Perspectives%26atitle%3DThe%252Bpotent%252Band%252Bselective%252B%2525CE%2525B1%252B4%252B%2525CE%2525B2%252B2%252A%25252F%252B%2525CE%2525B1%252B6%252A%2525E2%252580%252590nicotinic%252Bacetylcholine%252Breceptor%252Bpartial%252Bagonist%252B2%2525E2%252580%252590%25255B5%2525E2%252580%252590%25255B5%2525E2%252580%252590%252528%252528%252BS%252B%252529Azetidin%2525E2%252580%2525902%2525E2%252580%252590ylmethoxy%252529%2525E2%252580%2525903%2525E2%252580%252590pyridinyl%25255D%2525E2%252580%2525903%2525E2%252580%252590isoxazolyl%25255Dethanol%252Bdemonstrates%252Bantidepressive%2525E2%252580%252590like%252Bbehavior%252Bin%252Banimal%252Bmodels%252Band%252Ba%252Bfavorable%252BADME%2525E2%252580%252590tox%252Bprofile%26aulast%3DYu%26aufirst%3DLi%25E2%2580%2590Fang%26date%3D2014%26date%3D2014%26volume%3D2%26issue%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ruud  Zwart</span>, <span class="hlFld-ContribAuthor ">Merrick  Strotton</span>, <span class="hlFld-ContribAuthor ">Jennifer  Ching</span>, <span class="hlFld-ContribAuthor ">Peter C.  Astles</span>, <span class="hlFld-ContribAuthor ">Emanuele  Sher</span>. </span><span class="cited-content_cbyCitation_article-title">Unique pharmacology of heteromeric α7β2 nicotinic acetylcholine receptors expressed in Xenopus laevis oocytes. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmacology</span><span> <strong>2014,</strong> <em>726 </em>, 77-86. <a href="https://doi.org/10.1016/j.ejphar.2014.01.031" title="DOI URL">https://doi.org/10.1016/j.ejphar.2014.01.031</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejphar.2014.01.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejphar.2014.01.031%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmacology%26atitle%3DUnique%252Bpharmacology%252Bof%252Bheteromeric%252B%2525CE%2525B17%2525CE%2525B22%252Bnicotinic%252Bacetylcholine%252Breceptors%252Bexpressed%252Bin%252BXenopus%252Blaevis%252Boocytes%26aulast%3DZwart%26aufirst%3DRuud%26date%3D2014%26volume%3D726%26spage%3D77%26epage%3D86" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yang  Yuan</span>, <span class="hlFld-ContribAuthor ">Li-Fang  Yu</span>, <span class="hlFld-ContribAuthor ">Xi  Qiu</span>, <span class="hlFld-ContribAuthor ">Alan P.  Kozikowski</span>, <span class="hlFld-ContribAuthor ">Richard B.  van Breemen</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacokinetics and brain penetration of LF-3-88, (2-[5-[5-(2(S)-azetidinylmethoxyl)-3-pyridyl]-3-isoxazolyl]ethanol), a selective α4β2-nAChR partial agonist and promising antidepressant. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chromatography B</span><span> <strong>2013,</strong> <em>912 </em>, 38-42. <a href="https://doi.org/10.1016/j.jchromb.2012.11.011" title="DOI URL">https://doi.org/10.1016/j.jchromb.2012.11.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jchromb.2012.11.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jchromb.2012.11.011%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chromatography%2520B%26atitle%3DPharmacokinetics%252Band%252Bbrain%252Bpenetration%252Bof%252BLF-3-88%25252C%252B%2525282-%25255B5-%25255B5-%2525282%252528S%252529-azetidinylmethoxyl%252529-3-pyridyl%25255D-3-isoxazolyl%25255Dethanol%252529%25252C%252Ba%252Bselective%252B%2525CE%2525B14%2525CE%2525B22-nAChR%252Bpartial%252Bagonist%252Band%252Bpromising%252Bantidepressant%26aulast%3DYuan%26aufirst%3DYang%26date%3D2013%26volume%3D912%26spage%3D38%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Benito  Alcaide</span>, <span class="hlFld-ContribAuthor ">Pedro  Almendros</span>. </span><span class="cited-content_cbyCitation_article-title">Four-Membered Ring Systems. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2012,</strong>,, 115-137. <a href="https://doi.org/10.1016/B978-0-08-096807-0.00004-X" title="DOI URL">https://doi.org/10.1016/B978-0-08-096807-0.00004-X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-096807-0.00004-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-096807-0.00004-X%26sid%3Dliteratum%253Aachs%26atitle%3DFour-Membered%252BRing%252BSystems%26aulast%3DAlcaide%26aufirst%3DBenito%26date%3D2012%26spage%3D115%26epage%3D137%26pub%3DElsevier%26date%3D2012%26volume%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Noah S.  Philip</span>, <span class="hlFld-ContribAuthor ">Linda L.  Carpenter</span>, <span class="hlFld-ContribAuthor ">Audrey R.  Tyrka</span>, <span class="hlFld-ContribAuthor ">Lawrence H.  Price</span>. </span><span class="cited-content_cbyCitation_article-title">The Nicotinic Acetylcholine Receptor as a Target for Antidepressant Drug Development. </span><span class="cited-content_cbyCitation_journal-name">The Scientific World Journal</span><span> <strong>2012,</strong> <em>2012 </em>, 1-7. <a href="https://doi.org/10.1100/2012/104105" title="DOI URL">https://doi.org/10.1100/2012/104105</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1100/2012/104105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1100%2F2012%2F104105%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Scientific%2520World%2520Journal%26atitle%3DThe%252BNicotinic%252BAcetylcholine%252BReceptor%252Bas%252Ba%252BTarget%252Bfor%252BAntidepressant%252BDrug%252BDevelopment%26aulast%3DPhilip%26aufirst%3DNoah%2BS.%26date%3D2012%26volume%3D2012%26spage%3D1%26epage%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm200855b/production/images/medium/jm-2011-00855b_0004.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm200855b/production/images/large/jm-2011-00855b_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200855b&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm200855b/production/images/medium/jm-2011-00855b_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm200855b/production/images/large/jm-2011-00855b_0006.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure of sazetidine-A and proposed structure with a heteroaromatic ring replacing the acetylene group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm200855b/production/images/large/jm-2011-00855b_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200855b&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm200855b/production/images/medium/jm-2011-00855b_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm200855b/production/images/large/jm-2011-00855b_0007.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Analogues of sazetidine-A with an isoxazole ring in place of the acetylene group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm200855b/production/images/large/jm-2011-00855b_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200855b&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm200855b/production/images/medium/jm-2011-00855b_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm200855b/production/images/large/jm-2011-00855b_0008.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Compounds <b>3</b> and <b>5</b> reduced immobility in the forced swim test in mice at the medium and highest dose tested. Compound <b>4</b> showed an insignificant trend at the highest dose only. The SSRI sertraline produced the expected decrease in immobility. ANOVAs: <i>F</i> (11 108) = 6.9, <i>p</i> < 0.001. *Fisher’s PLSD post hoc test: <i>p</i> < 0.05 versus vehicle. All drugs were injected intraperitoneally; <i>n</i> = 10/group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm200855b/production/images/large/jm-2011-00855b_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200855b&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm200855b/production/images/medium/jm-2011-00855b_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm200855b/production/images/large/jm-2011-00855b_0001.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Receptor occupancy studies of compounds <b>3</b>–<b>5</b> in mice showed a significant occupancy level. Compound <b>5</b> showed a higher receptor occupancy than compounds <b>3</b> and <b>4</b>. *Mann–Whitney U: <i>p</i> < 0.05. All drugs were injected intraperitoneally; <i>n</i> = 3/group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm200855b/production/images/large/jm-2011-00855b_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200855b&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm200855b/production/images/medium/jm-2011-00855b_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm200855b/production/images/large/jm-2011-00855b_0002.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Compound <b>3</b> reduced immobility in the forced swim test in mice when given orally at 10 mg/kg. Immobility was slightly higher at the lowest dose. Compound <b>5</b> was efficacious at all doses tested. The SSRI sertraline produced the expected decrease in immobility. ANOVAs: <i>F</i> > 34.5; <i>p</i> < 0.001. *Fisher’s PLSD post hoc tests: <i>p</i> < 0.05 versus vehicle. <i>N</i> = 9–10/group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm200855b/production/images/large/jm-2011-00855b_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200855b&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm200855b/production/images/medium/jm-2011-00855b_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm200855b/production/images/large/jm-2011-00855b_0003.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm200855b/production/images/large/jm-2011-00855b_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200855b&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ethynyltrimethylsilane, CuI, PPh<sub>3</sub>, PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, Et<sub>3</sub>N; (b) (<i>n</i>-Bu)<sub>4</sub>NF, THF; (c) NaH, TBSCl, THF; (d) PPh<sub>3</sub>, imidazole, I<sub>2</sub>, Et<sub>2</sub>O/MeCN; (e) AgNO<sub>2</sub>, Et<sub>2</sub>O; (f) PhNCO, Et<sub>3</sub>N, toluene; (g) HCl, ether/MeOH.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i43">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64558" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64558" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 40 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">World Health Organization</span><span class="NLM_x">. </span> <span class="citation_source-book">Mental health and development: targeting people with mental health conditions as a vulnerable group</span>. <span class="NLM_publisher-name">WHO Press</span>: <span class="NLM_publisher-loc">Geneva, Switzerland</span>,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=World+Health+Organization&title=Mental+health+and+development%3A+targeting+people+with+mental+health+conditions+as+a+vulnerable+group"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3D%26btitle%3DMental%2520health%2520and%2520development%253A%2520targeting%2520people%2520with%2520mental%2520health%2520conditions%2520as%2520a%2520vulnerable%2520group%26pub%3DWHO%2520Press%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Henn, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vollmayr, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartorius, A.</span><span> </span><span class="NLM_article-title">Mechanisms of depression: the role of neurogenesis</span> <span class="citation_source-journal">Drug Discovery Today: Dis. Mech.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">407</span><span class="NLM_x">–</span> <span class="NLM_lpage">411</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm200855b&amp;key=10.1016%2Fj.ddmec.2004.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm200855b&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVOmtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2004&pages=407-411&author=F.+Hennauthor=B.+Vollmayrauthor=A.+Sartorius&title=Mechanisms+of+depression%3A+the+role+of+neurogenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of depression: the role of neurogenesis</span></div><div class="casAuthors">Henn, Fritz; Vollmayr, Barbara; Sartorius, Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today: Disease Mechanisms</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">407-411</span>CODEN:
                <span class="NLM_cas:coden">DDTDAO</span>;
        ISSN:<span class="NLM_cas:issn">1740-6765</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The behavioral changes in depression can relate to alterations in hippocampal function.  A variety of inputs to the hippocampus can effect mood, including norepinephrine (NE), serotonin (5HT) and cortisol, all factors activated by stress.  These are thought to act through activation of CREB and neurotrophins such as BDNF.  Stress was shown to decrease hippocampal neurogenesis and most antidepressants increase neurogenesis, leading to the hypothesis that changes in the rate of new neuron formation might underlie depressive illnesses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1cZS3WiwZirVg90H21EOLACvtfcHk0lh8gfcBgstVoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVOmtbk%253D&md5=1d0994df3b20b84496c49770384c4781</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.ddmec.2004.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ddmec.2004.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DHenn%26aufirst%3DF.%26aulast%3DVollmayr%26aufirst%3DB.%26aulast%3DSartorius%26aufirst%3DA.%26atitle%3DMechanisms%2520of%2520depression%253A%2520the%2520role%2520of%2520neurogenesis%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Dis.%2520Mech.%26date%3D2004%26volume%3D1%26spage%3D407%26epage%3D411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">World Health Organization</span><span class="NLM_x">. </span> <span class="citation_source-book">Global health risks: mortality and burden of disease attributable to selected major risks</span>. <span class="NLM_publisher-name">WHO Press</span>: <span class="NLM_publisher-loc">Geneva, Switzerland</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=World+Health+Organization&title=Global+health+risks%3A+mortality+and+burden+of+disease+attributable+to+selected+major+risks"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3D%26btitle%3DGlobal%2520health%2520risks%253A%2520mortality%2520and%2520burden%2520of%2520disease%2520attributable%2520to%2520selected%2520major%2520risks%26pub%3DWHO%2520Press%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Reeves, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladner, M. E.</span><span> </span><span class="NLM_article-title">Antidepressant-induced suicidality: an update</span> <span class="citation_source-journal">CNS Neurosci. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">227</span><span class="NLM_x">–</span> <span class="NLM_lpage">234</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm200855b&amp;key=20553304" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm200855b&amp;key=1%3ACAS%3A280%3ADC%252BC3cnmsl2ntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=227-234&author=R.+R.+Reevesauthor=M.+E.+Ladner&title=Antidepressant-induced+suicidality%3A+an+update"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Antidepressant-induced suicidality: an update</span></div><div class="casAuthors">Reeves Roy R; Ladner Mark E</div><div class="citationInfo"><span class="NLM_cas:title">CNS neuroscience & therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">227-34</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Evidence suggests that antidepressant treatment may in some cases result in worsening depression and increased risk of suicidality in pediatric and adolescent patients.  The United States Food and Drug Administration requires that antidepressants carry a black box warning regarding such a risk in patients up to age 24.  Many studies of antidepressant-induced suicidality among adults have also reported an increased risk, while several other investigations involving that population have not supported such a finding.  This article provides an update of the controversy surrounding antidepressants as a potential cause of suicidal ideations or behavior.  Antidepressant-induced suicidality appears to be an uncommon occurrence but also a legitimate phenomenon.  Close monitoring and a follow-up care should be provided for patients after initiation of a new antidepressant.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQpaJAtPTO0M8AKB7Fa-xrUfW6udTcc2eYhCJy1oVh8Wrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cnmsl2ntg%253D%253D&md5=0380a35990856318143fc5b8dcb4c884</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReeves%26aufirst%3DR.%2BR.%26aulast%3DLadner%26aufirst%3DM.%2BE.%26atitle%3DAntidepressant-induced%2520suicidality%253A%2520an%2520update%26jtitle%3DCNS%2520Neurosci.%2520Ther.%26date%3D2010%26volume%3D16%26spage%3D227%26epage%3D234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Berton, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nestler, E. J.</span><span> </span><span class="NLM_article-title">New approaches to antidepressant drug discovery: beyond monoamines</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">137</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm200855b&amp;key=10.1038%2Fnrn1846" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm200855b&amp;key=16429123" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm200855b&amp;key=1%3ACAS%3A528%3ADC%252BD28XlvV2qug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=137-151&author=O.+Bertonauthor=E.+J.+Nestler&title=New+approaches+to+antidepressant+drug+discovery%3A+beyond+monoamines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">New approaches to antidepressant drug discovery: beyond monoamines</span></div><div class="casAuthors">Berton, Olivier; Nestler, Eric J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">137-151</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  All available antidepressant medications are based on serendipitous discoveries of the clin. efficacy of two classes of antidepressants more than 50 years ago.  These tricyclic and monoamine oxidase inhibitor antidepressants were subsequently found to promote serotonin or noradrenaline function in the brain.  Newer agents are more specific but have the same core mechanisms of action in promoting these monoamine neurotransmitters.  This is unfortunate, because only ∼50% of individuals with depression show full remission in response to these mechanisms.  This review summarizes the obstacles that have hindered the development of non-monoamine-based antidepressants, and provides a progress report on some of the most promising current strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPjIkAa3yd1rVg90H21EOLACvtfcHk0liy2UfeQwbs1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlvV2qug%253D%253D&md5=78c0c58b7fd7cebfcdfe15e30eaa0c54</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrn1846&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn1846%26sid%3Dliteratum%253Aachs%26aulast%3DBerton%26aufirst%3DO.%26aulast%3DNestler%26aufirst%3DE.%2BJ.%26atitle%3DNew%2520approaches%2520to%2520antidepressant%2520drug%2520discovery%253A%2520beyond%2520monoamines%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2006%26volume%3D7%26spage%3D137%26epage%3D151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Zheng, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yap, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, Z. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, Z. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y. Z.</span><span> </span><span class="NLM_article-title">Therapeutic targets: progress of their exploration and investigation of their characteristics</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">259</span><span class="NLM_x">–</span> <span class="NLM_lpage">279</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2006&pages=259-279&author=C.+J.+Zhengauthor=L.+Y.+Hanauthor=C.+W.+Yapauthor=Z.+L.+Jiauthor=Z.+W.+Caoauthor=Y.+Z.+Chen&title=Therapeutic+targets%3A+progress+of+their+exploration+and+investigation+of+their+characteristics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DC.%2BJ.%26aulast%3DHan%26aufirst%3DL.%2BY.%26aulast%3DYap%26aufirst%3DC.%2BW.%26aulast%3DJi%26aufirst%3DZ.%2BL.%26aulast%3DCao%26aufirst%3DZ.%2BW.%26aulast%3DChen%26aufirst%3DY.%2BZ.%26atitle%3DTherapeutic%2520targets%253A%2520progress%2520of%2520their%2520exploration%2520and%2520investigation%2520of%2520their%2520characteristics%26jtitle%3DPharmacol.%2520Rev.%26date%3D2006%26volume%3D58%26spage%3D259%26epage%3D279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Abel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zukin, R. S.</span><span> </span><span class="NLM_article-title">Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">64</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm200855b&amp;key=10.1016%2Fj.coph.2007.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm200855b&amp;key=18206423" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm200855b&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVOgu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=57-64&author=T.+Abelauthor=R.+S.+Zukin&title=Epigenetic+targets+of+HDAC+inhibition+in+neurodegenerative+and+psychiatric+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders</span></div><div class="casAuthors">Abel, Ted; Zukin, R. Suzanne</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-64</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Epigenetic chromatin remodeling and modifications of DNA represent central mechanisms for regulation of gene expression during brain development and in memory formation.  Emerging evidence implicates epigenetic modifications in disorders of synaptic plasticity and cognition.  This review focuses on recent findings that HDAC inhibitors can ameliorate deficits in synaptic plasticity, cognition, and stress-related behaviors in a wide range of neurol. and psychiatric disorders including Huntington's disease, Parkinson's disease, anxiety and mood disorders, Rubinstein-Taybi syndrome, and Rett syndrome.  These agents may prove useful in the clinic for the treatment of the cognitive impairments that are central elements of many neurodevelopmental, neurol., and psychiatric disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo70UH4lz6tXbVg90H21EOLACvtfcHk0liy2UfeQwbs1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVOgu78%253D&md5=eda84c14cd5138b12b69ce51684459fd</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2007.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2007.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DAbel%26aufirst%3DT.%26aulast%3DZukin%26aufirst%3DR.%2BS.%26atitle%3DEpigenetic%2520targets%2520of%2520HDAC%2520inhibition%2520in%2520neurodegenerative%2520and%2520psychiatric%2520disorders%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2008%26volume%3D8%26spage%3D57%26epage%3D64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Schroeder, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crusio, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akbarian, S.</span><span> </span><span class="NLM_article-title">Antidepressant-like effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">55</span><span class="NLM_x">–</span> <span class="NLM_lpage">64</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm200855b&amp;key=10.1016%2Fj.biopsych.2006.06.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm200855b&amp;key=16945350" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm200855b&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmsFKrur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2007&pages=55-64&author=F.+A.+Schroederauthor=C.+L.+Linauthor=W.+E.+Crusioauthor=S.+Akbarian&title=Antidepressant-like+effects+of+the+histone+deacetylase+inhibitor%2C+sodium+butyrate%2C+in+the+mouse"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Antidepressant-Like Effects of the Histone Deacetylase Inhibitor, Sodium Butyrate, in the Mouse</span></div><div class="casAuthors">Schroeder, Frederick A.; Lin, Cong Lily; Crusio, Wim E.; Akbarian, Schahram</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-64</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Chromatin remodeling, including changes in histone acetylation, might play a role in the pathophysiol. and treatment of depression.  We investigated whether the histone deacetylase inhibitor sodium butyrate (SB) administered as single drug or in combination with the selective serotonin reuptake inhibitor (SSRI) fluoxetine exerts antidepressant-like effects in mice.  Mice (C57BL/6J) received injections of SB, fluoxetine, or a combination of both drugs either acutely or chronically for a period of 28 days and were subjected to a battery of tests to measure anxiety and behavioral despair.  Histone acetylation and expression of brain-derived neurotrophic factor (BDNF) were monitored in hippocampus and frontal cortex.  Co-treatment with SB and fluoxetine resulted in a significant 20-40% decrease in immobility scores in the tail suspension test (TST), a measure for behavioral despair, both acutely and chronically.  In contrast, decreased immobility after single drug regimens was limited either to the acute (fluoxetine) or chronic (SB) paradigm.  Systemic injection of SB induced short-lasting histone hyperacetylation in hippocampus and frontal cortex.  Among the four treatment paradigms that resulted in improved immobility scores in the TST, three were assocd. with a transient, at least 50% increase in BDNF transcript in frontal cortex, whereas changes in hippocampus were less consistent.  The histone deacetylase inhibitor SB exerts antidepressant-like effects in the mouse.  The therapeutic benefits and mol. actions of histone modifying drugs, including co-treatment with SSRIs and other newer generation antidepressant medications, warrant further exploration in exptl. models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHGR19kvoLIrVg90H21EOLACvtfcHk0liZ8ntTsnZQ4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmsFKrur0%253D&md5=a7337d9513d437a344bdc0374db1fac1</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2006.06.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2006.06.036%26sid%3Dliteratum%253Aachs%26aulast%3DSchroeder%26aufirst%3DF.%2BA.%26aulast%3DLin%26aufirst%3DC.%2BL.%26aulast%3DCrusio%26aufirst%3DW.%2BE.%26aulast%3DAkbarian%26aufirst%3DS.%26atitle%3DAntidepressant-like%2520effects%2520of%2520the%2520histone%2520deacetylase%2520inhibitor%252C%2520sodium%2520butyrate%252C%2520in%2520the%2520mouse%26jtitle%3DBiol.%2520Psychiatry%26date%3D2007%26volume%3D62%26spage%3D55%26epage%3D64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Miyamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mishina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nabeshima, T.</span><span> </span><span class="NLM_article-title">Lower sensitivity to stress and altered monoaminergic neuronal function in mice lacking the NMDA receptor epsilon 4 subunit</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2335</span><span class="NLM_x">–</span> <span class="NLM_lpage">2342</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm200855b&amp;key=11896172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm200855b&amp;key=1%3ACAS%3A528%3ADC%252BD38XisVGit7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2002&pages=2335-2342&author=Y.+Miyamotoauthor=K.+Yamadaauthor=Y.+Nodaauthor=H.+Moriauthor=M.+Mishinaauthor=T.+Nabeshima&title=Lower+sensitivity+to+stress+and+altered+monoaminergic+neuronal+function+in+mice+lacking+the+NMDA+receptor+epsilon+4+subunit"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Lower sensitivity to stress and altered monoaminergic neuronal function in mice lacking the NMDA receptor ε4 subunit</span></div><div class="casAuthors">Miyamoto, Yoshiaki; Yamada, Kiyofumi; Noda, Yukihiro; Mori, Hisashi; Mishina, Masayoshi; Nabeshima, Toshitaka</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2335-2342</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">NMDA receptors, an ionotropic subtype of glutamate receptors (GluRs), play an important role in excitatory neurotransmission, synaptic plasticity, and brain development.  They are composed of the GluRζ subunit (NR1) combined with any one of four GluRε subunits (GluRε1-GluRε4; NR2A-NR2D).  Although the GluRζ subunit exists in the majority of the CNS throughout all stages of development, the GluRε subunits are expressed in distinct temporal and spatial patterns.  In the present study, we investigated neuronal functions in mice lacking the embryonic GluRε4 subunit.  GluRε4 mutant mice exhibited redns. of [3H]MK-801 binding and 45Ca2+ uptake through the NMDA receptors.  The expression of GluRζ subunit protein, but not GluRε1 and GluRε2 subunit proteins, was reduced in the frontal cortex and striatum of the mutant mice.  A postmortem examn. in GluRε4 mutant mice revealed that tissue contents of norepinephrine, dopamine, serotonin, and their metabolites were reduced in the hippocampus and that dopamine, as well as serotonin, metab. was upregulated in the frontal cortex, striatum, hippocampus, and thalamus.  To clarify the phenotypical influences of the alteration in neuronal functions, performances in various behavioral tests were examd.  GluRε4 mutant mice showed reduced spontaneous locomotor activity in a novel environment and less sensitivity to stress induced by the elevated plus-maze, light-dark box, and forced swimming tests.  These findings suggest that GluRε4 mutant mice have dysfunctional NMDA receptors and altered emotional behavior probably caused by changes in monoaminergic neuronal activities in adulthood.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgUqNdgZA1frVg90H21EOLACvtfcHk0liZ8ntTsnZQ4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XisVGit7s%253D&md5=17535ed0fe971b546afbdc1b26d43c16</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMiyamoto%26aufirst%3DY.%26aulast%3DYamada%26aufirst%3DK.%26aulast%3DNoda%26aufirst%3DY.%26aulast%3DMori%26aufirst%3DH.%26aulast%3DMishina%26aufirst%3DM.%26aulast%3DNabeshima%26aufirst%3DT.%26atitle%3DLower%2520sensitivity%2520to%2520stress%2520and%2520altered%2520monoaminergic%2520neuronal%2520function%2520in%2520mice%2520lacking%2520the%2520NMDA%2520receptor%2520epsilon%25204%2520subunit%26jtitle%3DJ.%2520Neurosci.%26date%3D2002%26volume%3D22%26spage%3D2335%26epage%3D2342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Shytle, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silver, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehan, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanberg, P. R.</span><span> </span><span class="NLM_article-title">Nicotinic acetylcholine receptors as targets for antidepressants</span> <span class="citation_source-journal">Mol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">525</span><span class="NLM_x">–</span> <span class="NLM_lpage">535</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm200855b&amp;key=10.1038%2Fsj.mp.4001035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm200855b&amp;key=12140772" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm200855b&amp;key=1%3ACAS%3A528%3ADC%252BD38XlsFWrsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2002&pages=525-535&author=R.+D.+Shytleauthor=A.+A.+Silverauthor=R.+J.+Lukasauthor=M.+B.+Newmanauthor=D.+V.+Sheehanauthor=P.+R.+Sanberg&title=Nicotinic+acetylcholine+receptors+as+targets+for+antidepressants"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinic acetylcholine receptors as targets for antidepressants</span></div><div class="casAuthors">Shytle, R. D.; Silver, A. A.; Lukas, R. J.; Newman, M. B.; Sheehan, D. V.; Sanberg, P. R.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Psychiatry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">525-535</span>CODEN:
                <span class="NLM_cas:coden">MOPSFQ</span>;
        ISSN:<span class="NLM_cas:issn">1359-4184</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  While the monoamine deficiency hypothesis of depression is still most commonly used to explain the actions of antidepressant drugs, a growing body of evidence has accumulated that is not adequately explained by the hypothesis.  This article draws attention to contributions from another apparently common pharmacol. property of antidepressant medications - the inhibition of nicotinic acetylcholine receptors (nAChR).  Evidence is presented suggesting the hypercholinergic neurotransmission, which is assocd. with depressed mood states, may be mediated through excessive neuronal nicotinic receptor activation and that the therapeutic actions of many antidepressants may be, in part, mediated through inhibition of these receptors.  In support of this hypothesis, preliminary evidence is presented suggesting that the potent, centrally acting nAChR antagonist, mecamylamine, which is devoid of monoamine reuptake inhibition, may reduce symptoms of depression and mood instability in patients with comorbid depression and bipolar disorder.  If this hypothesis is supported by further preclin. and clin. research, nicotinic acetylcholine receptor antagonists may represent a novel class of therapeutic agents for treating mood disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-iysHOoVi_LVg90H21EOLACvtfcHk0liZ8ntTsnZQ4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlsFWrsb0%253D&md5=1c15fa7b0b0779aa69198a24c8546726</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fsj.mp.4001035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.mp.4001035%26sid%3Dliteratum%253Aachs%26aulast%3DShytle%26aufirst%3DR.%2BD.%26aulast%3DSilver%26aufirst%3DA.%2BA.%26aulast%3DLukas%26aufirst%3DR.%2BJ.%26aulast%3DNewman%26aufirst%3DM.%2BB.%26aulast%3DSheehan%26aufirst%3DD.%2BV.%26aulast%3DSanberg%26aufirst%3DP.%2BR.%26atitle%3DNicotinic%2520acetylcholine%2520receptors%2520as%2520targets%2520for%2520antidepressants%26jtitle%3DMol.%2520Psychiatry%26date%3D2002%26volume%3D7%26spage%3D525%26epage%3D535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Buckley, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surowy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curzon, P.</span><span> </span><span class="NLM_article-title">Mechanism of action of A-85380 in an animal model of depression</span> <span class="citation_source-journal">Prog. Neuropsychopharmacol. Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">723</span><span class="NLM_x">–</span> <span class="NLM_lpage">730</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm200855b&amp;key=10.1016%2Fj.pnpbp.2004.05.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm200855b&amp;key=15276699" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm200855b&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtVansLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2004&pages=723-730&author=M.+J.+Buckleyauthor=C.+Surowyauthor=M.+Meyerauthor=P.+Curzon&title=Mechanism+of+action+of+A-85380+in+an+animal+model+of+depression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of action of A-85380 in an animal model of depression</span></div><div class="casAuthors">Buckley, Michael J.; Surowy, Carol; Meyer, Michael; Curzon, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neuro-Psychopharmacology & Biological Psychiatry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">723-730</span>CODEN:
                <span class="NLM_cas:coden">PNPPD7</span>;
        ISSN:<span class="NLM_cas:issn">0278-5846</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A role for neuronal nicotinic receptor (NNR) activation in animal models of depression has been established.  In order to det. the mechanism by which NNR ligands exert their antidepressant effects, expts. using different NNR receptor antagonists in both the mouse and the rat forced swim test (RFST) were performed.  In the mouse forced swim test (MFST), A-85380 (0.62 μmol/kg=0.14 mg/kg, i.p.), an NNR agonist, increased swim distance when administered 15 min prior to test.  This effect was blocked by pre-treatment with mecamylamine (1.5 μmol/kg=0.3 mg/kg, i.p.), suggesting that an NNR mechanism is involved.  Further, chlorisondamine at a non-central nervous system (CNS) penetrating dose (1.6 μmol/kg=1 mg/kg, i.p.) did not antagonize A-85380 in this model, thus implicating central rather than peripheral nicotinic receptors.  Dihydro-β-erythroidine (DHβE, 0.3 μmol/kg=0.1 mg/kg, i.p.) pre-treatment also blocked this effect, indicating that the α4β2 receptor subtype may be involved in A-85380-induced antidepressant effects.  Finally, methiothepin (0.33 μmol/kg=0.14 mg/kg, i.p.) pre-treatment antagonized this effect, suggesting serotonergic involvement.  In the rat modified forced swim test, sub-acute administration of A-85380 (0.62 μmol/kg, i.p.) increased swimming behavior and decreased immobility.  Climbing behavior was unaffected.  In contrast, desipramine treatment (33 μmol/kg=10 mg/kg, i.p.) resulted in an increase in climbing behavior with no effect on swimming.  This behavioral profile has been shown to be more typical of serotonergic rather than noradrenergic antidepressants, suggesting that A-85380 exerts its effects via NNR activation of serotonergic systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpat5Oy_ll2BbVg90H21EOLACvtfcHk0lhLteQHhekiZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtVansLY%253D&md5=441e1ee97e800531a136c4003ada9028</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.pnpbp.2004.05.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pnpbp.2004.05.012%26sid%3Dliteratum%253Aachs%26aulast%3DBuckley%26aufirst%3DM.%2BJ.%26aulast%3DSurowy%26aufirst%3DC.%26aulast%3DMeyer%26aufirst%3DM.%26aulast%3DCurzon%26aufirst%3DP.%26atitle%3DMechanism%2520of%2520action%2520of%2520A-85380%2520in%2520an%2520animal%2520model%2520of%2520depression%26jtitle%3DProg.%2520Neuropsychopharmacol.%2520Biol.%2520Psychiatry%26date%3D2004%26volume%3D28%26spage%3D723%26epage%3D730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Ferguson, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodkin, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lloyd, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menzaghi, F.</span><span> </span><span class="NLM_article-title">Antidepressant-like effects of the subtype-selective nicotinic acetylcholine receptor agonist, SIB-1508Y, in the learned helplessness rat model of depression</span> <span class="citation_source-journal">Psychopharmacology (Berlin)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">152</span><span class="NLM_x">, </span> <span class="NLM_fpage">295</span><span class="NLM_x">–</span> <span class="NLM_lpage">303</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm200855b&amp;key=10.1007%2Fs002130000531" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm200855b&amp;key=11105940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm200855b&amp;key=1%3ACAS%3A528%3ADC%252BD3cXosVKrs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=2000&pages=295-303&author=S.+M.+Fergusonauthor=J.+D.+Brodkinauthor=G.+K.+Lloydauthor=F.+Menzaghi&title=Antidepressant-like+effects+of+the+subtype-selective+nicotinic+acetylcholine+receptor+agonist%2C+SIB-1508Y%2C+in+the+learned+helplessness+rat+model+of+depression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Antidepressant-like effects of the subtype-selective nicotinic acetylcholine receptor agonist, SIB-1508Y, in the learned helplessness rat model of depression</span></div><div class="casAuthors">Ferguson, Susan M.; Brodkin, Jesse D.; Lloyd, G. Kenneth; Menzaghi, Frederique</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">152</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">295-303</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Rationale: Epidemiol. studies of smokers suggest that there is a link between nicotine and depression.  Nonetheless, few studies have examd. the potential use of nicotinic ligands in the treatment of depression.  Objectives: The goal of this study was to evaluate the effects of SIB-1508Y, a novel subtype-selective ligand for high affinity nicotinic acetylcholine receptors (nAChRs), in the learned helplessness model of depression in rats.  Methods: In this model, exposure to inescapable foot-shock produces a lasting deficit in escape responses emitted in a subsequent conditioned avoidance procedure (learned helplessness).  The effect of SIB-1508Y on learned helplessness was compared to the clin. used antidepressants, imipramine and fluoxetine, and the non-selective nAChR ligand, nicotine.  Results: Similarly to imipramine and fluoxetine, subchronic treatment (5 days) with SIB-1508Y reversed the escape deficit in the learned helplessness model in a dose dependent manner.  The effect of SIB-1508Y on learned helplessness was still apparent 1 wk following drug administration and was also maintained after 4 wk of daily administration.  In contrast, while nicotine was able to attenuate the learned helplessness deficit, this trend only reached statistical significance after chronic administration.  The non-competitive ion channel blocker mecamylamine increased escape failures when administered alone and blocked the effects of SIB-1508Y but not imipramine.  SIB-1508Y also produced an increase in avoidance responding, which suggests an enhancement of learning.  Conclusion: These results not only suggest a role for nAChRs in the development of a depressive-like syndrome, but also that subtype-selective nAChR agonists, such as SIB-1508Y, may offer a novel therapeutic approach to the treatment of depression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIrOZoKkV0KbVg90H21EOLACvtfcHk0lhLteQHhekiZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXosVKrs7s%253D&md5=e666d9ee7d29027f862915024bd27f52</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1007%2Fs002130000531&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002130000531%26sid%3Dliteratum%253Aachs%26aulast%3DFerguson%26aufirst%3DS.%2BM.%26aulast%3DBrodkin%26aufirst%3DJ.%2BD.%26aulast%3DLloyd%26aufirst%3DG.%2BK.%26aulast%3DMenzaghi%26aufirst%3DF.%26atitle%3DAntidepressant-like%2520effects%2520of%2520the%2520subtype-selective%2520nicotinic%2520acetylcholine%2520receptor%2520agonist%252C%2520SIB-1508Y%252C%2520in%2520the%2520learned%2520helplessness%2520rat%2520model%2520of%2520depression%26jtitle%3DPsychopharmacology%2520%2528Berlin%2529%26date%3D2000%26volume%3D152%26spage%3D295%26epage%3D303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Rabenstein, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldarone, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picciotto, M. R.</span><span> </span><span class="NLM_article-title">The nicotinic antagonist mecamylamine has antidepressant-like effects in wild-type but not beta2- or alpha7-nicotinic acetylcholine receptor subunit knockout mice</span> <span class="citation_source-journal">Psychopharmacology (Berlin)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">189</span><span class="NLM_x">, </span> <span class="NLM_fpage">395</span><span class="NLM_x">–</span> <span class="NLM_lpage">401</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm200855b&amp;key=10.1007%2Fs00213-006-0568-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm200855b&amp;key=17016705" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm200855b&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1WltrfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=189&publication_year=2006&pages=395-401&author=R.+L.+Rabensteinauthor=B.+J.+Caldaroneauthor=M.+R.+Picciotto&title=The+nicotinic+antagonist+mecamylamine+has+antidepressant-like+effects+in+wild-type+but+not+beta2-+or+alpha7-nicotinic+acetylcholine+receptor+subunit+knockout+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The nicotinic antagonist mecamylamine has antidepressant-like effects in wild-type but not β2- or α7-nicotinic acetylcholine receptor subunit knockout mice</span></div><div class="casAuthors">Rabenstein, R. L.; Caldarone, B. J.; Picciotto, M. R.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">189</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">395-401</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">Increases in cholinergic transmission are linked to depression in human subjects and animal models.  We therefore examd. the effect of decreasing nicotinic acetylcholine receptor (nAChR) activity in tests of antidepressant efficacy using C57BL/6J mice.  We detd. whether the noncompetitive nAChR antagonist mecamylamine had antidepressant-like effects in the forced swim test (FST) and tail suspension test (TST).  These expts. were repeated in mice lacking either the β2- or α7-nAChR subunits to identify the nAChR subunits involved in mediating the antidepressant response to mecamylamine.  Adult mice on the C57BL/6J background were acutely administered mecamylamine i.p. 30 min before testing in the FST or TST.  A dose-response study showed that mecamylamine significantly decreased immobility time in the TST at the 1.0-mg/kg dose but did not alter baseline locomotor activity.  The competitive nAChR antagonist dihydro-β-erythroidine, but not the blood-brain barrier impermeant antagonist hexamethonium, also decreased immobility in the TST.  One milligram per kg of mecamylamine also significantly decreased time immobile in the FST whereas both β2- and α7-knockout mice were insensitive to the effects of mecamylamine in the FST.  Decreased activity of central nAChRs has antidepressant-like effects in both the TST and FST and these effects are dependent on both β2 and α7 subunits.  Therefore, compds. that decrease nAChR activity may be attractive new candidates for development as antidepressants in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4zVDjRJ7VULVg90H21EOLACvtfcHk0ljdHT48fNW7ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1WltrfK&md5=b99a73e6e5569f34c9d45c79c50cb540</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1007%2Fs00213-006-0568-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-006-0568-z%26sid%3Dliteratum%253Aachs%26aulast%3DRabenstein%26aufirst%3DR.%2BL.%26aulast%3DCaldarone%26aufirst%3DB.%2BJ.%26aulast%3DPicciotto%26aufirst%3DM.%2BR.%26atitle%3DThe%2520nicotinic%2520antagonist%2520mecamylamine%2520has%2520antidepressant-like%2520effects%2520in%2520wild-type%2520but%2520not%2520beta2-%2520or%2520alpha7-nicotinic%2520acetylcholine%2520receptor%2520subunit%2520knockout%2520mice%26jtitle%3DPsychopharmacology%2520%2528Berlin%2529%26date%3D2006%26volume%3D189%26spage%3D395%26epage%3D401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Caldarone, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrist, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleary, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beech, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picciotto, M. R.</span><span> </span><span class="NLM_article-title">High-affinity nicotinic acetylcholine receptors are required for antidepressant effects of amitriptyline on behavior and hippocampal cell proliferation</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">657</span><span class="NLM_x">–</span> <span class="NLM_lpage">664</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm200855b&amp;key=10.1016%2Fj.biopsych.2004.08.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm200855b&amp;key=15522249" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm200855b&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptFOmtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2004&pages=657-664&author=B.+J.+Caldaroneauthor=A.+Harristauthor=M.+A.+Clearyauthor=R.+D.+Beechauthor=S.+L.+Kingauthor=M.+R.+Picciotto&title=High-affinity+nicotinic+acetylcholine+receptors+are+required+for+antidepressant+effects+of+amitriptyline+on+behavior+and+hippocampal+cell+proliferation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">High-affinity nicotinic acetylcholine receptors are required for antidepressant effects of amitriptyline on behavior and hippocampal cell proliferation</span></div><div class="casAuthors">Caldarone, Barbara J.; Harrist, Alexia; Cleary, Muriel A.; Beech, Robert D.; King, Sarah L.; Picciotto, Marina R.</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">657-664</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A wide variety of antidepressants act as noncompetitive antagonists of nicotinic acetylcholine receptors (nAChRs), but the relationship between this antagonism and the therapeutic effects of antidepressants is unknown.  Antidepressant properties of the noncompetitive nAChR antagonist mecamylamine in the forced swim test were tested alone and in combination with the tricyclic antidepressant amitriptyline.  Mice lacking high-affinity nAChRs were tested in three behavioral models to det. whether these receptors are required for behavioral effects of amitriptyline in common models of antidepressant action.  Finally, the brains of wild-type and knockout animals treated with amitriptyline were examd. to det. whether high-affinity nAChRs are required for antidepressant-induced increases in hippocampal cell proliferation.  Inhibition of nAChRs by mecamylamine had antidepressant-like effects in the forced swim test and potentiated the antidepressant activity of amitriptyline when the two drugs were used in combination.  Mice lacking high-affinity nAChRs showed no behavioral response to amitriptyline.  Finally, after chronic treatment with amitriptyline, nAChR knockout mice did not show the increase in hippocampal cell proliferation seen in wild-type mice.  These data support the hypothesis that antagonism of nAChRs is an essential component of the therapeutic action of antidepressants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbp5wZl3o94bVg90H21EOLACvtfcHk0ljdHT48fNW7ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptFOmtrc%253D&md5=90c1ee0ae0910945d98113e7eb9d7b9e</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2004.08.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2004.08.010%26sid%3Dliteratum%253Aachs%26aulast%3DCaldarone%26aufirst%3DB.%2BJ.%26aulast%3DHarrist%26aufirst%3DA.%26aulast%3DCleary%26aufirst%3DM.%2BA.%26aulast%3DBeech%26aufirst%3DR.%2BD.%26aulast%3DKing%26aufirst%3DS.%2BL.%26aulast%3DPicciotto%26aufirst%3DM.%2BR.%26atitle%3DHigh-affinity%2520nicotinic%2520acetylcholine%2520receptors%2520are%2520required%2520for%2520antidepressant%2520effects%2520of%2520amitriptyline%2520on%2520behavior%2520and%2520hippocampal%2520cell%2520proliferation%26jtitle%3DBiol.%2520Psychiatry%26date%3D2004%26volume%3D56%26spage%3D657%26epage%3D664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Picciotto, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lena, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bessis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lallemand, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Novere, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincent, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pich, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brulet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Changeux, J. P.</span><span> </span><span class="NLM_article-title">Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">374</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">67</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=374&publication_year=1995&pages=65-67&author=M.+R.+Picciottoauthor=M.+Zoliauthor=C.+Lenaauthor=A.+Bessisauthor=Y.+Lallemandauthor=N.+Le+Novereauthor=P.+Vincentauthor=E.+M.+Pichauthor=P.+Bruletauthor=J.+P.+Changeux&title=Abnormal+avoidance+learning+in+mice+lacking+functional+high-affinity+nicotine+receptor+in+the+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPicciotto%26aufirst%3DM.%2BR.%26aulast%3DZoli%26aufirst%3DM.%26aulast%3DLena%26aufirst%3DC.%26aulast%3DBessis%26aufirst%3DA.%26aulast%3DLallemand%26aufirst%3DY.%26aulast%3DLe%2BNovere%26aufirst%3DN.%26aulast%3DVincent%26aufirst%3DP.%26aulast%3DPich%26aufirst%3DE.%2BM.%26aulast%3DBrulet%26aufirst%3DP.%26aulast%3DChangeux%26aufirst%3DJ.%2BP.%26atitle%3DAbnormal%2520avoidance%2520learning%2520in%2520mice%2520lacking%2520functional%2520high-affinity%2520nicotine%2520receptor%2520in%2520the%2520brain%26jtitle%3DNature%26date%3D1995%26volume%3D374%26spage%3D65%26epage%3D67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Romanelli, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gratteri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guandalini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonaccini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gualtieri, F.</span><span> </span><span class="NLM_article-title">Central nicotinic receptors: structure, function, ligands, and therapeutic potential</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">746</span><span class="NLM_x">–</span> <span class="NLM_lpage">767</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=746-767&author=M.+N.+Romanelliauthor=P.+Gratteriauthor=L.+Guandaliniauthor=E.+Martiniauthor=C.+Bonacciniauthor=F.+Gualtieri&title=Central+nicotinic+receptors%3A+structure%2C+function%2C+ligands%2C+and+therapeutic+potential"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRomanelli%26aufirst%3DM.%2BN.%26aulast%3DGratteri%26aufirst%3DP.%26aulast%3DGuandalini%26aufirst%3DL.%26aulast%3DMartini%26aufirst%3DE.%26aulast%3DBonaccini%26aufirst%3DC.%26aulast%3DGualtieri%26aufirst%3DF.%26atitle%3DCentral%2520nicotinic%2520receptors%253A%2520structure%252C%2520function%252C%2520ligands%252C%2520and%2520therapeutic%2520potential%26jtitle%3DChemMedChem%26date%3D2007%26volume%3D2%26spage%3D746%26epage%3D767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Gotti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clementi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fornari, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaimarri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guiducci, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manfredi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moretti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedrazzi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pucci, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoli, M.</span><span> </span><span class="NLM_article-title">Structural and functional diversity of native brain neuronal nicotinic receptors</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">703</span><span class="NLM_x">–</span> <span class="NLM_lpage">711</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2009&pages=703-711&author=C.+Gottiauthor=F.+Clementiauthor=A.+Fornariauthor=A.+Gaimarriauthor=S.+Guiducciauthor=I.+Manfrediauthor=M.+Morettiauthor=P.+Pedrazziauthor=L.+Pucciauthor=M.+Zoli&title=Structural+and+functional+diversity+of+native+brain+neuronal+nicotinic+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGotti%26aufirst%3DC.%26aulast%3DClementi%26aufirst%3DF.%26aulast%3DFornari%26aufirst%3DA.%26aulast%3DGaimarri%26aufirst%3DA.%26aulast%3DGuiducci%26aufirst%3DS.%26aulast%3DManfredi%26aufirst%3DI.%26aulast%3DMoretti%26aufirst%3DM.%26aulast%3DPedrazzi%26aufirst%3DP.%26aulast%3DPucci%26aufirst%3DL.%26aulast%3DZoli%26aufirst%3DM.%26atitle%3DStructural%2520and%2520functional%2520diversity%2520of%2520native%2520brain%2520neuronal%2520nicotinic%2520receptors%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2009%26volume%3D78%26spage%3D703%26epage%3D711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Zwart, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carbone, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moroni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bermudez, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mogg, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folly, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broad, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinz, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sher, E.</span><span> </span><span class="NLM_article-title">Sazetidine-A is a potent and selective agonist at native and recombinant alpha 4 beta 2 nicotinic acetylcholine receptors</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">1838</span><span class="NLM_x">–</span> <span class="NLM_lpage">1843</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2008&pages=1838-1843&author=R.+Zwartauthor=A.+L.+Carboneauthor=M.+Moroniauthor=I.+Bermudezauthor=A.+J.+Moggauthor=E.+A.+Follyauthor=L.+M.+Broadauthor=A.+C.+Williamsauthor=D.+Zhangauthor=C.+Dingauthor=B.+A.+Heinzauthor=E.+Sher&title=Sazetidine-A+is+a+potent+and+selective+agonist+at+native+and+recombinant+alpha+4+beta+2+nicotinic+acetylcholine+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZwart%26aufirst%3DR.%26aulast%3DCarbone%26aufirst%3DA.%2BL.%26aulast%3DMoroni%26aufirst%3DM.%26aulast%3DBermudez%26aufirst%3DI.%26aulast%3DMogg%26aufirst%3DA.%2BJ.%26aulast%3DFolly%26aufirst%3DE.%2BA.%26aulast%3DBroad%26aufirst%3DL.%2BM.%26aulast%3DWilliams%26aufirst%3DA.%2BC.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DDing%26aufirst%3DC.%26aulast%3DHeinz%26aufirst%3DB.%2BA.%26aulast%3DSher%26aufirst%3DE.%26atitle%3DSazetidine-A%2520is%2520a%2520potent%2520and%2520selective%2520agonist%2520at%2520native%2520and%2520recombinant%2520alpha%25204%2520beta%25202%2520nicotinic%2520acetylcholine%2520receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2008%26volume%3D73%26spage%3D1838%26epage%3D1843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Xiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musachio, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, Z. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chellappan, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellar, K. J.</span><span> </span><span class="NLM_article-title">Sazetidine-A, a novel ligand that desensitizes alpha4beta2 nicotinic acetylcholine receptors without activating them</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">1454</span><span class="NLM_x">–</span> <span class="NLM_lpage">1460</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2006&pages=1454-1460&author=Y.+Xiaoauthor=H.+Fanauthor=J.+L.+Musachioauthor=Z.+L.+Weiauthor=S.+K.+Chellappanauthor=A.+P.+Kozikowskiauthor=K.+J.+Kellar&title=Sazetidine-A%2C+a+novel+ligand+that+desensitizes+alpha4beta2+nicotinic+acetylcholine+receptors+without+activating+them"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DFan%26aufirst%3DH.%26aulast%3DMusachio%26aufirst%3DJ.%2BL.%26aulast%3DWei%26aufirst%3DZ.%2BL.%26aulast%3DChellappan%26aufirst%3DS.%2BK.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26aulast%3DKellar%26aufirst%3DK.%2BJ.%26atitle%3DSazetidine-A%252C%2520a%2520novel%2520ligand%2520that%2520desensitizes%2520alpha4beta2%2520nicotinic%2520acetylcholine%2520receptors%2520without%2520activating%2520them%26jtitle%3DMol.%2520Pharmacol.%26date%3D2006%26volume%3D70%26spage%3D1454%26epage%3D1460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eaton, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajjuri, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chellappan, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karadi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldarone, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manzano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuen, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, R. J.</span><span> </span><span class="NLM_article-title">Chemistry and pharmacology of nicotinic ligands based on 6-[5-(azetidin-2-ylmethoxy)pyridin-3-yl]hex-5-yn-1-ol (AMOP-H-OH) for possible use in depression</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1279</span><span class="NLM_x">–</span> <span class="NLM_lpage">1291</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=1279-1291&author=A.+P.+Kozikowskiauthor=J.+B.+Eatonauthor=K.+M.+Bajjuriauthor=S.+K.+Chellappanauthor=Y.+Chenauthor=S.+Karadiauthor=R.+Heauthor=B.+Caldaroneauthor=M.+Manzanoauthor=P.+W.+Yuenauthor=R.+J.+Lukas&title=Chemistry+and+pharmacology+of+nicotinic+ligands+based+on+6-%5B5-%28azetidin-2-ylmethoxy%29pyridin-3-yl%5Dhex-5-yn-1-ol+%28AMOP-H-OH%29+for+possible+use+in+depression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26aulast%3DEaton%26aufirst%3DJ.%2BB.%26aulast%3DBajjuri%26aufirst%3DK.%2BM.%26aulast%3DChellappan%26aufirst%3DS.%2BK.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DKaradi%26aufirst%3DS.%26aulast%3DHe%26aufirst%3DR.%26aulast%3DCaldarone%26aufirst%3DB.%26aulast%3DManzano%26aufirst%3DM.%26aulast%3DYuen%26aufirst%3DP.%2BW.%26aulast%3DLukas%26aufirst%3DR.%2BJ.%26atitle%3DChemistry%2520and%2520pharmacology%2520of%2520nicotinic%2520ligands%2520based%2520on%25206-%255B5-%2528azetidin-2-ylmethoxy%2529pyridin-3-yl%255Dhex-5-yn-1-ol%2520%2528AMOP-H-OH%2529%2520for%2520possible%2520use%2520in%2520depression%26jtitle%3DChemMedChem%26date%3D2009%26volume%3D4%26spage%3D1279%26epage%3D1291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eaton, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldarone, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span> </span><span class="NLM_article-title">Chemistry and pharmacological characterization of novel nitrogen analogues of AMOP-H-OH (Sazetidine-A, 6-[5-(azetidin-2-ylmethoxy)pyridin-3-yl]hex-5-yn-1-ol) as alpha4beta2-nicotinic acetylcholine receptor-selective partial agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">6973</span><span class="NLM_x">–</span> <span class="NLM_lpage">6985</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100765u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=6973-6985&author=J.+Liuauthor=J.+B.+Eatonauthor=B.+Caldaroneauthor=R.+J.+Lukasauthor=A.+P.+Kozikowski&title=Chemistry+and+pharmacological+characterization+of+novel+nitrogen+analogues+of+AMOP-H-OH+%28Sazetidine-A%2C+6-%5B5-%28azetidin-2-ylmethoxy%29pyridin-3-yl%5Dhex-5-yn-1-ol%29+as+alpha4beta2-nicotinic+acetylcholine+receptor-selective+partial+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm100765u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100765u%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DEaton%26aufirst%3DJ.%2BB.%26aulast%3DCaldarone%26aufirst%3DB.%26aulast%3DLukas%26aufirst%3DR.%2BJ.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DChemistry%2520and%2520pharmacological%2520characterization%2520of%2520novel%2520nitrogen%2520analogues%2520of%2520AMOP-H-OH%2520%2528Sazetidine-A%252C%25206-%255B5-%2528azetidin-2-ylmethoxy%2529pyridin-3-yl%255Dhex-5-yn-1-ol%2529%2520as%2520alpha4beta2-nicotinic%2520acetylcholine%2520receptor-selective%2520partial%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D6973%26epage%3D6985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Tapadar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luchini, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billadeau, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span> </span><span class="NLM_article-title">Isoxazole moiety in the linker region of HDAC inhibitors adjacent to the Zn-chelating group: effects on HDAC biology and antiproliferative activity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">3023</span><span class="NLM_x">–</span> <span class="NLM_lpage">3026</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm200855b&amp;key=10.1016%2Fj.bmcl.2009.04.058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm200855b&amp;key=19419863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm200855b&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtVersrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=3023-3026&author=S.+Tapadarauthor=R.+Heauthor=D.+N.+Luchiniauthor=D.+D.+Billadeauauthor=A.+P.+Kozikowski&title=Isoxazole+moiety+in+the+linker+region+of+HDAC+inhibitors+adjacent+to+the+Zn-chelating+group%3A+effects+on+HDAC+biology+and+antiproliferative+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Isoxazole moiety in the linker region of HDAC inhibitors adjacent to the Zn-chelating group: Effects on HDAC biology and antiproliferative activity</span></div><div class="casAuthors">Tapadar, Subhasish; He, Rong; Luchini, Doris N.; Billadeau, Daniel D.; Kozikowski, Alan P.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3023-3026</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of hydroxamic acid based histone deacetylase inhibitors 6-15, contg. an isoxazole moiety adjacent to the Zn-chelating hydroxamic acid, is reported herein.  Some of these compds. showed nanomolar activity in the HDAC isoform inhibitory assay and exhibited micromolar inhibitory activity against five pancreatic cancer cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrta5zk6I47pLVg90H21EOLACvtfcHk0lhkpAW1iBj3_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtVersrs%253D&md5=affc37e7890fc939db595fa48397390c</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.04.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.04.058%26sid%3Dliteratum%253Aachs%26aulast%3DTapadar%26aufirst%3DS.%26aulast%3DHe%26aufirst%3DR.%26aulast%3DLuchini%26aufirst%3DD.%2BN.%26aulast%3DBilladeau%26aufirst%3DD.%2BD.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DIsoxazole%2520moiety%2520in%2520the%2520linker%2520region%2520of%2520HDAC%2520inhibitors%2520adjacent%2520to%2520the%2520Zn-chelating%2520group%253A%2520effects%2520on%2520HDAC%2520biology%2520and%2520antiproliferative%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D3023%26epage%3D3026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Huang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brun, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franzblau, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span> </span><span class="NLM_article-title">Searching for new cures for tuberculosis: design, synthesis, and biological evaluation of 2-methylbenzothiazoles</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6757</span><span class="NLM_x">–</span> <span class="NLM_lpage">6767</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901112f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6757-6767&author=Q.+Huangauthor=J.+Maoauthor=B.+Wanauthor=Y.+Wangauthor=R.+Brunauthor=S.+G.+Franzblauauthor=A.+P.+Kozikowski&title=Searching+for+new+cures+for+tuberculosis%3A+design%2C+synthesis%2C+and+biological+evaluation+of+2-methylbenzothiazoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm901112f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901112f%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DMao%26aufirst%3DJ.%26aulast%3DWan%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DFranzblau%26aufirst%3DS.%2BG.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DSearching%2520for%2520new%2520cures%2520for%2520tuberculosis%253A%2520design%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%25202-methylbenzothiazoles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6757%26epage%3D6767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Lilienkampf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pieroni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franzblau, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span> </span><span class="NLM_article-title">Rational design of 5-phenyl-3-isoxazolecarboxylic acid ethyl esters as growth inhibitors of <i>Mycobacterium tuberculosis</i>: a potent and selective series for further drug development</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">678</span><span class="NLM_x">–</span> <span class="NLM_lpage">688</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901273n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=678-688&author=A.+Lilienkampfauthor=M.+Pieroniauthor=B.+Wanauthor=Y.+Wangauthor=S.+G.+Franzblauauthor=A.+P.+Kozikowski&title=Rational+design+of+5-phenyl-3-isoxazolecarboxylic+acid+ethyl+esters+as+growth+inhibitors+of+Mycobacterium+tuberculosis%3A+a+potent+and+selective+series+for+further+drug+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm901273n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901273n%26sid%3Dliteratum%253Aachs%26aulast%3DLilienkampf%26aufirst%3DA.%26aulast%3DPieroni%26aufirst%3DM.%26aulast%3DWan%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DFranzblau%26aufirst%3DS.%2BG.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DRational%2520design%2520of%25205-phenyl-3-isoxazolecarboxylic%2520acid%2520ethyl%2520esters%2520as%2520growth%2520inhibitors%2520of%2520Mycobacterium%2520tuberculosis%253A%2520a%2520potent%2520and%2520selective%2520series%2520for%2520further%2520drug%2520development%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D678%26epage%3D688" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Wei, Z. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petukhov, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bizik, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teixeira, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercola, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpe, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glazer, R. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span> </span><span class="NLM_article-title">Isoxazolyl-serine-based agonists of peroxisome proliferator-activated receptor: design, synthesis, and effects on cardiomyocyte differentiation</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">16714</span><span class="NLM_x">–</span> <span class="NLM_lpage">16715</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja046386l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2004&pages=16714-16715&author=Z.+L.+Weiauthor=P.+A.+Petukhovauthor=F.+Bizikauthor=J.+C.+Teixeiraauthor=M.+Mercolaauthor=E.+A.+Volpeauthor=R.+I.+Glazerauthor=T.+M.+Willsonauthor=A.+P.+Kozikowski&title=Isoxazolyl-serine-based+agonists+of+peroxisome+proliferator-activated+receptor%3A+design%2C+synthesis%2C+and+effects+on+cardiomyocyte+differentiation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fja046386l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja046386l%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DZ.%2BL.%26aulast%3DPetukhov%26aufirst%3DP.%2BA.%26aulast%3DBizik%26aufirst%3DF.%26aulast%3DTeixeira%26aufirst%3DJ.%2BC.%26aulast%3DMercola%26aufirst%3DM.%26aulast%3DVolpe%26aufirst%3DE.%2BA.%26aulast%3DGlazer%26aufirst%3DR.%2BI.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DIsoxazolyl-serine-based%2520agonists%2520of%2520peroxisome%2520proliferator-activated%2520receptor%253A%2520design%252C%2520synthesis%252C%2520and%2520effects%2520on%2520cardiomyocyte%2520differentiation%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2004%26volume%3D126%26spage%3D16714%26epage%3D16715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Gotti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clementi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fornari, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaimarri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guiducci, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manfredi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moretti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedrazzi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pucci, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoli, M.</span><span> </span><span class="NLM_article-title">Structural and functional diversity of native brain neuronal nicotinic receptors</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">703</span><span class="NLM_x">–</span> <span class="NLM_lpage">711</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2009&pages=703-711&author=C.+Gottiauthor=F.+Clementiauthor=A.+Fornariauthor=A.+Gaimarriauthor=S.+Guiducciauthor=I.+Manfrediauthor=M.+Morettiauthor=P.+Pedrazziauthor=L.+Pucciauthor=M.+Zoli&title=Structural+and+functional+diversity+of+native+brain+neuronal+nicotinic+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGotti%26aufirst%3DC.%26aulast%3DClementi%26aufirst%3DF.%26aulast%3DFornari%26aufirst%3DA.%26aulast%3DGaimarri%26aufirst%3DA.%26aulast%3DGuiducci%26aufirst%3DS.%26aulast%3DManfredi%26aufirst%3DI.%26aulast%3DMoretti%26aufirst%3DM.%26aulast%3DPedrazzi%26aufirst%3DP.%26aulast%3DPucci%26aufirst%3DL.%26aulast%3DZoli%26aufirst%3DM.%26atitle%3DStructural%2520and%2520functional%2520diversity%2520of%2520native%2520brain%2520neuronal%2520nicotinic%2520receptors%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2009%26volume%3D78%26spage%3D703%26epage%3D711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Nicolazzo, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, W. N.</span><span> </span><span class="NLM_article-title">Methods to assess drug permeability across the blood-brain barrier</span> <span class="citation_source-journal">J. Pharm. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">281</span><span class="NLM_x">–</span> <span class="NLM_lpage">293</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm200855b&amp;key=10.1211%2Fjpp.58.3.0001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm200855b&amp;key=16536894" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm200855b&amp;key=1%3ACAS%3A528%3ADC%252BD28XpsFKgsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2006&pages=281-293&author=J.+A.+Nicolazzoauthor=S.+A.+Charmanauthor=W.+N.+Charman&title=Methods+to+assess+drug+permeability+across+the+blood-brain+barrier"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Methods to assess drug permeability across the blood-brain barrier</span></div><div class="casAuthors">Nicolazzo, Joseph A.; Charman, Susan A.; Charman, William N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">281-293</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Press</span>)
        </div><div class="casAbstract">A review.  Much research has focussed on the development of novel therapeutic agents to target various central nervous system disorders, however less attention has been given to detg. the potential of such agents to permeate the blood-brain barrier (BBB), a factor that will ultimately govern the effectiveness of these agents in man.  In order to assess the potential for novel compds. to permeate the BBB, various in-vitro, in-vivo and in-silico methods may be employed.  Although in-vitro models (such as primary cell culture and immortalized cell lines) are useful as a screening method and can appropriately rank compds. in order of BBB permeability, they often correlate poorly to in-vivo brain uptake due to down-regulation of some BBB-specific transporters.  In-vivo models (such as the internal carotid artery single injection or perfusion, i.v. bolus injection, brain efflux index and intracerebral microdialysis) provide more accurate information regarding brain uptake, and these can be complemented with novel imaging techniques (such as magnetic resonance imaging and positron emission tomog.), although such methods are not suited to high-throughput permeability assessment.  This paper reviews current methods used for assessing BBB permeability and highlights the particular advantages and disadvantages assocd. with each method, with a particular focus on methods suitable for moderate- to high-throughput screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvRYDVgPWxirVg90H21EOLACvtfcHk0lg0yXkcBw5hkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpsFKgsrs%253D&md5=32914c526d7600d0af89f03bad207cef</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1211%2Fjpp.58.3.0001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1211%252Fjpp.58.3.0001%26sid%3Dliteratum%253Aachs%26aulast%3DNicolazzo%26aufirst%3DJ.%2BA.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DCharman%26aufirst%3DW.%2BN.%26atitle%3DMethods%2520to%2520assess%2520drug%2520permeability%2520across%2520the%2520blood-brain%2520barrier%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D2006%26volume%3D58%26spage%3D281%26epage%3D293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Fan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unwalla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerns, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diller, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humblet, C.</span><span> </span><span class="NLM_article-title">Insights for predicting blood-brain barrier penetration of CNS targeted molecules using QSPR approaches</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1123</span><span class="NLM_x">–</span> <span class="NLM_lpage">1133</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci900384c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm200855b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtFektb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2010&pages=1123-1133&author=Y.+Fanauthor=R.+Unwallaauthor=R.+A.+Dennyauthor=L.+Diauthor=E.+H.+Kernsauthor=D.+J.+Dillerauthor=C.+Humblet&title=Insights+for+predicting+blood-brain+barrier+penetration+of+CNS+targeted+molecules+using+QSPR+approaches"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Insights for Predicting Blood-Brain Barrier Penetration of CNS Targeted Molecules Using QSPR Approaches</span></div><div class="casAuthors">Fan, Yi; Unwalla, Rayomand; Denny, Rajiah A.; Di, Li; Kerns, Edward H.; Diller, David J.; Humblet, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1123-1133</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Due to the high attrition rate of central nervous system drug candidates during clin. trials, the assessment of blood-brain barrier (BBB) penetration in early research is particularly important.  A genetic approxn. (GA)-based regression model was developed for predicting in vivo blood-brain partitioning data, expressed as log BB (log[brain]/[blood]).  The model was built using an inhouse data set of 193 compds. assembled from 22 different therapeutic projects.  The final model (cross-validated r2 = 0.72) with five mol. descriptors was selected based on validation using several large internal and external test sets.  We demonstrate the potential utility of the model by applying it to a set of literature reported secretase inhibitors.  In addn., we describe a rule-based approach for rapid assessment of brain penetration with several simple mol. descriptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoimKmKOsuC7Vg90H21EOLACvtfcHk0lg0yXkcBw5hkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtFektb4%253D&md5=e826f236637d324f641f7f6511f9b7f6</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fci900384c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci900384c%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DY.%26aulast%3DUnwalla%26aufirst%3DR.%26aulast%3DDenny%26aufirst%3DR.%2BA.%26aulast%3DDi%26aufirst%3DL.%26aulast%3DKerns%26aufirst%3DE.%2BH.%26aulast%3DDiller%26aufirst%3DD.%2BJ.%26aulast%3DHumblet%26aufirst%3DC.%26atitle%3DInsights%2520for%2520predicting%2520blood-brain%2520barrier%2520penetration%2520of%2520CNS%2520targeted%2520molecules%2520using%2520QSPR%2520approaches%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2010%26volume%3D50%26spage%3D1123%26epage%3D1133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Romanelli, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gratteri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guandalini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonaccini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gualtieri, F.</span><span> </span><span class="NLM_article-title">Central nicotinic receptors: structure, function, ligands, and therapeutic potential</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">746</span><span class="NLM_x">–</span> <span class="NLM_lpage">767</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=746-767&author=M.+N.+Romanelliauthor=P.+Gratteriauthor=L.+Guandaliniauthor=E.+Martiniauthor=C.+Bonacciniauthor=F.+Gualtieri&title=Central+nicotinic+receptors%3A+structure%2C+function%2C+ligands%2C+and+therapeutic+potential"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRomanelli%26aufirst%3DM.%2BN.%26aulast%3DGratteri%26aufirst%3DP.%26aulast%3DGuandalini%26aufirst%3DL.%26aulast%3DMartini%26aufirst%3DE.%26aulast%3DBonaccini%26aufirst%3DC.%26aulast%3DGualtieri%26aufirst%3DF.%26atitle%3DCentral%2520nicotinic%2520receptors%253A%2520structure%252C%2520function%252C%2520ligands%252C%2520and%2520therapeutic%2520potential%26jtitle%3DChemMedChem%26date%3D2007%26volume%3D2%26spage%3D746%26epage%3D767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Lukas, R. J.; Fryer, J. D.; Eaton, J. B.; Gentry, C. L.</span><span> </span><span class="NLM_article-title">Some methods for studies of nicotinic acetylcholine receptor pharmacology</span>. In  <span class="citation_source-book">Nicotinic Receptors and the Nervous System</span>; <span class="NLM_contrib-group">Levin, E. D.</span>, Ed.; <span class="NLM_publisher-name">CRC Press</span>: <span class="NLM_publisher-loc">Boca Raton, FL</span>,<span class="NLM_x"> </span><span class="NLM_year">2002</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&pages=3-27&author=R.+J.+Lukas&author=J.+D.+Fryer&author=J.+B.+Eaton&author=C.+L.+Gentryauthor=E.+D.+Levin&title=Nicotinic+Receptors+and+the+Nervous+System"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DLukas%26aufirst%3DR.%2BJ.%26atitle%3DSome%2520methods%2520for%2520studies%2520of%2520nicotinic%2520acetylcholine%2520receptor%2520pharmacology%26btitle%3DNicotinic%2520Receptors%2520and%2520the%2520Nervous%2520System%26aulast%3DLevin%26aufirst%3DE.%2BD.%26pub%3DCRC%2520Press%26date%3D2002%26spage%3D3%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Paterson, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Min, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hackett, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanania, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldarone, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghavami, A.</span><span> </span><span class="NLM_article-title">The high-affinity nAChR partial agonists varenicline and sazetidine-A exhibit reinforcing properties in rats</span> <span class="citation_source-journal">Prog. Neuropsychopharmacol. Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1455</span><span class="NLM_x">–</span> <span class="NLM_lpage">1464</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm200855b&amp;key=10.1016%2Fj.pnpbp.2010.07.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm200855b&amp;key=20708056" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm200855b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsV2jtrnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2010&pages=1455-1464&author=N.+E.+Patersonauthor=W.+Minauthor=A.+Hackettauthor=D.+Loweauthor=T.+Hananiaauthor=B.+Caldaroneauthor=A.+Ghavami&title=The+high-affinity+nAChR+partial+agonists+varenicline+and+sazetidine-A+exhibit+reinforcing+properties+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">The high-affinity nAChR partial agonists varenicline and sazetidine-A exhibit reinforcing properties in rats</span></div><div class="casAuthors">Paterson, Neil E.; Min, Wenzhong; Hackett, Adrian; Lowe, David; Hanania, Taleen; Caldarone, Barbara; Ghavami, Afshin</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neuro-Psychopharmacology & Biological Psychiatry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1455-1464</span>CODEN:
                <span class="NLM_cas:coden">PNPPD7</span>;
        ISSN:<span class="NLM_cas:issn">0278-5846</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Varenicline (Chantix, Champix) is a nicotinic acetylcholine receptor (nAChR) partial agonist clin. approved for smoking cessation, yet its potential abuse liability properties have not been fully characterized.  The nAChR ligand sazetidine-A has been reported as a selective full or partial agonist at α4β2* nAChR subtypes in in vitro studies.  In the present studies, varenicline, sazetidine-A and nicotine exhibited inverted U-shaped dose-response functions under fixed-ratio (peak responding at 30, 60 and 10-30 μg/kg/inf, resp.) or progressive-ratio (peak responding at 30-60, 30-100 and 30 μg/kg/inf, resp.) schedules in rats trained to self-administer nicotine.  Varenicline (ED50 0.2 mg/kg) and sazetidine-A (ED50 0.44 mg/kg) fully substituted for nicotine (ED50 0.09 mg/kg) in rats trained to discriminate nicotine (0.4 mg/kg, i.p.) from saline.  The reinforcing and discriminative stimulus (DS) properties of sazetidine-A, varenicline and nicotine were attenuated by acute pretreatment with the non-selective neuronal non-competitive nAChR antagonist mecamylamine or the α4* nAChR-selective antagonist dihydro-β-erythroidine, but not by the α7 nAChR subtype antagonist methyllycaconitine.  Drug-naive rats acquired stable self-administration of varenicline (30 μg/kg/inf), and sazetidine-A (60 μg/kg/inf), at doses that supported peak responding under a fixed-ratio 3 schedule in nicotine-trained rats.  Nonetheless, self-administration and re-acquisition of varenicline and sazetidine-A were less robust than nicotine.  Thus, partial activation of α4β2* nAChRs by varenicline or sazetidine-A is sufficient to mimic the DS and reinforcing properties of nicotine in nicotine-experienced rats, although the reinforcing properties of partial agonists are diminished in nicotine-naive rats.  Future studies should assess nicotine withdrawal measures in animals chronically exposed to varenicline or sazetidine-A.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGor9g7aPkUlPbVg90H21EOLACvtfcHk0lgvJhjOOwPNIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsV2jtrnI&md5=22e90c57dd320216c0a745bfd7e424bf</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.pnpbp.2010.07.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pnpbp.2010.07.037%26sid%3Dliteratum%253Aachs%26aulast%3DPaterson%26aufirst%3DN.%2BE.%26aulast%3DMin%26aufirst%3DW.%26aulast%3DHackett%26aufirst%3DA.%26aulast%3DLowe%26aufirst%3DD.%26aulast%3DHanania%26aufirst%3DT.%26aulast%3DCaldarone%26aufirst%3DB.%26aulast%3DGhavami%26aufirst%3DA.%26atitle%3DThe%2520high-affinity%2520nAChR%2520partial%2520agonists%2520varenicline%2520and%2520sazetidine-A%2520exhibit%2520reinforcing%2520properties%2520in%2520rats%26jtitle%3DProg.%2520Neuropsychopharmacol.%2520Biol.%2520Psychiatry%26date%3D2010%26volume%3D34%26spage%3D1455%26epage%3D1464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Turner, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castellano, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blendy, J. A.</span><span> </span><span class="NLM_article-title">Nicotinic partial agonists varenicline and sazetidine-A have differential effects on affective behavior</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">334</span><span class="NLM_x">, </span> <span class="NLM_fpage">665</span><span class="NLM_x">–</span> <span class="NLM_lpage">672</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm200855b&amp;key=10.1124%2Fjpet.110.166280" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm200855b&amp;key=20435920" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm200855b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1Kisb%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=334&publication_year=2010&pages=665-672&author=J.+R.+Turnerauthor=L.+M.+Castellanoauthor=J.+A.+Blendy&title=Nicotinic+partial+agonists+varenicline+and+sazetidine-A+have+differential+effects+on+affective+behavior"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinic partial agonists varenicline and sazetidine-A have differential effects on affective behavior</span></div><div class="casAuthors">Turner, Jill R.; Castellano, Laura M.; Blendy, Julie A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">334</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">665-672</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Clin. and preclin. studies suggest that nicotinic acetylcholine receptors are involved in affective disorders; therefore, the potential therapeutic value of nicotinic partial agonists as treatments of these disorders is of growing interest.  This study evaluated the effects of acute and chronic administration of nicotine and the α4β2 nicotinic partial agonists varenicline and sazetidine-A in mouse models of anxiety and depression.  Acutely, only nicotine and varenicline had anxiolytic effects in the marble-burying test and in the novelty-induced hypophagia (NIH) test.  In contrast, in animal models of antidepressant efficacy, such as the forced swim and the tail suspension test, only acute sazetidine-A had significant antidepressant-like effects.  The NIH test provides an anxiety-related measure that is sensitive to the effects of chronic but not acute antidepressant treatment.  Chronic nicotine and chronic sazetidine-A treatment were effective in this paradigm, but varenicline was ineffective.  These results suggest that the partial agonists varenicline and sazetidine-A may have diverse therapeutic benefits in affective disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogo1Sj2UHr5bVg90H21EOLACvtfcHk0lgvJhjOOwPNIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1Kisb%252FE&md5=79c7a0573c7aea5e0bb72ab5d5a4e05d</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1124%2Fjpet.110.166280&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.110.166280%26sid%3Dliteratum%253Aachs%26aulast%3DTurner%26aufirst%3DJ.%2BR.%26aulast%3DCastellano%26aufirst%3DL.%2BM.%26aulast%3DBlendy%26aufirst%3DJ.%2BA.%26atitle%3DNicotinic%2520partial%2520agonists%2520varenicline%2520and%2520sazetidine-A%2520have%2520differential%2520effects%2520on%2520affective%2520behavior%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2010%26volume%3D334%26spage%3D665%26epage%3D672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eaton, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajjuri, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chellappan, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karadi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldarone, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manzano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuen, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, R. J.</span><span> </span><span class="NLM_article-title">Chemistry and pharmacology of nicotinic ligands based on 6-[5-(azetidin-2-ylmethoxy)pyridin-3-yl]hex-5-yn-1-ol (AMOP-H-OH) for possible use in depression</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1279</span><span class="NLM_x">–</span> <span class="NLM_lpage">1291</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=1279-1291&author=A.+P.+Kozikowskiauthor=J.+B.+Eatonauthor=K.+M.+Bajjuriauthor=S.+K.+Chellappanauthor=Y.+Chenauthor=S.+Karadiauthor=R.+Heauthor=B.+Caldaroneauthor=M.+Manzanoauthor=P.+W.+Yuenauthor=R.+J.+Lukas&title=Chemistry+and+pharmacology+of+nicotinic+ligands+based+on+6-%5B5-%28azetidin-2-ylmethoxy%29pyridin-3-yl%5Dhex-5-yn-1-ol+%28AMOP-H-OH%29+for+possible+use+in+depression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26aulast%3DEaton%26aufirst%3DJ.%2BB.%26aulast%3DBajjuri%26aufirst%3DK.%2BM.%26aulast%3DChellappan%26aufirst%3DS.%2BK.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DKaradi%26aufirst%3DS.%26aulast%3DHe%26aufirst%3DR.%26aulast%3DCaldarone%26aufirst%3DB.%26aulast%3DManzano%26aufirst%3DM.%26aulast%3DYuen%26aufirst%3DP.%2BW.%26aulast%3DLukas%26aufirst%3DR.%2BJ.%26atitle%3DChemistry%2520and%2520pharmacology%2520of%2520nicotinic%2520ligands%2520based%2520on%25206-%255B5-%2528azetidin-2-ylmethoxy%2529pyridin-3-yl%255Dhex-5-yn-1-ol%2520%2528AMOP-H-OH%2529%2520for%2520possible%2520use%2520in%2520depression%26jtitle%3DChemMedChem%26date%3D2009%26volume%3D4%26spage%3D1279%26epage%3D1291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Porsolt, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jalfre, M.</span><span> </span><span class="NLM_article-title">Behavioral despair in mice: a primary screening test for antidepressants</span> <span class="citation_source-journal">Arch. Int. Pharmacodyn. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">229</span><span class="NLM_x">, </span> <span class="NLM_fpage">327</span><span class="NLM_x">–</span> <span class="NLM_lpage">336</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm200855b&amp;key=596982" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm200855b&amp;key=1%3ACAS%3A528%3ADyaE1cXktlKgsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=229&publication_year=1977&pages=327-336&author=R.+D.+Porsoltauthor=A.+Bertinauthor=M.+Jalfre&title=Behavioral+despair+in+mice%3A+a+primary+screening+test+for+antidepressants"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Behavioral despair in mice:  a primary screening test for antidepressants</span></div><div class="casAuthors">Porsolt, R. D.; Bertin, A.; Jalfre, M.</div><div class="citationInfo"><span class="NLM_cas:title">Archives Internationales de Pharmacodynamie et de Therapie</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">229</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">327-36</span>CODEN:
                <span class="NLM_cas:coden">AIPTAK</span>;
        ISSN:<span class="NLM_cas:issn">0003-9780</span>.
    </div><div class="casAbstract">A depressed state can be induced in mice by forcing them to swim in a narrow cylinder from which they cannot escape.  After a brief period of vigorous activity the mice adopt a characteristic immobile posture which is readily identifiable.  Immobility was reduced by tricyclic antidepressants, monoamine oxidase inhibitors and atypical antidepressants, as well as by electroconvulsive shock.  Psychostimulants also reduced immobility but in contrast to antidepressants caused marked motor stimulation.  Immobility was not affected by minor or major tranquilizers.  These findings, closely parallel to those previously reported in rats, suggest that the procedure is selectively senstitive to antidepressant treatments.  The mouse procedure is, however, more rapid and less costly than that with rats and is thus more suitable for the primary screening of antidepressant drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3THea0LRwE7Vg90H21EOLACvtfcHk0lifVhMoxeHmng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXktlKgsbs%253D&md5=70dd5706992ee8151a9801a2aeb42961</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPorsolt%26aufirst%3DR.%2BD.%26aulast%3DBertin%26aufirst%3DA.%26aulast%3DJalfre%26aufirst%3DM.%26atitle%3DBehavioral%2520despair%2520in%2520mice%253A%2520a%2520primary%2520screening%2520test%2520for%2520antidepressants%26jtitle%3DArch.%2520Int.%2520Pharmacodyn.%2520Ther.%26date%3D1977%26volume%3D229%26spage%3D327%26epage%3D336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="note"><p class="first last">Preliminary ADMET studies were carried out by Cerep, Inc.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Jamieson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moir, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wishart, G.</span><span> </span><span class="NLM_article-title">Medicinal chemistry of hERG optimizations: Highlights and hang-ups</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">5029</span><span class="NLM_x">–</span> <span class="NLM_lpage">5046</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060379l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm200855b&amp;key=1%3ACAS%3A528%3ADC%252BD28Xns1WqsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=5029-5046&author=C.+Jamiesonauthor=E.+M.+Moirauthor=Z.+Rankovicauthor=G.+Wishart&title=Medicinal+chemistry+of+hERG+optimizations%3A+Highlights+and+hang-ups"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemistry of hERG optimizations: Highlights and hang-ups</span></div><div class="casAuthors">Jamieson, Craig; Moir, Elizabeth M.; Rankovic, Zoran; Wishart, Grant</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5029-5046</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  A brief summary of the in silico, in vitro, and in vivo approaches employed to measure blockade of hERG and QT prolongation is detailed.  The discussion aims to summarize the approaches engaged to circumvent activity at hERG, identified through an extensive literature survey.  The optimizations are recorded as pairs of compds., which have been categorized in terms of the tactics employed to diminish hERG activity. Examn. of the properties of the compds. within each category has enabled formulation os some empirical guidelines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqv6eM5w53KebVg90H21EOLACvtfcHk0lifVhMoxeHmng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xns1WqsL8%253D&md5=117c84a010f877c835b7dbc945996b92</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm060379l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060379l%26sid%3Dliteratum%253Aachs%26aulast%3DJamieson%26aufirst%3DC.%26aulast%3DMoir%26aufirst%3DE.%2BM.%26aulast%3DRankovic%26aufirst%3DZ.%26aulast%3DWishart%26aufirst%3DG.%26atitle%3DMedicinal%2520chemistry%2520of%2520hERG%2520optimizations%253A%2520Highlights%2520and%2520hang-ups%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D5029%26epage%3D5046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Lin, N.-H.; He, Y.; Li, Y.; Holladay, M. W.; Ryther, K.</span><span> </span><span class="NLM_article-title">3-Pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission</span>. U.S. Patent 5629325, May 13,<span class="NLM_x"> </span><span class="NLM_year">1997</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&author=N.-H.+Lin&author=Y.+He&author=Y.+Li&author=M.+W.+Holladay&author=K.+Ryther&title=3-Pyridyloxymethyl+heterocyclic+ether+compounds+useful+in+controlling+chemical+synaptic+transmission"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DN.-H.%26atitle%3D3-Pyridyloxymethyl%2520heterocyclic%2520ether%2520compounds%2520useful%2520in%2520controlling%2520chemical%2520synaptic%2520transmission%26date%3D1997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Lukas, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norman, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucero, L.</span><span> </span><span class="NLM_article-title">Characterization of nicotinic acetylcholine receptors expressed by cells of the SH-SY5Y human neuroblastoma clonal line</span> <span class="citation_source-journal">Mol. Cell Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm200855b&amp;key=10.1006%2Fmcne.1993.1001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm200855b&amp;key=19912902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm200855b&amp;key=1%3ACAS%3A528%3ADyaK3sXit1Khs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1993&pages=1-12&author=R.+J.+Lukasauthor=S.+A.+Normanauthor=L.+Lucero&title=Characterization+of+nicotinic+acetylcholine+receptors+expressed+by+cells+of+the+SH-SY5Y+human+neuroblastoma+clonal+line"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of nicotinic acetylcholine receptors expressed by cells of the SH-SY5Y human neuroblastoma clonal line</span></div><div class="casAuthors">Lukas, Ronald J.; Norman, Sylvia A.; Lucero, Linda</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Neuroscience</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-12</span>CODEN:
                <span class="NLM_cas:coden">MOCNED</span>;
        ISSN:<span class="NLM_cas:issn">1044-7431</span>.
    </div><div class="casAbstract">Radioligand binding studies show that cells of the SH-SY5Y human neuroblastoma clonal line express a single class of neuronal/nicotinic α-bungarotoxin binding sites (nBgtS).  These sites are defined by their ability to bind radioiodinated α-bungarotoxin (Bgt) with high affinity (KD = 4 nM) and nicotinic ligands with lower (μM) affinities.  Radioligand binding studies also show that SH-SY5Y cells express high affinity specific binding sites for 3H-labeled acetylcholine that could reflect interactions with two classes of sites (KD' = 1 nM, KD' = 100 nM).  These sites are distinguished from nBgtS by their insensitivity to blockade by Bgt and by their ability to bind other nicotinic agonists with high (nM) affinity.  86Rb+ efflux studies indicate that SH-SY5Y cells express functional nicotinic acetylcholine receptor (nAChR) ion channels that, like radioagonist binding sites, are insensitive to blockade by Bgt.  However, there are far more functional nAChR than high affinity radioagonist binding sites.  Functional nAChR have a pharmacol. profile expected of ganglia-type receptors composed of nAChR alpha3 and beta4 subunits.  Northern blot anal. indicates that genes corresponding to human alpha3, alpha5, beta2, and beta4 subunits are expressed by SH-SY5Y cells.  The authors conclude that SH-SY5Y cells express at least two members of the nAChR family (nBgtS and ganglia-type nAChR) and that high affinity radioagonist binding sites are a subset of functional ganglia-type nAChR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonLYzJClIqI7Vg90H21EOLACvtfcHk0lifVhMoxeHmng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXit1Khs7g%253D&md5=f71050efab7399610c03f3d9e262660a</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1006%2Fmcne.1993.1001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fmcne.1993.1001%26sid%3Dliteratum%253Aachs%26aulast%3DLukas%26aufirst%3DR.%2BJ.%26aulast%3DNorman%26aufirst%3DS.%2BA.%26aulast%3DLucero%26aufirst%3DL.%26atitle%3DCharacterization%2520of%2520nicotinic%2520acetylcholine%2520receptors%2520expressed%2520by%2520cells%2520of%2520the%2520SH-SY5Y%2520human%2520neuroblastoma%2520clonal%2520line%26jtitle%3DMol.%2520Cell%2520Neurosci.%26date%3D1993%26volume%3D4%26spage%3D1%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Eaton, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeder, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fryer, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buhlman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, Y. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinlein, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, R. J.</span><span> </span><span class="NLM_article-title">Characterization of human alpha 4 beta 2-nicotinic acetylcholine receptors stably and heterologously expressed in native nicotinic receptor-null SH-EP1 human epithelial cells</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">1283</span><span class="NLM_x">–</span> <span class="NLM_lpage">1294</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2003&pages=1283-1294&author=J.+B.+Eatonauthor=J.+H.+Pengauthor=K.+M.+Schroederauthor=A.+A.+Georgeauthor=J.+D.+Fryerauthor=C.+Krishnanauthor=L.+Buhlmanauthor=Y.+P.+Kuoauthor=O.+Steinleinauthor=R.+J.+Lukas&title=Characterization+of+human+alpha+4+beta+2-nicotinic+acetylcholine+receptors+stably+and+heterologously+expressed+in+native+nicotinic+receptor-null+SH-EP1+human+epithelial+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEaton%26aufirst%3DJ.%2BB.%26aulast%3DPeng%26aufirst%3DJ.%2BH.%26aulast%3DSchroeder%26aufirst%3DK.%2BM.%26aulast%3DGeorge%26aufirst%3DA.%2BA.%26aulast%3DFryer%26aufirst%3DJ.%2BD.%26aulast%3DKrishnan%26aufirst%3DC.%26aulast%3DBuhlman%26aufirst%3DL.%26aulast%3DKuo%26aufirst%3DY.%2BP.%26aulast%3DSteinlein%26aufirst%3DO.%26aulast%3DLukas%26aufirst%3DR.%2BJ.%26atitle%3DCharacterization%2520of%2520human%2520alpha%25204%2520beta%25202-nicotinic%2520acetylcholine%2520receptors%2520stably%2520and%2520heterologously%2520expressed%2520in%2520native%2520nicotinic%2520receptor-null%2520SH-EP1%2520human%2520epithelial%2520cells%26jtitle%3DMol.%2520Pharmacol.%26date%3D2003%26volume%3D64%26spage%3D1283%26epage%3D1294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Caldarone, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paterson, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manzano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedolak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavino, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanania, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chellappan, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picciotto, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghavami, A.</span><span> </span><span class="NLM_article-title">Dissociation between duration of action in the forced swim test in mice and nicotinic acetylcholine receptor occupancy with sazetidine, varenicline, and 5-I-A85380</span> <span class="citation_source-journal">Psychopharmacology (Berlin)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">217</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">–</span> <span class="NLM_lpage">210</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm200855b&amp;key=10.1007%2Fs00213-011-2271-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm200855b&amp;key=21487659" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm200855b&amp;key=1%3ACAS%3A528%3ADC%252BC3MXksFymt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=217&publication_year=2011&pages=199-210&author=B.+J.+Caldaroneauthor=D.+Wangauthor=N.+E.+Patersonauthor=M.+Manzanoauthor=A.+Fedolakauthor=K.+Cavinoauthor=M.+Kwanauthor=T.+Hananiaauthor=S.+K.+Chellappanauthor=A.+P.+Kozikowskiauthor=B.+Olivierauthor=M.+R.+Picciottoauthor=A.+Ghavami&title=Dissociation+between+duration+of+action+in+the+forced+swim+test+in+mice+and+nicotinic+acetylcholine+receptor+occupancy+with+sazetidine%2C+varenicline%2C+and+5-I-A85380"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Dissociation between duration of action in the forced swim test in mice and nicotinic acetylcholine receptor occupancy with sazetidine, varenicline, and 5-I-A85380</span></div><div class="casAuthors">Caldarone, Barbara J.; Wang, Daguang; Paterson, Neil E.; Manzano, Michael; Fedolak, Allison; Cavino, Katie; Kwan, Mei; Hanania, Taleen; Chellappan, Sheela K.; Kozikowski, Alan P.; Olivier, Berend; Picciotto, Marina R.; Ghavami, Afshin</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Heidelberg, Germany)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">217</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">199-210</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Rationale: Nicotinic acetylcholine receptor (nAChR) agonists, partial agonists, and antagonists have antidepressant-like effects in rodents and reduce symptoms of depression in humans.  Objectives: The study detd. whether the antidepressant-like effect of the nAChR β2* partial agonist sazetidine-A (sazetidine) in the forced swim test was due to activation or desensitization of β2* nAChRs.  The study also detd. if sazetidine's behavioral responses in the forced swim test corresponded to β2* nAChRs receptor occupancy and drug bioavailability.  Results: Acute antidepressant-like effects in the forced swim test were seen with sazetidine and the full β2* agonist 5-I-A8350 (BALB/cJ mice) and the less selective β2* partial agonist varenicline in C57BL/6J but not BALB/cJ mice.  The role of β2* nAChRs was confirmed by results showing: (1) reversal of sazetidine's antidepressant-like effects in the forced swim test by nAChR antagonists mecamylamine and dihydro-β-erythroidine; (2) absence of sazetidine's effect in mice lacking the β2 subunit of the nAChR; and (3) a high correspondence between behaviorally active doses of sazetidine and β2* receptor occupancy. β2* receptor occupancy following acute sazetidine, varenicline, and 5-I-A8350 lasted beyond the duration of action in the forced swim test.  Sazetidine's long lasting receptor occupancy did not diminish behavioral efficacy in the forced swim test following repeated dosing.  Conclusions: Results demonstrate that activation of a small population of β2* nAChRs (10-40%) is sufficient to elicit sazetidine's antidepressant-like actions without producing tolerance and suggest that ligands that activate β2* nAChRs would be promising targets for the development of a new class of antidepressant.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriIAbTX2Qb67Vg90H21EOLACvtfcHk0lhxU7dXVLA3LA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXksFymt7g%253D&md5=794495af9e8426b2ab966c35efa35c54</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1007%2Fs00213-011-2271-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-011-2271-y%26sid%3Dliteratum%253Aachs%26aulast%3DCaldarone%26aufirst%3DB.%2BJ.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DPaterson%26aufirst%3DN.%2BE.%26aulast%3DManzano%26aufirst%3DM.%26aulast%3DFedolak%26aufirst%3DA.%26aulast%3DCavino%26aufirst%3DK.%26aulast%3DKwan%26aufirst%3DM.%26aulast%3DHanania%26aufirst%3DT.%26aulast%3DChellappan%26aufirst%3DS.%2BK.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26aulast%3DOlivier%26aufirst%3DB.%26aulast%3DPicciotto%26aufirst%3DM.%2BR.%26aulast%3DGhavami%26aufirst%3DA.%26atitle%3DDissociation%2520between%2520duration%2520of%2520action%2520in%2520the%2520forced%2520swim%2520test%2520in%2520mice%2520and%2520nicotinic%2520acetylcholine%2520receptor%2520occupancy%2520with%2520sazetidine%252C%2520varenicline%252C%2520and%25205-I-A85380%26jtitle%3DPsychopharmacology%2520%2528Berlin%2529%26date%3D2011%26volume%3D217%26spage%3D199%26epage%3D210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm200855b&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2011.54.issue-20%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Fjm200855b" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm200855b" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799396fda3b3285","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
